 EXHIBIT 2.1    



  

Exhibit 2.1

  



  

AGREEMENT AND PLAN OF MERGER

  



  

by and among

  



  

Covis Group S.a r.l.,

  



  

Covis Mergerco Inc.,

  



  

AMAG Pharmaceuticals, Inc.

  



  

and, solely with respect to certain sections,

  



  

Covis Finco S.a r.l.

  



  

Dated as of October 1, 2020

  



  

   

 | | 
---|---|--- 

 



    



  

     Article 1 DEFINITIONS  | 2 
---|--- 
     | 
   Section 1.1. Definitions  | 2 
     | 
   Article 2 THE OFFER  | 16 
     | 
   Section 2.1. Tender Offer  | 16 
   Section 2.2. Actions of Parent and Merger Sub  | 18 
   Section 2.3. Actions of the Company  | 19 
     | 
   Article 3 THE MERGER; EFFECTIVE TIME  | 22 
     | 
   Section 3.1. The Merger  | 22 
   Section 3.2. Effect of the Merger  | 22 
   Section 3.3. Closing; Effective Time  | 22 
   Section 3.4. Certificate of Incorporation and Bylaws; Directors  | 23 
   Section 3.5. Conversion of Company Common Stock  | 23 
   Section 3.6. Payment for Company Common Stock  | 24 
   Section 3.7. Company Compensatory Awards  | 26 
   Section 3.8. Appraisal Rights  | 27 
   Section 3.9. Merger Without Meeting of Stockholders  | 28 
   Section 3.10. Further Action  | 28 
     | 
   Article 4 REPRESENTATIONS AND WARRANTIES OF THE COMPANY  | 28 
     | 
   Section 4.1. Due Organization and Good Standing; Subsidiaries  | 28 
   Section 4.2. Organizational Documents  | 29 
   Section 4.3. Capitalization  | 29 
   Section 4.4. SEC Filings; Financial Statements  | 31 
   Section 4.5. Absence of Certain Changes  | 32 
   Section 4.6. Intellectual Property Rights  | 32 
   Section 4.7. Title to Assets; Real Property  | 33 
   Section 4.8. Contracts  | 34 
   Section 4.9. Compliance  | 35 
   Section 4.10. Certain Business Practices  | 35 
   Section 4.11. Legal Proceedings; Orders  | 36 
   Section 4.12. Tax Matters  | 36 
   Section 4.13. Employee Benefit Plans  | 38 
   Section 4.14. Labor Matters  | 40 
   Section 4.15. Company Products.  | 41 
   Section 4.16. Environmental Matters  | 42 
   Section 4.17. Insurance  | 42 
   Section 4.18. Privacy and Data Security  | 42 
   Section 4.19. Authority; Binding Nature of Agreement  | 42 
   Section 4.20. No Vote Required  | 43 
   Section 4.21. Non-Contravention; Consents  | 43 
   Section 4.22. Section 203 of the DGCL  | 43 
   Section 4.23. Opinion of Financial Advisor  | 43 
   Section 4.24. Brokers  | 44 
   Section 4.25. Schedule 14D-9  | 44 
  



  

   

 | i| 
---|---|--- 

 



    



  

     Article 5 REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB  |
44 
---|--- 
     | 
   Section 5.1. Due Organization and Good Standing  | 44 
   Section 5.2. Legal Proceedings; Orders  | 44 
   Section 5.3. Authority; Binding Nature of Agreement  | 45 
   Section 5.4. Non-Contravention; Consents  | 46 
   Section 5.5. Not an Interested Stockholder  | 46 
   Section 5.6. Financing  | 47 
   Section 5.7. Offer Documents  | 48 
   Section 5.8. Information in Schedule 14D-9  | 48 
   Section 5.9. Brokers  | 48 
   Section 5.10. Merger Sub  | 48 
   Section 5.11. Stockholder, Labor and Employee Matters  | 48 
   Section 5.12. Competing Businesses  | 49 
   Section 5.13. Limited Guarantee; Solvency  | 49 
     | 
   Article 6 COVENANTS  | 49 
     | 
   Section 6.1. Interim Operations of the Company  | 49 
   Section 6.2. No Solicitation  | 52 
   Section 6.3. Filings; Other Action  | 54 
   Section 6.4. Access  | 56 
   Section 6.5. Interim Operations of Merger Sub  | 56 
   Section 6.6. Publicity  | 56 
   Section 6.7. Other Employee Benefits  | 57 
   Section 6.8. Compensation Arrangements  | 59 
   Section 6.9. Indemnification; Directors' and Officers' Insurance  | 59 
   Section 6.10. Section 16 Matters  | 61 
   Section 6.11. Transaction Litigation  | 61 
   Section 6.12. Convertible Notes  | 61 
   Section 6.13. Delisting of Company Common Stock  | 63 
   Section 6.14. Financing  | 64 
   Section 6.15. Financing Assistance  | 65 
     | 
   Article 7 CONDITIONS TO EACH PARTY'S OBLIGATION TO EFFECT THE MERGER  |
67 
     | 
   Section 7.1. Consummation of the Offer  | 67 
   Section 7.2. No Restraints  | 67 
     | 
   Article 8 TERMINATION  | 68 
     | 
   Section 8.1. Termination  | 68 
   Section 8.2. Effect of Termination  | 70 
   Section 8.3. Expenses; Termination Fees  | 70 
   



  

   

 | ii| 
---|---|--- 

 



    



     Article 9 MISCELLANEOUS PROVISIONS  | 72 
---|--- 
     | 
   Section 9.1. Amendment  | 72 
   Section 9.2. Waiver  | 72 
   Section 9.3. No Survival of Representations and Warranties  | 72 
    Section 9.4. Entire Agreement  | 73 
   Section 9.5. Applicable Law; Jurisdiction  | 73 
   Section 9.6. Assignability; Parties in Interest  | 75 
   Section 9.7. Notices  | 75 
   Section 9.8. Severability  | 76 
   Section 9.9. Counterparts  | 76 
   Section 9.10. Obligation of Parent  | 76 
   Section 9.11. Disclosure  | 77 
   Section 9.12. Specific Performance  | 78 
   Section 9.13. Waiver of Jury Trial  | 78 
   Section 9.14. Debt Financing Sources  | 78 
   Section 9.15. Non-Recourse  | 79 
   Section 9.16. Construction  | 80 
  



  

Annex I Offer Conditions

  

Exhibit A Form of Certificate of Incorporation of Surviving Company

  

Exhibit B Form of Bylaws of Surviving Company

  



  

   

 | iii| 
---|---|--- 

 



    

     



  

AGREEMENT AND PLAN OF MERGER

  



  

This Agreement and Plan of Merger (this "Agreement") is made and entered into
on October 1, 2020, by and among: Covis Group S.a r.l., a Luxembourg company
("Parent"); Covis Mergerco Inc., a Delaware corporation and an indirect
wholly owned subsidiary of Parent ("Merger Sub"); AMAG Pharmaceuticals,
Inc., a Delaware corporation (the "Company") and, solely with respect to
Sections _5.1_ , _5.2_ , _5.3_ ,  _5.4_ , _5.6_ , _6.14_ and _6.15_ , Covis
Finco S.a r.l., a Luxembourg company and the direct parent of Parent ("Debt
Financing Borrower") .

  



  

RECITALS

  



  

A. The Company's outstanding capital stock consists of shares of common
stock, par value $0.01 per share ("Company Common Stock").

  



  

B. Upon the terms and subject to the conditions of this Agreement,
Merger Sub has agreed to commence a cash tender offer (as it may be extended
and amended from time to time as permitted under this Agreement, the "Offer")
to acquire all of the issued and outstanding shares of Company Common Stock
for $13.75 per share of Company Common Stock, net to the seller in
cash, without interest (such amount, or any different amount per share paid
pursuant to the Offer to the extent permitted under this Agreement, being the
"Offer Price").

  



  

C. As soon as practicable following the consummation of the Offer, upon
the terms and conditions set forth herein and in accordance with the General
Corporation Law of the State of Delaware (the "DGCL"), Merger Sub will be
merged with and into the Company (the "Merger") with the Company as the
surviving corporation (the "Surviving Corporation"), whereby each share
(except as otherwise provided herein) of Company Common Stock not owned
directly or indirectly by Parent, Merger Sub or the Company will be converted
into the right to receive the Offer Price, net to the seller in cash, without
interest, upon the terms and subject to the conditions of this Agreement.

  



  

D. The parties acknowledge and agree that the Merger will be effected
under Section 251(h) of the DGCL and will be effected as soon as practicable
following the consummation of the Offer and subject to the terms of this
Agreement.

  



  

E. The Board of Directors of the Company (the "Company Board") has (i)
approved, adopted and declared advisable this Agreement and the transactions
contemplated hereby, including the Offer and the Merger, (ii) determined that
the transactions contemplated by this Agreement, including the Offer and the
Merger, are in the best interests of the Company and its stockholders, (iii)
agreed that this Agreement will be effected under Section 251(h) of the DGCL,
and (iv) resolved to recommend that the stockholders of the Company accept
the Offer and tender their shares of Company Common Stock to Merger Sub
pursuant to the Offer.

  



  

F. The Board of Directors of Parent has, on the terms and subject to
the conditions set forth herein, approved, adopted and declared
advisable this Agreement and the transactions contemplated hereby, including
the Offer and the Merger.

  



  

G. The Board of Directors of Merger Sub has declared that, on the terms
and subject to the conditions set forth herein, this Agreement and the
transactions contemplated hereby, including the Offer and the Merger, are
advisable and in the best interests of Merger Sub and its sole stockholder,
and has approved and adopted this Agreement and the transactions contemplated
hereby, including the Offer and the Merger.

  



  

   



 



    



  

H. Concurrently with the execution of this Agreement, and as a
condition and inducement to the Company's willingness to enter into this
Agreement, Apollo Overseas Partners (892 AIV) IX, L.P., Apollo Overseas
Partners (Delaware) IX, L.P., Apollo Overseas Partners (Lux) IX, L.P., Apollo
Overseas Partners IX, L.P., and AP IX (Euro AIV), L.P. (collectively, the
"Guarantors") are entering into the Limited Guarantee with respect to certain
obligations of Parent and Merger Sub under this Agreement.

  



  

AGREEMENT

  



  

The parties to this Agreement, intending to be legally bound, agree as
follows:

  



  

Article 1 
 DEFINITIONS

  



  

Section 1.1.   _Definitions_.

  



  

(a)  As used herein, the following terms have the following
meanings:

  



  

"Acceptable Confidentiality Agreement" means a confidentiality agreement
containing terms not materially less restrictive in the aggregate to the
counterparty thereto than the terms of the Confidentiality Agreement (it being
agreed that such confidentiality agreement need not prohibit the making of an
Acquisition Proposal or otherwise contain any standstill or similar
provision). Notwithstanding the foregoing, a Person who has previously
entered into a confidentiality agreement with the Company, on or after January
1, 2020, shall not be required to enter into a new or revised confidentiality
agreement, and such existing confidentiality agreement shall be deemed to be
an Acceptable Confidentiality Agreement.

  



  

"Acceptance Time" means the first time at which Merger Sub irrevocably
accepts for payment any Company Common Stock tendered pursuant to the Offer
in accordance with Section 2.1(b).

  



  

"Acquired Companies" means the Company and each of its Subsidiaries,
collectively.

  



  

"Acquisition Inquiry" means an inquiry, indication of interest or request for
information (other than an inquiry, indication of interest or request for
information made or submitted by or on behalf of Parent or any of its
Affiliates) that could reasonably be expected to lead to an Acquisition
Proposal.

  



  

   

 | 2| 
---|---|--- 

 



    



  

"Acquisition Proposal" means any proposal or offer relating to (i) the
acquisition of twenty percent (20%) or more of the Company Common Stock by
any Third Party, (ii) any merger, consolidation, business combination,
reorganization, sale of assets, recapitalization, liquidation, dissolution or
other similar transaction that would result in any Third Party acquiring
assets (including intellectual property rights or the capital stock of or
interest in any Subsidiary of the Company) representing, directly or
indirectly, twenty percent (20%) or more of the assets of the Acquired
Companies, taken as a whole, (iii) any tender offer or exchange offer, as
such terms are defined under the Exchange Act, that, if consummated, would
result in any Third Party beneficially owning twenty percent (20%) or more of
the outstanding shares of Company Common Stock (or instruments convertible
into or exchangeable for twenty percent (20%) or more of such outstanding
shares), (iv) any merger, consolidation, business combination,
reorganization, recapitalization, liquidation, dissolution or other
similar transaction involving the Company that would result in any Third
Party (or stockholders of such Third Party) holding twenty percent (20%) or
more of the equity interests in the surviving or resulting entity of such
transaction or (v) any combination of the foregoing.

  



  

"Affiliate" of any Person means another Person that directly or indirectly,
through one or more intermediaries, controls, is controlled by, or is under
common control with, such first Person. For purposes of the immediately
preceding sentence, the term "control" (including, with correlative meanings,
the terms "controlling," "controlled by" and "under common control with") as
used with respect to any Person, means the possession, directly or indirectly,
of the power to direct or cause the direction of the management and policies
of such Person, whether through ownership of voting securities, by
contract or otherwise.

  



  

"Agreement" means this Agreement and Plan of Merger, together with _Annex I_
, as such Agreement and Plan of Merger (including _Annex I_ ) may be amended
from time to time.

  



  

"Antitrust Law" means any antitrust, unfair competition, merger or
acquisition notification, or merger or acquisition control Law under any
applicable jurisdictions, whether federal, state, local or foreign.

  



  

"Business Day" means any day other than a Saturday, Sunday or a day on which
banking institutions in New York, New York are authorized or obligated by Law
or executive order to be closed.

  



  

"Code" means the Internal Revenue Code of 1986, as amended.

  



  

"Commitment Letters" means the Equity Commitment Letter and Debt Commitment
Letter.

  



  

"Company Associate" means any current employee (including officers) and any
other individual who is a director, in each case, of any of the
Acquired Companies.

  



  

"Company Benefit Plan" means each "employee benefit plan," as defined in
Section 3(3) of ERISA, and each other stock bonus, stock purchase, stock
option, stock-based, restricted stock, stock appreciation right or other
equity or equity-based, deferred-compensation, employment, savings,
retirement, health and welfare-benefit, bonus, incentive, commission, change
in control, retention, severance, separation, termination, paid time off, or
fringe benefit or other benefit or compensation plan, policy, program,
Contract or arrangement, whether or not subject to ERISA (including
any related funding mechanism), in each case other than a "multiemployer
plan" (as defined in Section 3(37) of ERISA), under which (i) any current or
former employee, officer, director, contractor or consultant of the Company or
any of its Subsidiaries has any present or future right to benefits and which
are entered into, contributed to, sponsored by or maintained by the Company
or any of its Subsidiaries or (ii) the Company or any of its Subsidiaries has
any present or future liability.

  



  

   

 | 3| 
---|---|--- 

 



    



  

"Company Bylaws" means the Amended and Restated Bylaws of the Company, as in
effect as of the date hereof.

  



  

"Company Certificate of Incorporation" means the Company's Restated
Certificate of Incorporation, as amended and in effect as of the date hereof.

  



  

"Company Compensatory Award" means each Company Option, Company RSU and
Company PRSU.

  



  

"Company Disclosure Schedule" means the Company Disclosure Schedule dated as
of the date hereof and delivered by the Company to Parent prior to or
simultaneously with the execution of this Agreement.

  



  

"Company Equity Incentive Plans" means the AMAG Pharmaceuticals, Inc. 2019
Equity Incentive Plan, the AMAG Pharmaceuticals, Inc. Fourth Amended and
Restated 2007 Equity Incentive Plan, the Lumara Health Inc. Amended and
Restated 2013 Incentive Compensation Plan, and any other stock option, stock
incentive, stock award, or equity compensation plans sponsored or maintained
by any of the Acquired Companies (in each case, including all amendments
thereto), other than the Company ESPP.

  



  

"Company ESPP" means the AMAG Pharmaceuticals, Inc. 2015 Employee Stock
Purchase Plan, including all amendments thereto.

  



  

"Company In-the-Money Options" means outstanding options (whether vested or
unvested) to purchase Company Common Stock from the Company, whether granted
pursuant to the Company Equity Incentive Plans or otherwise, with respect to
which the applicable exercise price per share of Company Common Stock is less
than the Merger Consideration.

  



  

"Company Inbound License" means any Contract to which any of the Acquired
Companies is a party pursuant to which any Intellectual Property of another
Person (other than an Affiliate of the Company) that is material to the
business of the Acquired Companies taken as a whole, is licensed to any
Acquired Company, in each case, other than (i) agreements between any Acquired
Company and its employees or consultants, (ii) agreements for any third-party
commercially available services or non-customized commercially available
software, (iii) non-disclosure agreements entered into in the ordinary course
of business, and (iv) agreements with contract manufacturing or research
organizations, or other agreements for materials used in connection with the
manufacture of Company Products, entered into in the ordinary course of
business.

  



  

"Company Intellectual Property" means all Intellectual Property owned solely
or jointly by the Acquired Companies and used by the Acquired Companies in
the operation of the business of the Acquired Companies as presently
conducted.

  



  

   

 | 4| 
---|---|--- 

 



    



  

"Company Material Adverse Effect" means, with respect to the Company, any
Effect that (1) would reasonably be expected to have, a material adverse
effect on the business, financial condition or results of operations of the
Acquired Companies taken as a whole, or (2) would reasonably be expected to
prevent or materially delay the Company from consummating the Offer and the
Merger; _provided_ that in no event shall any of the following (alone or in
combination), or any Effect to the extent arising out of or resulting from
any of the following (alone or in combination), be taken into account in
determining whether a Company Material Adverse Effect has occurred or may,
would or could occur:

  



  

(i) changes in the Company's stock price or trading volume ( _provided_
that the exception in this clause (i) shall not prevent or otherwise affect a
determination that any Effect underlying such failures has resulted in, or
contributed to, a Company Material Adverse Effect);

  



  

(ii) any failure by the Company to meet, or changes to, public estimates
or forecasts of revenues, earnings or other financial metrics, or any failure
by the Company to meet any internal projections, forecasts or budgets of
revenues, earnings or other financial metrics ( _provided_ that the exception
in this clause (ii) shall not prevent or otherwise affect a determination that
any Effect underlying such failures has resulted in, or contributed to, a
Company Material Adverse Effect);

  



  

(iii) general business, economic or political conditions, including a
government shutdown, in the United States or any other country or region in
the world, or changes therein;

  



  

(iv) conditions in the financial, credit, banking, capital or currency
markets in the United States or any other country or region in the world, or
changes therein, including (A) changes in interest rates in the United States
or any other country and changes in exchange rates for the currencies of any
countries and (B) any suspension of trading in securities (whether equity,
debt, derivative or hybrid securities) generally on any securities exchange
or over-the-counter market operating in the United States or any other
country or region in the world;

  



  

(v) changes in general conditions in an industry in which the Acquired
Companies operate or in any specific jurisdiction or geographical area in the
United States or elsewhere in the world;

  



  

(vi) acts of hostilities, war, sabotage, cyberterrorism, terrorism or
military actions (including any outbreak, escalation or general worsening of
any such acts of hostilities, war, sabotage, cyberterrorism, terrorism or
military actions) in the United States or any other country or region in the
world;

  



  

(vii) earthquakes, hurricanes, tsunamis, tornadoes, floods, mudslides,
wild fires, weather conditions or other natural or man-made disasters or
acts of God in the United States or any other country or region in the world,
or any escalation of the foregoing;

  



  

(viii) any pandemic (including precautionary or emergency measures,
recommendations, protocols or orders taken or issued by any Person
in response to the COVID-19 pandemic), epidemic, plague, or other outbreak of
illness or public health event;

  



  

(ix) the execution or announcement of this Agreement or the pendency or
consummation of the Transactions, including the impact thereof on the
relationships, contractual or otherwise, of the Acquired Companies with
employees, customers, investors, contractors, lenders, suppliers, vendors,
partners, licensors, licensees, payors, Governmental Entities or other Third
Parties related thereto or any litigation, or the identity of Parent or any
of its Affiliates as the acquiror of the Company, or any facts
or circumstances concerning Parent or any of its Affiliates;

  



  

   

 | 5| 
---|---|--- 

 



    



  

(x) (A) any action taken, or failure to take any action, in each case
to which Parent has in writing approved, consented to or requested, (B) any
action taken in compliance with the terms of, or the taking of any action
required by, this Agreement or (C) the failure to take any action prohibited
by this Agreement;

  



  

(xi) changes or proposed changes in Law, regulation or other legal or
regulatory conditions (or the enforcement or interpretation of any of the
foregoing);

  



  

(xii) changes or proposed changes in GAAP or other accounting standards
(or the enforcement or interpretation of any of the foregoing);

  



  

(xiii) the availability or cost of equity, debt or other financing to
Parent, Merger Sub or the Surviving Corporation;

  



  

(xiv) any (A) demand or Legal Proceeding existing as of the date hereof or
arising out of any action or inaction described in clause (x) above or (B)
Transaction Litigation, including for appraisal of the fair value of any
shares of Company Common Stock pursuant to the DGCL in connection herewith;
and

  



  

(xv) any regulatory, preclinical, clinical, competitive, pricing,
manufacturing, reimbursement or supply chain outcomes, events, changes,
effects, occurrences, circumstances or developments relating to or affecting
any Company Product or activity (including (A) any suspension, rejection,
refusal of, request to refile or any delay in obtaining, making, or
maintaining any regulatory application or filing relating to any Company
Product, (B) any negative regulatory actions, requests, recommendations,
determinations or decisions of any Governmental Entity relating to any Company
Product or the manufacture or commercialization thereof, or any other
regulatory or preclinical or clinical development relating to any Company
Product, (C) any outcomes of preclinical or clinical studies, trials, tests,
results, adverse events, side effects or safety observations, or
announcements of any of the foregoing, with respect to any Company Product,
(D) any delay, hold or termination of any preclinical or clinical study,
trial or test or any delay, hold or termination of any planned
application for investigational new drug application or application for
marketing approval with respect to any Company Product whether such delay,
hold, or termination is imposed by Government Entities or an outside
institutional review board or ethics committee, (E) any preclinical or
clinical studies, trials, tests, results, adverse events, side effects or
safety observations, or announcements of any of the foregoing, with respect
to any product or product candidate competitive with or related to any
Company Product, (F) FDA approval (or other preclinical or clinical or
regulatory developments), market entry or threatened market entry of any
product or product candidate competitive with or related to any Company
Product, including any generic versions of any Company Product, (G) any
production or supply chain disruption affecting the manufacture of
any Company Product or (H) any recommendations, statements, decisions or
other pronouncements made, published or proposed by professional medical
organizations, payors, Governmental Entities or representatives of any of the
foregoing, or any panel or advisory body empowered or appointed thereby,
relating to any Company Product or any products or product candidates of
any competitors of the Company); _provided_ that, in each of the foregoing
clauses (iii), (iv), (v), (viii), (xi) and (xii), such Effects referred to
therein may be taken into account to the extent that the Company is materially
disproportionally affected relative to other similarly-situated companies in
the industry in which the Acquired Companies operate, in which case only the
incremental disproportionate impact or impacts may be taken into account in
determining whether or not there has been a Company Material Adverse Effect.

  



  

   

 | 6| 
---|---|--- 

 



    



  

"Company Options" means the Company In-the-Money Options and the Company Out-
of-the-Money Options.

  



  

"Company Out-of-the-Money Options" means outstanding options (whether vested
or unvested) to purchase Company Common Stock from the Company,
whether granted pursuant to the Company Equity Incentive Plans or otherwise,
with respect to which the applicable exercise price per share of Company
Common Stock is greater than or equal to the Merger Consideration.

  



  

"Company Outbound License" means any Contract to which any of the Acquired
Companies is a party pursuant to which any Intellectual Property that is
material to the business of the Acquired Companies taken as a whole and are
owned by any of the Acquired Companies is licensed to another Person (other
than an Affiliate of the Company), in each case, other than (i) any non-
exclusive outbound license agreements entered into in the ordinary course of
business consistent with past practice and (ii) agreements with contract
manufacturing or research organizations, or other agreements for materials
used in connection with the manufacture of Company Products, entered into in
the ordinary course of business.

  



  

"Company Product" means each product or product candidate that is being
researched, tested, developed, commercialized, manufactured, sold or
distributed by or on behalf of the Acquired Companies.

  



  

"Company PRSUs" means the outstanding restricted stock units of the Company
that are subject to performance-based vesting as of immediately prior to the
Expiration Date and issued pursuant to the Company Equity Incentive Plans.

  



  

"Company Related Party" means the Company and its Subsidiaries and any of
their respective former, current or future stockholders, directors, officers,
employees, Affiliates or Representatives.

  



  

"Company Representatives" means the directors, officers, financial and legal
advisors, accountants, agents and other representatives of the Company or
any of its Subsidiaries.

  



  

"Company RSUs" means the outstanding restricted stock units of the Company
that are not subject to performance-based vesting as of immediately prior to
the Expiration Date, whether issued pursuant to the Company Equity Incentive
Plans or otherwise.

  



  

"Confidentiality Agreement" means the Confidentiality Agreement, between the
Company and Parent, dated as of May 29, 2020.

  



  

"Contract" means any written agreement, contract, subcontract, lease,
instrument, bond, mortgage, indenture, license or sublicense, or
other legally binding commitment.

  



  

   

 | 7| 
---|---|--- 

 



    

     



  

"Convertible Notes" means those certain $320 million aggregate principal
amount of 3.25% senior unsecured convertible notes due 2022 issued by the
Company pursuant to the Indenture.

  



  

"Covis Parties" means Parent, Merger Sub and (solely with respect to Sections
_5.1_ , _5.2_ , _5.3_ , _5.4_ , _5.6_ , _6.14_  and _6.15_ ) the Debt
Financing Borrower.

  



  

"Debt Commitment Letter" means the commitment letter, dated October 1, 2020,
issued by the Debt Financing Sources to and for the benefit of the Debt
Financing Borrower, as it may be amended, restated, supplemented or otherwise
modified or replaced to the extent permitted by the terms of this Agreement.

  



  

"Debt Failure" means that the Debt Financing is not able to be funded in
accordance with the terms of the Debt Commitment Letter primarily as a result
of the non-performance of the Debt Financing Sources (other than as a result
of a material breach by any of the Covis Parties of any of their
representations, warranties or covenants set forth in _Section 5.6_ or
_Section 6.14_ ).

  



  

"Debt Financing" means the incremental term loan financing contemplated by
the Debt Commitment Letter (excluding, for the avoidance of doubt,
the incremental revolving loan financing and the delayed draw term loan
financing contemplated by the Debt Commitment Letter).

  



  

"Debt Financing Sources" means the financial institutions and other lenders
party to the Debt Commitment Letter (excluding any Parent Related Party).

  



  

"Debt Financing Sources Related Party" means the Debt Financing Sources,
together with their respective Affiliates, and the respective future, current
and former directors, officers, employees, partners, members, managers,
agents, advisors, attorneys, controlling persons, and the other
representatives, successors and assigns of each of the foregoing (excluding
any Parent Related Party).

  



  

"Effect" means any event, change, effect, occurrence, circumstance or
development.

  



  

"Encumbrance" means any lien, mortgage, pledge, deed of trust, security
interest, charge, encumbrance or other adverse claim or interest.

  



  

"Entity" means any corporation (including any non-profit corporation),
general partnership, limited partnership, limited liability
partnership, joint venture, estate, trust, company (including any company
limited by shares, limited liability company or joint stock company), firm,
society or other enterprise, association, organization or entity (including
any Governmental Entity).

  



  

"Environmental Claims" means any and all claims or Orders by any Governmental
Entity or other Person alleging that any Acquired Company is in violation of,
or has liability under, any Environmental Law.

  



  

   

 | 8| 
---|---|--- 

 



    

     



  

"Environmental Law" means all applicable Laws concerning pollution or
protection of the environment, including any such Law relating to the
manufacture, handling, transport, use, treatment, storage, disposal or release
of any Hazardous Materials.

  



  

"Environmental Permits" means all permits required to be obtained by the
Company in connection with its business as presently conducted under
applicable Environmental Law.

  



  

"Equity Commitment Letter" means the commitment letter, dated October 1, 2020
issued by Apollo Overseas Partners (892 AIV) IX, L.P., Apollo Overseas
Partners (Delaware) IX, L.P., Apollo Overseas Partners (Lux) IX, L.P., Apollo
Overseas Partners IX, L.P., and AP IX (Euro AIV), L.P. (collectively, the
"Equity Financing Sources") to and for the benefit of Parent and Merger Sub.

  



  

"Equity Financing" means the equity financing contemplated by the Equity
Commitment Letter.

  



  

"Equity Financing Sources" has the meaning set forth in the definition of
"Equity Commitment Letter."

  



  

"ERISA" means the Employee Retirement Income Security Act of 1974, as
amended.

  



  

"ERISA Affiliate" of any entity means any other entity that, together with
such entity, would be treated as a single employer within the meaning of
Section 414(b), (c), (m) or (o) of the Code or Section 4001(b)(1) of ERISA.

  



  

"Exchange Act" means the Securities Exchange Act of 1934, as amended.

  



  

"FDA" means the U.S. Food and Drug Administration.

  



  

"FDCA" shall mean the Federal Food, Drug and Cosmetic Act, as amended, and
all related rules, regulations and guidelines.

  



  

"Financing" means the Equity Financing and the Debt Financing.

  



  

"Financing Sources" means the Equity Financing Sources and the Debt Financing
Sources.

  



  

"GAAP" means United States generally accepted accounting principles.

  



  

"Governmental Entity" means any federal, domestic, territorial, state or
local governmental authority (including any government and any governmental
agency, instrumentality, tribunal or commission, or any subdivision,
department or branch of any of the foregoing) or body exercising or entitled
to exercise any administrative, executive, judicial, legislative, police,
regulatory or taxing authority or power of any nature.

  



  

"Hazardous Materials" means all hazardous, toxic, explosive or radioactive
substances, wastes or other pollutants or contaminants regulated under
Environmental Law, including petroleum or petroleum distillates, medical
waste, asbestos and polychlorinated biphenyls.

  



  

   

 | 9| 
---|---|--- 

 



    

     



  

"Healthcare Laws" means all healthcare Laws applicable to the business of the
Company and its Subsidiaries as currently conducted, including the Federal
Health Care Program Anti-Kickback Statute; the False Claims Act; the Program
Fraud Civil Remedies Act; the Anti-Kickback Act of 1986; the Civil Monetary
Penalties Law; the Health Insurance Portability and Accountability Act of
1996; any applicable healthcare Laws relating to billing or claims for
reimbursement submitted to any Governmental Health Program; the
Deficit Reduction Act of 2005; and the Patient Protection and Affordable Care
Act of 2010, in each case as applicable.

  



  

"HSR Act" means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended, and the rules and regulations promulgated thereunder.

  



  

"Indenture" means that certain base indenture for senior debt securities, as
supplemented by the first supplemental indenture thereto, each dated as of
May 10, 2017, by and between the Company and Wilmington Trust, National
Association, as trustee.

  



  

"Intellectual Property" means (i) patents and patent applications
(collectively, "Patents"); (ii) trade names, logos, slogans, Internet domain
names, registered and unregistered trademarks and service marks and related
registrations and applications for registration (collectively, "Marks");
(iii) copyrights in both published and unpublished works, including all
compilations, databases and computer programs, manuals and other documentation
and all copyright registrations and applications (collectively,
"Copyrights"); and (iv) rights under applicable trade secret Laws as are
applicable to know-how, inventions (including as disclosed in invention
disclosures and discoveries) and confidential information (collectively,
"Trade Secret Rights").

  



  

"IRS" means the Internal Revenue Service.

  



  

"Knowledge", whether or not capitalized, or any similar expression used with
respect to the Company, means the actual knowledge (after reasonable inquiry)
of those individuals listed in _Section 1.1(a)_ of the Company Disclosure
Schedule.

  



  

"Law" means any federal, state, local or foreign statute, law, regulation,
requirement, interpretation, permit, license, approval,
authorization, decision, directive, decree, rule, ruling, Order, ordinance,
code, policy or rule of common law of any Governmental Entity, including any
judicial or administrative interpretation thereof.

  



  

"Leased Real Property" means the leasehold or subleasehold interests and any
other rights to use or occupy any land, buildings, structures, improvements,
fixtures or other interests in real property currently held by the Acquired
Companies.

  



  

"Legal Proceeding" means any lawsuit, court action or other court proceeding
or any arbitration proceeding.

  



  

"made available to Parent" means that such information, document or material
was: (a) publicly available on the SEC EDGAR database prior to the execution
of this Agreement; (b) delivered by or on behalf of the Company to Parent or
Parent's representatives via electronic mail or in hard copy form prior to
the execution of this Agreement; or (c) made available for review by Parent
or Parent's representatives prior to the execution of this Agreement in the
virtual "data room" hosted by Datasite and maintained by the Company in
connection with the Offer and the Merger.

  



  

   

 | 10| 
---|---|--- 

 



    



  

"Most Recent Balance Sheet" means the balance sheet of the Company as of June
30, 2020 and the footnotes thereto set forth in the Company SEC Documents.

  



  

"NASDAQ" means The NASDAQ Global Select Market, or any successor thereto.

  



  

"Order" means any writ, judgment, injunction, consent, order, decree,
stipulation, award or executive order of or by any Governmental Entity.

  



  

"Organizational Documents" means, with respect to any Entity, (a) if such
Entity is a corporation, such Entity's certificate or articles of
incorporation, bylaws and similar organizational documents, as amended and in
effect on the date hereof, (b) if such Entity is a limited liability company,
such Entity's certificate or articles of formation or organization and
operating agreement or limited liability company agreement, and (c) for any
other form of Entity, the organizational documents of such Entity.

  



  

"Parent Material Adverse Effect" means, with respect to Parent, any Effect
that, individually or taken together with all other Effects that have
occurred prior to the date of determination of the occurrence of the Parent
Material Adverse Effect, is or would be reasonably likely to prevent or
materially delay the performance by Parent of any of its obligations under
this Agreement or the consummation of the Offer, the Merger or the other
transactions contemplated by the Transaction Documents.

  



  

"Parent Related Party" means Parent, Merger Sub, the Debt Financing Borrower,
the Guarantors and any of the foregoing's respective former, current or
future Affiliates and any of the foregoing's respective former, current or
future, direct or indirect, officers, directors, employees, Affiliates,
stockholders, equity holders, managers, members, partners, agents, attorneys,
advisors or other Representatives or any of the foregoing's respective
successors or assigns.

  



  

"Permitted Encumbrances" means (i) Encumbrances disclosed on the Most Recent
Balance Sheet, (ii) any Encumbrances for taxes, assessments and other
governmental levies, fees or charges that are not yet due and payable, or that
are being contested in good faith and for which appropriate reserves have
been established in accordance with GAAP, (iii) mechanics, carriers, workmen,
warehouseman, repairmen and materialmen liens and similar liens for labor,
materials or supplies incurred in the ordinary course of business for amounts
that are not yet due and payable, or that are being contested in good faith,
(iv) zoning, building codes and other land use Law regulating the use or
occupancy of real property or the activities conducted thereon that are
imposed by any Governmental Entity having jurisdiction over such real property
that are not violated in any material respect by the use or occupancy of such
real property in the operation of the business presently conducted
thereon, (v) restrictions of record identified in any title reports obtained
by or made available to Parent, or easements, covenants, conditions,
restrictions, defects and other similar matters of record affecting title to
real property that do not or would not materially impair the use or occupancy
of such real property in the operation of the business presently
conducted thereon, (vi) liens imposed by Law, (vii) non-exclusive rights or
licenses granted in the ordinary course of business, (viii) deposits or
pledges to secure the payment of workers' compensation, unemployment
insurance, social security benefits or obligations arising under similar
Laws, or to secure the performance of public or statutory obligations, surety
or appeal bonds, and other obligations of a like nature, in each case in the
ordinary course of business and which are not yet due and payable, and (ix)
other Encumbrances that do not materially and adversely affect the use or
operation of the asset subject thereto.

  



  

   

 | 11| 
---|---|--- 

 



    



  

"Person" means any individual, corporation, partnership (general or limited),
limited liability company, limited liability partnership, trust, joint
venture, joint stock company, syndicate, association, entity, unincorporated
organization or government, or any political subdivision, agency or
instrumentality thereof.

  



  

"Personal Information" means data and information concerning an identifiable
natural person.

  



  

"Privacy Laws" mean Laws relating to privacy and/or data security of Personal
Information.

  



  

"Related Party" means a Company Related Party or a Parent Related Party, as
applicable.

  



  

"Sanctioned Person" means at any time any Person: (i) listed on or otherwise
the subject of any Sanctions-related list of designated or blocked Persons;
(ii) a Governmental Entity of, ordinarily resident in, or organized under the
laws of a country or territory that is the subject of comprehensive Sanctions
(as of the date of this Agreement, Cuba, Iran, North Korea, Syria, and the
Crimea region); or (iii) owned directly or indirectly, fifty percent or more
(in the aggregate) or controlled by any of the foregoing.

  



  

"Sanctions" means all economic or financial sanctions or trade embargoes
imposed, administered or enforced from time to time by (a) the
U.S. government, including those administered by the U.S. Department of the
Treasury or the U.S. Department of State, (b) the United Nations Security
Council, the European Union, any European Union member state, or Her Majesty's
Treasury of the United Kingdom.

  



  

"Sarbanes-Oxley Act" means the Sarbanes-Oxley Act of 2002.

  



  

"SEC" means the United States Securities and Exchange Commission.

  



  

"Securities Act" means the Securities Act of 1933, as amended.

  



  

"Solvent" with respect to the Debt Financing Borrower and its Subsidiaries on
a consolidated basis shall mean: (a) the fair value of the assets of the Debt
Financing Borrower and its Subsidiaries on a consolidated basis, at a fair
valuation, will exceed the debts and liabilities, direct, subordinated,
contingent or otherwise, of the Debt Financing Borrower and its Subsidiaries
on a consolidated basis; (b) the present fair saleable value of the property
of the Debt Financing Borrower and its Subsidiaries on a consolidated basis
will be greater than the amount that will be required to pay the probable
liability of the Debt Financing Borrower and its Subsidiaries on a
consolidated basis on their debts and other liabilities, direct,
subordinated, contingent or otherwise, as such debts and other liabilities
become absolute and matured; (c) the Debt Financing Borrower and its
Subsidiaries on a consolidated basis will not have, as of such date, an
unreasonably small amount of capital for the operation of the businesses in
which they are engaged, as such businesses are now engaged or proposed to be
conducted following such date; and (d) the Debt Financing Borrower and its
Subsidiaries on a consolidated basis will be able to pay their liabilities,
including contingent and other liabilities, as they become absolute and
mature.

  



  

   

 | 12| 
---|---|--- 

 



    



  

"Subsidiary" of any Person means any corporation, partnership, limited
liability company, joint venture or other legal entity of which such Person
(either directly or through or together with another Subsidiary of such
Person) owns more than 50% of the voting stock or value of such corporation,
partnership, limited liability company, joint venture or other legal entity.

  



  

"Superior Proposal" means a _bona fide_ written Acquisition Proposal (with
all of the references to 20% included in the definition of Acquisition
Proposal being deemed to be replaced with references to 50%) that the Company
Board (or a committee thereof) determines in good faith, after consultation
with the Company's financial advisor and outside legal counsel, and taking
into consideration, among other things, any legal, financial, regulatory and
other aspects of such Acquisition Proposal and this Agreement that
the Company Board (or a committee thereof) deems relevant (in each case
taking into account any revisions to this Agreement made in writing by Parent
prior to the time of determination pursuant to _Section 2.3(d)_ ), would
result in a transaction more favorable to the holders of Company Common Stock
than the transactions provided for in this Agreement.

  



  

"Tax" (and, with correlative meaning, "Taxes") means any federal, state,
local, foreign or other tax, levy, duty, fee or other similar governmental
assessment, including any income, profits, gross receipts, capital stock,
capital gains, branch, personal property, real property, production, sales,
use, goods and services, escheat, capital, license, franchise,
employment, payroll, premium, withholding, unemployment, compensation,
utility, social security, disability, severance, occupation, import, custom,
alternative or added minimum, value added, ad valorem, transfer, stamp,
registration or excise tax, or any other tax in the nature of the foregoing,
together with any interest or penalty or addition thereto, whether disputed or
not, imposed by any Governmental Entity.

  



  

"Tax Return" means any return, report or similar written statement filed or
required to be filed with a taxing authority with respect to any Tax
(including any amendments thereto or attached schedules), including any
information report or return, claim for refund, election, claim, disclosure,
amended return or declaration of estimated Tax.

  



  

"Third Party" means any Person or group (as defined in Section 13(d)(3) of
the Exchange Act) other than the Company, Parent, Merger Sub or
any Affiliates thereof.

  



  

"Transaction Documents" means this Agreement, the Commitment Letters, the
Limited Guarantee and all other agreements, instruments and documents to be
executed by Parent, Merger Sub and/or the Company in connection with the
transactions contemplated by this Agreement (but not, for the avoidance of
doubt, the Confidentiality Agreement).

  



  

   

 | 13| 
---|---|--- 

 



    



  

"Transaction Litigation" means any claim, demand or Legal Proceeding
(including any class action or derivative litigation) asserted, commenced or
threatened by, on behalf of or in the name of, against or otherwise involving
the Company, the Company Board, any committee thereof and/or any of the
Company's directors or officers relating directly or indirectly to
this Agreement, the Offer, the Merger or any of the Transactions (including
any such claim or Legal Proceeding based on allegations that the Company's
entry into this Agreement or the terms and conditions of this Agreement or any
of the Transactions constituted a breach of the fiduciary duties of any
member of the Company Board or any officer of the Company).

  



  

"Transactions" means the transactions contemplated by this Agreement,
including the Offer and the Merger.

  



  

"WARN Act" means the United States Worker Adjustment and Retraining
Notification Act, as amended, or any state Mini-WARN Law.

  



  

"Willful and Material Breach" means a breach that is a consequence of an
intentional act or intentional failure to act undertaken by the breaching
party with actual knowledge that such party's act or failure to act would
cause, result in or constitute a breach.

  



  

(b)  Each of the following terms is defined in the Section set
forth opposite such term:

  



     Term  | Section 
---|--- 
   Agreement  | Preamble 
   Alternative Acquisition Agreement  | Section 2.3(c) 
   Alternative Financing  | Section 6.14(b) 
   Alternative Financing Commitment Letter  | Section 6.14(b) 
   Appraisal Shares  | Section 3.8(c) 
   Assumed Employee Arrangements  | Section 6.7(d) 
   Book Entry Share  | Section 3.5(a)(i) 
   Capitalization Date  | Section 4.3(a) 
   Change in Circumstances  | Section 2.3(d)(ii) 
   Change in Circumstances Notice  | Section 2.3(d)(ii) 
   Change in Recommendation  | Section 2.3(c) 
   Closing  | Section 3.3 
   Closing Date  | Section 3.3 
   Company  | Preamble 
   Company 401(k) Plans  | Section 6.7(e) 
   Company Board  | Recitals 
   Company Board Recommendation  | Section 2.3(a) 
   Company Common Stock  | Recitals 
   Company Preferred Stock  | Section 4.3(a) 
   Company Registered IP  | Section 4.6(a) 
   Company SEC Documents  | Section 4.4(a) 
   Company Stock Certificate  | Section 3.5(a)(i) 
   Company's Notice  | Section 8.1(j) 
   Compensation Committee  | Section 6.8 
   Continuing Employee  | Section 6.7(a) 
   Current Premium  | Section 6.9(a) 
     



  

   

 | 14| 
---|---|--- 

 



    



     Term  | Section 
---|--- 
    Debt Financing Action  | Section 9.14(a) 
   Debt Financing Borrower  | Recitals 
   Debt Offer  | Section 6.12(a) 
   Debt Offer Documents  | Section 6.12(a) 
   Delaware Courts  | Section 9.5 
   DGCL  | Recitals 
   Effective Time  | Section 3.3 
   End Date  | Section 8.1(b) 
   Excluded Shares  | Section 3.5(a)(i) 
   Expiration Date  | Section 2.1(d) 
   Failure Notice Period  | Section 8.1(j) 
   FDA Application Integrity Policy  | Section 4.15(b) 
   Guarantors  | Recitals 
   Indemnified Party  | Section 6.9(b) 
   Indemnified Party Proceeding  | Section 6.9(b) 
   Initial Expiration Date  | Section 2.1(d) 
   Limited Guarantee  | Section 5.13 
   Material Contract  | Section 4.8(b) 
   Merger  | Recitals 
   Merger Consideration  | Section 3.5(a)(i) 
   Merger Sub  | Preamble 
   Minimum Condition  | Annex I 
   Offer  | Recitals 
   Offer Closing  | Section 3.3 
   Offer Commencement Date  | Section 2.1(a) 
   Offer Conditions  | Section 2.1(a) 
   Offer Documents  | Section 2.2(a) 
   Offer Price  | Recitals 
   Parent  | Preamble 
   Parent Termination Fee  | Section 8.3(c) 
   Parent Welfare Plan  | Section 6.7(c) 
   Paying Agent  | Section 3.6(a) 
   Privacy Policies  | Section 4.18 
   Required Amount  | Section 5.6 
   Schedule 14D-9  | Section 2.3(a) 
   Schedule TO  | Section 2.2(a) 
   Stockholder List Date  | Section 2.3(e) 
   Superior Proposal Notice  | Section 2.3(d)(i) 
   Surviving Corporation  | Recitals 
   Termination Fee  | Section 8.3(b) 
  



  

   

 | 15| 
---|---|--- 

 



    



   



  



  



  

Article 2

  

THE OFFER

  



  

Section 2.1.   _Tender Offer_.

  



  

(a)  Unless this Agreement shall have previously been validly
terminated in accordance with _Article 8_ , as promptly as reasonably
practicable, but in any event on or prior to the tenth (10th) Business Day
following the date hereof, Merger Sub shall commence (within the meaning of
Rule 14d-2 under the Exchange Act) the Offer to purchase for cash all of
the outstanding Company Common Stock at a price per share equal to the Offer
Price. The date on which Merger Sub commences the Offer, within the meaning
of Rule 14d-2 under the Exchange Act, is referred to as the "Offer
Commencement Date." The Offer shall be subject only to the conditions set
forth on _Annex I_ (the "Offer Conditions").

  



  

(b)  Subject to the provisions of this _Section 2.1_ , as
promptly as practicable on the later of (i) the earliest date as of which
Merger Sub is permitted under applicable Law to accept for payment Company
Common Stock tendered pursuant to the Offer (and not validly withdrawn), and
(ii) the earliest date as of which each of the Offer Conditions shall have
been satisfied or waived, Merger Sub shall (and Parent shall cause Merger Sub
to) irrevocably accept for payment all Company Common Stock tendered pursuant
to the Offer (and not validly withdrawn). The obligation of Merger Sub to
irrevocably accept for payment Company Common Stock tendered pursuant to the
Offer shall be subject only to the satisfaction or waiver of each of the Offer
Conditions (and shall not be subject to any other conditions). As promptly as
possible after (and in any event, no more than two (2) Business Days
after) the irrevocable acceptance for payment of any shares of Company Common
Stock tendered pursuant to the Offer, Merger Sub shall pay for all shares of
Company Common Stock validly tendered and not properly withdrawn pursuant to
the Offer.

  



  

(c)  Notwithstanding anything to the contrary contained in this
Agreement, neither Parent nor Merger Sub shall (without the prior written
consent of the Company):

  



  

(i)  amend, modify or waive the Minimum Condition;

  



  

(ii)  decrease the number of shares of Company Common Stock
sought to be purchased by Merger Sub in the Offer;

  



  

(iii)  reduce the Offer Price (except to the extent required
pursuant to _Section 2.1(g))_ ;

  



  

(iv)  increase the Offer Price, except in response to a Change in
Recommendation, a Change in Circumstances Notice or a Superior Proposal
Notice;

  



  

(v)  extend or otherwise change the expiration date of the Offer
(except as otherwise provided in this _Section 2.1_ );

  



  

(vi)  change the form of consideration payable in the Offer;

  



  

   

16

 



    



  

(vii)   impose any condition to the Offer in addition to the Offer
Conditions;

  



  

(viii)  amend, modify or supplement any of the terms of the Offer in
any manner adversely affecting, or that could reasonably be expected to have
an adverse effect on, any of the holders of Company Common Stock; or

  



  

(ix)  take any action (or fail to take any action) that would
result in the Merger not being permitted to be effected pursuant to Section
251(h) of the DGCL.

  



  

(d)  Unless extended pursuant to and in accordance with the
terms of this Agreement, the Offer shall expire at midnight (New York City
time) on the date that is twenty (20) business days (for this purpose
determined as set forth in Rule 14d-1(g)(3) under the Exchange Act) following
the commencement (within the meaning of Rule 14d-2 under the Exchange Act) of
the Offer (such date and time, the "Initial Expiration Date") or, in the
event the Initial Expiration Date has been extended pursuant to and in
accordance with this Agreement, the date and time to which the Offer has been
so extended (the Initial Expiration Date, as it may be extended pursuant to
and in accordance with this Agreement, the "Expiration Date").

  



  

(e)  Merger Sub shall, and Parent shall cause Merger Sub to,
extend the Offer from time to time as follows: (i) if on the then scheduled
Expiration Date, the Minimum Condition has not been satisfied or any of the
other Offer Conditions has not been satisfied, or waived by Parent or Merger
Sub if permitted hereunder, then Merger Sub shall extend the Offer for one (1)
or more occasions in consecutive increments of up to ten (10) Business Days
each (or such longer period as may be agreed by the Company and Parent) in
order to permit the satisfaction of such Offer Conditions (subject to the
right of Parent or Merger Sub to waive any Offer Condition to the extent
permitted hereunder); _provided_ , _however_ , that Merger Sub shall not be
required to extend the Offer and the then scheduled Expiration Date to a date
later than the End Date; and (ii) Merger Sub shall extend the Offer for the
minimum period required by applicable Law, interpretation or position of the
SEC or its staff or NASDAQ or its staff.

  



  

(f)  If on any then scheduled Expiration Date (i) all of the
Offer Conditions have been satisfied (other than those Offer Conditions that
by their nature are to be satisfied at the Acceptance Time, but which
conditions would be capable of being satisfied as of such scheduled
Expiration Date) and (ii) the full amount of the Debt Financing has not been
funded and will not be available to be funded at the Offer Closing and the
Closing, other than as a result of a breach or failure to perform by any of
the Covis Parties of any of their representations, warranties or covenants
set forth in _Section 5.6_ or _Section 6.14_ , then (1) Merger Sub shall, and
Parent shall cause Merger Sub to, extend the Offer for two (2) successive
periods of up to five (5) Business Days per extension (each such period to
end at midnight (New York City time) on the last Business Day of such
period) and (2) thereafter Merger Sub shall have the right in its sole
discretion to extend the Offer for additional successive periods of up to
five (5) Business Days per extension (each such period to end at midnight (New
York City time) on the last Business Day of such period), the length of each
such period to be determined by Parent in its sole discretion; _provided_ that
(x) in no event shall the Offer be extended to a date later than the End Date
and (y) if Merger Sub so extends the Offer pursuant to this clause all Offer
Conditions set forth in clauses 2(c)(i) and 2(f) of _Annex 1_ will be deemed
to have been irrevocably satisfied or waived from and at all times after the
initial extension of the Offer by Merger Sub pursuant to this clause.

  



  

   

17

 



    



  

(g)  If, between the date hereof and the Acceptance Time, the
outstanding Company Common Stock are changed into a different number or class
of shares by reason of any stock split, division or subdivision of shares,
stock dividend, reverse stock split, consolidation of shares,
reclassification, recapitalization or other similar transaction, then the
Offer Price shall be adjusted to the extent appropriate; _provided_ that
nothing in this _Section 2.1(g) _shall be construed to permit the Company to
take any action with respect to its securities that is prohibited by the terms
of this Agreement.

  



  

(h)  Neither Parent nor Merger Sub shall terminate or withdraw
the Offer prior to the then scheduled Expiration Date unless this Agreement
is validly terminated in accordance with the terms hereof. In the event that
this Agreement is terminated pursuant to the terms hereof, Merger Sub shall
(and Parent shall cause Merger Sub to) promptly (and in any event within
twenty-four (24) hours of such termination), irrevocably and unconditionally
terminate the Offer, shall not acquire any shares of Company Common Stock
pursuant to the Offer and shall cause any depository acting on behalf of
Merger Sub to return, in accordance with applicable Law, all tendered shares
of Company Common Stock to the registered holders thereof.

  



  

Section 2.2.   _Actions of Parent and Merger Sub_.

  



  

(a)  As promptly as practicable on the Offer Commencement Date,
Parent and Merger Sub shall (i) file with the SEC a Tender Offer Statement on
Schedule TO with respect to the Offer (together with all amendments and
supplements thereto and including exhibits thereto, the "Schedule TO") that
will contain or incorporate by reference an offer to purchase and form of the
related letter of transmittal and (ii) cause the Schedule TO, the offer to
purchase and related documents to be disseminated to holders of shares of
Company Common Stock. Parent and Merger Sub agree that they shall cause the
Schedule TO, together with all documents included therein pursuant to which
the Offer will be made (collectively and with any supplements or amendments
thereto, the "Offer Documents") filed by either Parent or Merger Sub with the
SEC to comply in all material respects with the Exchange Act and the rules
and regulations thereunder and other applicable Law. Each of Parent, Merger
Sub and the Company agrees to promptly correct any information provided by it
for use in the Offer Documents if and to the extent that such
information shall have become false or misleading in any material respect,
and Parent further agrees to use all reasonable efforts to promptly cause the
Offer Documents, as so corrected, to be filed with the SEC and to promptly be
disseminated to holders of shares of Company Common Stock as and to the
extent required by applicable Law. The Company shall promptly furnish or
otherwise make available to Parent, Merger Sub or Parent's legal counsel any
information concerning the Acquired Companies and the Company's
stockholders that is required or reasonably requested in connection with any
action contemplated by this _Section 2.2(a)_. The Company and its counsel
shall be given reasonable opportunity to review and comment on the Offer
Documents prior to the filing thereof with the SEC and Parent and Merger Sub
shall give reasonable and good faith consideration to any such comments made
by the Company or its counsel. Parent and Merger Sub agree to (i) provide the
Company and its counsel with a copy of any written comments (and a summary of
any oral comments) that Parent, Merger Sub or their counsel may receive from
the SEC or its staff with respect to the Offer Documents promptly after
receipt of such comments, (ii) to give the Company and its counsel a
reasonable opportunity to review and comment on any response to such comments
provided to the SEC or its staff, (iii) give reasonable and good
faith consideration to any such comments made in respect of any such proposed
responses and (iv) to the extent reasonably practicable, provide the Company
and its counsel a reasonable opportunity to participate in any material
discussions with the SEC or its staff concerning such comments. Each of
Parent and Merger Sub shall respond promptly to any comments of the SEC or its
staff with respect to the Offer Documents or the Offer.

  



  

   

18

 



    



  

(b)  For purposes of this Agreement, and the Offer, unless
otherwise mutually agreed to by the Company and Merger Sub, any shares of
Company Common Stock subject to notices of guaranteed delivery shall be deemed
not to be validly tendered into the Offer unless and until the shares
underlying such notices of guaranteed delivery are delivered to Merger Sub or
to an agent of Merger Sub.

  



  

(c)  Without limiting the generality of _Section 9.10_ , Parent
shall cause to be provided to Merger Sub, on a timely basis, all of the funds
necessary to purchase any shares of Company Common Stock that Merger Sub
becomes obligated to purchase pursuant to the Offer, which funds shall be
deposited with the Paying Agent promptly (and in any event no later than the
second (2nd) Business Day) following the Acceptance Time and shall cause
Merger Sub to perform, on a timely basis, all of Merger Sub's obligations
under this Agreement. Parent and Merger Sub shall, and each of Parent and
Merger Sub shall ensure that all of their respective Affiliates shall, tender
any shares of Company Common Stock held by them into the Offer.

  



  

(d)  This Agreement and the transactions contemplated hereby
shall be effected under Section 251(h) of the DGCL and Parent and Merger Sub
shall cause the Merger to be effected as soon as practicable following the
consummation of the Offer.

  



  

Section 2.3.   _Actions of the Company_.

  



  

(a)  On or as promptly as practicable after the Offer
Commencement Date, the Company shall file with the SEC and (following or
contemporaneously with the initial dissemination of the Offer Documents to
holders of Company Common Stock to the extent required by applicable federal
securities laws, and subject to the final sentence of _Section 2.3(b)_ )
disseminate to holders of Company Common Stock a Tender Offer
Solicitation/Recommendation Statement on Schedule 14D-9 (together with any
amendments or supplements thereto, the "Schedule 14D-9") that, subject to
_Section 2.3(d)_ , shall contain the recommendation of the Company Board that
stockholders of the Company tender their shares of Company Common Stock
pursuant to the Offer (the "Company Board Recommendation"), shall set the
Stockholder List Date as the record date for purposes of receiving the
notice required by Section 262(d)(2) of the DGCL and also shall contain a
notice of appraisal rights in compliance with Section 262(d) of the DGCL.
Parent and its counsel shall be given a reasonable opportunity to review and
comment on the Schedule 14D-9 (including any amendment or supplement thereto)
prior to the filing thereof with the SEC or the dissemination thereof to
holders of Company Common Stock and the Company shall give reasonable and
good faith consideration to any such comments made by Parent or its counsel; 
_provided_ , _however_ , that the Company need not give Parent and its counsel
such opportunity to review and comment in connection with any amendment or
supplement to the Schedule 14D-9 that relates to any Acquisition Proposal or
any Change in Recommendation. The Company shall promptly provide Parent and
its counsel with a copy or a description of any written comments (and a
summary of any oral comments) received by the Company (or its counsel) from
the SEC or its staff with respect to the Schedule 14D-9. The Company shall
(i) respond promptly to any comments of the SEC or its staff with respect to
the Schedule 14D-9, (ii) give Parent and its counsel a reasonable opportunity
to review and comment on any response to such comments provided to the SEC or
its staff and (iii) give reasonable and good faith consideration to any such
comments made in respect of any such proposed responses; _provided_ ,
_however_ , that the Company need not give Parent and its counsel such
opportunity to review and comment in connection with any such response or
comments that relate to any Acquisition Proposal or any Change in
Recommendation.

  



  

   

19

 



    



  

(b)  To the extent required by the applicable requirements of
the Exchange Act and the rules and regulations thereunder, (i) each of
Parent, Merger Sub and the Company shall promptly correct any information
provided by it for use in the Schedule 14D-9 if such information shall have
become false or misleading in any material respect, and (ii) the Company shall
take all steps necessary to promptly cause the Schedule 14D-9, as
supplemented or amended to correct such information, to be filed with the SEC
and, subject to the final sentence of this _Section 2.3(b)_ , to be
disseminated to holders of Company Common Stock. Parent and Merger Sub shall
promptly furnish to the Company all information concerning Parent or Merger
Sub that may be reasonably requested by the Company in connection with any
action contemplated by this _Section 2.3(b)_. To the extent requested by the
Company, Parent shall cause the Schedule 14D-9 and any supplement or
amendment thereto to be mailed or otherwise disseminated to the holders of
Company Common Stock together with the Offer Documents disseminated to the
holders of Company Common Stock.

  



  

(c)  Neither the Company Board nor any committee thereof shall,
except as permitted by _Section 2.3(d)_ or _Section 6.2_ : (i) withdraw,
modify, amend or qualify, in a manner adverse to Parent and Merger Sub, the
Company Board Recommendation; (ii) approve, recommend or declare advisable
any Acquisition Proposal; (iii) publicly propose or announce any intention to
take any of the foregoing actions (any action described in clause (i), (ii)
or clause (iii) being referred to as a "Change in Recommendation"); or (iv)
cause the Company to enter into any contract (other than a confidentiality
agreement entered into in compliance with _Section 6.2(a)_ ) contemplating an
Acquisition Proposal (any such contract, an "Alternative Acquisition
Agreement").

  



  

(d)  Notwithstanding anything to the contrary contained in this
Agreement, at any time prior to the Acceptance Time, the Company Board may:

  



  

(i)  make a Change in Recommendation in response to an
Acquisition Proposal and/or cause the Company to enter into an Alternative
Acquisition Agreement concerning an Acquisition Proposal if: (A) such
Acquisition Proposal did not result from a material breach of _Section
6.2(a)_ ; (B) the Company Board (or a committee thereof) determines in good
faith (1) after consultation with the Company's outside legal counsel and
financial advisor, that such Acquisition Proposal would constitute a
Superior Proposal and (2) after consultation with the Company's outside legal
counsel, that in light of such Acquisition Proposal, a failure to make a
Change in Recommendation and/or to cause the Company to enter into such
Alternative Acquisition Agreement would reasonably be expected to be
inconsistent with the Company Board's fiduciary obligations to the Company's
stockholders under applicable Law; (C) the Company delivers to Parent a
written notice (the "Superior Proposal Notice") stating that the Company
Board intends to take such action and (in the event the Company Board
contemplates causing the Company to enter into an Alternative Acquisition
Agreement) including a summary of the material terms and conditions of such
Alternative Acquisition Agreement; (D) during the three (3) Business Day
period commencing on the date of Parent's receipt of such Superior Proposal
Notice, the Company shall have negotiated in good faith and have made its
representatives reasonably available for the purpose of engaging in
negotiations with Parent (to the extent Parent desires to negotiate) regarding
a possible amendment of this Agreement or the Offer or a possible alternative
transaction so that the Acquisition Proposal that is the subject of
the Superior Proposal Notice ceases to be a Superior Proposal; (E) after the
expiration of the negotiation period described in clause (D) above, the
Company Board (or a committee thereof) shall have determined in good faith,
after taking into account any amendments to this Agreement and the Offer that
Parent and Merger Sub have irrevocably agreed in writing to make as a result
of the negotiations contemplated by clause (D) above, that (1) after
consultation with the Company's outside legal counsel and financial
advisor, such Acquisition Proposal constitutes a Superior Proposal, and (2)
after consultation with the Company's outside legal counsel, the failure to
make a Change in Recommendation and/or enter into such Alternative Acquisition
Agreement would reasonably be expected to be inconsistent with the Company
Board's fiduciary obligations to the Company's stockholders under applicable
Law; and (F) if the Company enters into an Alternative Acquisition Agreement
concerning such Superior Proposal, the Company terminates this Agreement in
accordance with _Section 8.1(f)_ ; _provided, however_ , that, in the event of
any material amendment to the terms of any Superior Proposal, the Company
shall deliver an additional Superior Proposal Notice and comply again
with clauses (C) through (E) of this _Section 2.3(d)(i)_ ; or

  



  

   

20

 



    



  

(ii)  make a Change in Recommendation not related to an
Acquisition Proposal if: (A) any material change in circumstances arises
affecting the Company that does not relate to any Acquisition Proposal and was
not known or reasonably foreseeable by the Company Board prior to the date
hereof (or if known or reasonably foreseeable, the material consequences of
which were not known) (any such change in circumstances unrelated to an
Acquisition Proposal being referred to as a "Change in Circumstances"); (B)
the Company Board (or a committee thereof) determines in good faith, after
consultation with its outside legal counsel, that, in light of such Change in
Circumstances, a failure to effect a Change in Recommendation would be
inconsistent with the Company Board's fiduciary duties to the Company's
stockholders under applicable Law; (C) such Change in Recommendation is not
effected prior to the fourth (4th) Business Day after Parent receives written
notice (the "Change in Circumstances Notice") from the Company confirming
that the Company Board intends to effect such Change in Recommendation and
specifying in reasonable detail the reasons therefor; (D) during such four
(4) Business Day period, if requested by Parent, the Company engages in good
faith negotiations with Parent to amend this Agreement or the Offer or enter
into an alternative transaction; and (E) at the end of such four (4) Business
Day period, the Company Board (or a committee thereof) determines in good
faith, after consultation with its outside legal counsel and after taking
into account any amendments to this Agreement and the Offer that Parent and
Merger Sub have irrevocably agreed in writing to make as a result of the
negotiations contemplated by clause (D) above, that, in light of such Change
in Circumstances, a failure to effect a Change in Recommendation would be
inconsistent with the Company Board's fiduciary duties to the Company's
stockholders under applicable Law; _provided, however,_ that after compliance
with clauses (C) through (E) of this _Section 2.3(d)(ii)_ with respect to
any Change in Circumstances, the Company shall have no further obligations
under clauses (C) through (E) of this _Section 2.3(d)(ii)_.

  



  

   

21

 



    



  

(e)  In connection with the Offer, the Company shall instruct
its transfer agent to furnish to Merger Sub a list, as of a recent date, of
the record holders of Company Common Stock and their addresses, as well as
mailing labels containing such names and addresses (the date of the list used
to determine the Persons to whom the Offer Documents and Schedule 14D-9 are
first disseminated, the "Stockholder List Date"). The Company will furnish
Merger Sub with such additional information (including any security position
listings in the Company's possession) and assistance as Merger Sub may
reasonably request for purposes of communicating the Offer to the holders of
Company Common Stock. All information furnished in accordance with this
_Section 2.3(e)_ shall be held in confidence by Parent and Merger Sub (and
their agents) in accordance with the requirements of the
Confidentiality Agreement, and shall be used by Parent and Merger Sub (and
their agents) only in connection with the communication of the Offer to the
holders of Company Common Stock. If this Agreement is terminated, Parent and
Merger Sub shall deliver, and shall use their reasonable best efforts to
cause their agents to deliver, to the Company (or destroy, at the Company's
election) all copies and any extracts or summaries from such information
furnished in accordance with this _Section 2.3(e)_ then in their possession
or control.

  



  

Article 3 
 THE MERGER; EFFECTIVE TIME

  



  

Section 3.1.   _The Merger_. Upon the terms and subject to the
conditions set forth in this Agreement and in accordance with the DGCL
(including Section 251(h) of the DGCL), at the Effective Time, Merger Sub
shall be merged with and into the Company, and the separate existence of
Merger Sub shall cease. The Company will continue as the Surviving
Corporation. The Merger shall be effected under Section 251(h) of the DGCL as
soon as practicable following the consummation of the Offer.

  



  

Section 3.2.   _Effect of the Merger_. The Merger shall have the
effects set forth in this Agreement and in the applicable provisions of the
DGCL.

  



  

Section 3.3.   _Closing; Effective Time_. The consummation of the
Merger (the "Closing") shall take place at the offices of Goodwin Procter
LLP, 100 Northern Avenue, Boston, Massachusetts 02210 at 9:00 a.m. local time
as soon as practicable following the consummation (as defined in Section
251(h) of the DGCL) of the Offer (the "Offer Closing"), subject to the
satisfaction or, to the extent permitted by applicable Law, the waiver of the
conditions set forth in _Article 7_  by the parties entitled thereto, but in
any event no later than the second (2nd) Business Day after the
satisfaction or waiver of the last to be satisfied or waived of the
conditions set forth in _Article 7_ (other than those conditions that by
their nature are to be satisfied at the Closing, but subject to the
satisfaction or waiver of such conditions) (the date on which the Closing
occurs, the "Closing Date"). The parties shall use reasonable efforts to align
the timing of the Offer Closing with the Closing Date. The parties intend
that the Closing will be effected, to the extent practicable, by conference
call, the electronic delivery of documents, and, if requested by a party, the
prior physical exchange of certain other documents and instruments to be held
in escrow by outside counsel to the recipient party pending authorization to
release at the Closing. Subject to the provisions of this Agreement, a
certificate of merger satisfying the applicable requirements of the
DGCL shall be duly executed by the Company and, as soon as practicable on the
Closing Date, delivered to the Secretary of State of the State of Delaware
for filing. The Merger shall become effective upon the date and time of the
filing of such certificate of merger with the Secretary of State of the State
of Delaware or such later date and time as is agreed upon in writing by the
parties hereto and specified in the certificate of merger (such date and
time, the "Effective Time"). From and after the Effective Time, the Surviving
Corporation shall possess all the rights, privileges, powers and franchises
and be subject to all of the restrictions, disabilities and duties of the
Company and Merger Sub, all as provided in the DGCL.

  



  

   

22

 



    



  

Section 3.4.   _Certificate of Incorporation and Bylaws; Directors_.
At the Effective Time, unless otherwise jointly determined by Parent and the
Company prior to the Effective Time:

  



  

(a)  the Certificate of Incorporation of the Surviving
Corporation shall be amended and restated in its entirety as of the Effective
Time to read as set forth on _Exhibit A_ hereto, and, as so amended and
restated shall be the Certificate of Incorporation of the Surviving
Corporation, until thereafter amended in accordance with its terms and as
provided in the DGCL (subject to _Section 6.9(b)_ );

  



  

(b)  the Bylaws of the Surviving Corporation shall be amended
and restated as of the Effective Time to read as set forth on _Exhibit B_
hereto, and, as so amended and restated shall be the Bylaws of the Surviving
Corporation, until thereafter amended in accordance with its terms and as
provided in the DGCL (subject to _Section 6.9(b)_ ); and

  



  

(c)  (i) the directors of Merger Sub immediately prior to the
Effective Time shall be the directors of the Surviving Corporation and (ii)
the officers of the Company immediately prior to the Effective Time shall be
the officers of the Surviving Corporation, in each case until their
respective successors are duly elected or appointed and qualified in
accordance with applicable Law.

  



  

Section 3.5.   _Conversion of Company Common Stock_.

  



  

(a)  Subject to _Section 3.8_ , at the Effective Time, by virtue
of the Merger and without any action on the part of Parent, Merger Sub, the
Company or any holder of Company Common Stock:

  



  

(i)  Each share of Company Common Stock (other than shares of
Company Common Stock (a) held in the treasury of the Company, (b) that at the
commencement of the Offer were owned by Parent or Merger Sub, or (c)
irrevocably accepted for payment in the Offer (collectively, the "Excluded
Shares")) shall be automatically canceled and converted into the right to
receive an amount in cash equal to the Offer Price (the "Merger
Consideration"), without interest. At the Effective Time, all of the shares
of Company Common Stock shall cease to be outstanding, shall automatically be
cancelled and shall cease to exist, and each certificate (a "Company Stock
Certificate") formerly representing any of such shares (other than Excluded
Shares) and each non-certificated share represented by book entry (a "Book
Entry Share") (other than Excluded Shares) shall thereafter represent only
the right to receive the Merger Consideration, without interest, to be
paid upon surrender of such Company Stock Certificate or Book Entry Share in
accordance with _Section 3.6_.

  



  

   

23

 



    



  

(ii)  Each Excluded Share shall, by virtue of the Merger and
without any action on the part of the holder thereof, cease to be
outstanding, shall be cancelled without payment of any consideration therefor
and shall cease to exist.

  



  

(iii)  At the Effective Time, each share of common stock, par value
$0.01 per share, of Merger Sub issued and outstanding immediately prior to
the Effective Time shall automatically be converted into one share of common
stock, par value $0.01 per share, of the Surviving Corporation.

  



  

(b)  Without duplication of the effects of _Section 2.1(g)_ ,
if, between the date hereof and the Effective Time, the outstanding Company
Common Stock are changed into a different number or class of shares by reason
of any stock split, division or subdivision of shares, stock dividend,
reverse stock split, consolidation of shares, reclassification,
recapitalization or other similar transaction, then the consideration into
which each share of Company Common Stock is converted in the Merger shall be
adjusted to the extent appropriate; _provided_ that nothing in this _Section
3.5(b)_ shall be construed to permit the Company to take any action with
respect to its securities that is prohibited by the terms of this Agreement.

  



  

Section 3.6.   _Payment for Company Common Stock_.

  



  

(a)  Prior to the Effective Time, (i) Parent shall engage
American Stock Transfer and Trust Company, or such other bank or trust company
reasonably acceptable to the Company, to act as paying agent with respect to
the Merger (the "Paying Agent"), and (ii) Parent shall deposit, or shall
cause to be deposited, with the Paying Agent cash amounts sufficient to
enable the Paying Agent to make payments of the aggregate Merger Consideration
payable pursuant to _Section 3.5_ to holders of Company Common Stock
outstanding immediately prior to the Effective Time.

  



  

(b)  Within two (2) Business Days after the Effective Time,
Parent and the Surviving Corporation shall cause the Paying Agent to mail to
each Person who was, immediately prior to the Effective Time, a holder of
record of Company Common Stock described in _Section 3.5_ a form of letter of
transmittal (mutually approved by Parent and the Company) and instructions for
use in effecting the surrender of Company Stock Certificates or Book Entry
Shares previously representing such Company Common Stock in exchange for
payment therefor. Parent shall ensure that, upon surrender to the Paying Agent
of each such Company Stock Certificate or Book Entry Share (or affidavits of
loss in lieu of the Company Stock Certificate pursuant to _Section 3.6(d)_ ),
together with a properly executed letter of transmittal, the holder of such
Company Stock Certificate or Book Entry Share (or, under the circumstances
described in _Section 3.6(d)_ , the transferee of the Company Common Stock
previously represented by such Company Stock Certificate or Book Entry Share)
shall promptly receive in exchange therefor the Merger Consideration for each
share of Company Common Stock formerly represented by such Company Stock
Certificate or Book Entry Share pursuant to _Section 3.5_. Exchange of any
Book Entry Shares shall be effected in accordance with the Paying Agent's
customary procedures with respect to securities represented by book entry.

  



  

   

24

 



    



  

(c)  On or after the first anniversary of the Effective Time,
the Surviving Corporation shall be entitled to cause the Paying Agent to
deliver to the Surviving Corporation any funds made available by Parent to the
Paying Agent which have not been disbursed to holders of Company Stock
Certificates or Book Entry Shares in accordance with this _Section 3.6_ , and
thereafter such holders shall be entitled to look to Parent and the Surviving
Corporation with respect to the cash amounts payable upon surrender of their
Company Stock Certificates or Book Entry Shares. Neither the Paying Agent nor
the Surviving Corporation shall be liable to any holder of a Company Stock
Certificate or Book Entry Share for any amount properly paid to a public
official pursuant to any applicable abandoned property or escheat law.

  



  

(d)  If any Company Stock Certificate shall have been lost,
stolen or destroyed, then, upon the making of an affidavit of that fact by
the Person claiming such Company Stock Certificate to be lost, stolen or
destroyed, and if requested by the Parent, the provision of any surety bond
or indemnity with respect to such lost, stolen or destroyed Company Stock
Certificate, Parent shall cause the Paying Agent to pay in exchange for such
lost, stolen or destroyed Company Stock Certificate the cash amount
payable in respect thereof pursuant to this Agreement.

  



  

(e)  In the event of a transfer of ownership of Company Common
Stock that is not registered in the transfer records of the Company, payment
may be made with respect to such Company Common Stock to a transferee of such
Company Common Stock if the Company Stock Certificate (if applicable)
previously representing such Company Common Stock is presented to the Paying
Agent, accompanied by all documents reasonably required by the Paying Agent
to evidence and effect such transfer and to evidence that any
applicable stock transfer taxes relating to such transfer have been paid.

  



  

(f)  At the Effective Time, the stock transfer books of the
Company shall be closed with respect to all shares of Company Common Stock
outstanding immediately prior to the Effective Time. No further transfer of
any such shares of Company Common Stock shall be made on such stock transfer
books after the Effective Time. If, after the Effective Time, a valid Company
Stock Certificate, which shares were outstanding immediately prior to the
Effective Time and converted into the right to receive the Merger
Consideration in accordance with this _Section 3.6_ , is presented to the
Paying Agent or to the Surviving Corporation or Parent, such Company Stock
Certificate shall be canceled and shall be exchanged as provided in this
_Section 3.6_.

  



  

   

25

 



    



  

(g)   The Surviving Corporation shall bear and pay all charges
and expenses, including those of the Paying Agent, incurred in connection
with the payment for Company Common Stock.

  



  

(h)  The Surviving Corporation, Parent and Merger Sub, and their
respective Affiliates, shall be entitled to deduct and withhold (or cause the
Paying Agent to deduct and withhold) from the Merger Consideration payable to
any holder of shares of Company Common Stock, such amounts in respect of
Taxes as it is required by applicable Law to deduct and withhold. To the
extent that any such amounts are so withheld and paid over to the appropriate
Governmental Entity, such withheld amounts shall be treated for purposes of
this Agreement as having been paid to the holder of shares of Company Common
Stock in respect of which such deduction and withholding was made.

  



  

Section 3.7.   _Company Compensatory Awards_.

  



  

(a)   _Company Options_. Immediately prior to the Effective
Time, by virtue of the Merger and without any action on the part of the
holder thereof, each Company In-the-Money Option, whether vested or unvested,
that is outstanding and unexercised immediately prior to the Effective Time
shall be cancelled and automatically converted into the right to receive for
each share of Company Common Stock underlying such Company Option, without
interest and subject to deduction for any required withholding under
applicable Tax Law, an amount in cash from Parent or the Surviving Corporation
equal to the excess of the Merger Consideration over the per share exercise
price of such Company Option.

  



  

(b)   _Company RSU Awards._ Immediately prior to the Effective
Time, by virtue of the Merger and without any action on the part of the
holder thereof, each Company RSU that is outstanding immediately prior to the
Effective Time, whether vested or unvested, shall be cancelled and
automatically converted into the right to receive for each share of Company
Common Stock underlying such Company RSU, without interest and subject to
deduction for any required withholding under applicable Tax Law, an amount
in cash from Parent or the Surviving Corporation equal to the Merger
Consideration.

  



  

(c)   _Company PRSU Awards_. Immediately prior to the Effective
Time, by virtue of the Merger and without any action on the part of the
holder thereof, each Company PRSU that is outstanding immediately prior to the
Effective Time, whether vested or unvested, shall be cancelled and
automatically converted into the right to receive for each share of Company
Common Stock underlying such Company PRSU that would vest at the higher of
(i) 100% target performance level, multiplied by a fraction, the numerator
of which shall be the number of calendar days from the first day of the
Company PRSU's performance measurement period to the Expiration Date and the
denominator of which shall be the number of days in the Company PRSU's
performance measurement period, or (ii) the actual level of achievement of
performance goals, calculated from the first day of the Company PRSU's
performance measurement period through the end of the calendar month
immediately preceding the Expiration Date, without interest and subject to
deduction for any required withholding under applicable Tax Law, an amount in
cash from Parent or the Surviving Corporation equal to the Merger
Consideration.

  



  

   

26

 



    



  

(d)   _General_. Prior to the Effective Time, the Company shall
take any and all such actions as are necessary (under the Company Equity
Incentive Plans, applicable award agreements, applicable Law or otherwise) to
effect the foregoing provisions of this _Section 3.7_. At or prior to the
Effective Time, Parent shall deposit, or cause to be deposited, funds
sufficient to pay the aggregate amount payable to the holders of Company
Compensatory Awards pursuant to the provisions of this _Section 3.7_  to an
account or accounts identified by the Company prior to the Effective Time. The
payments with respect to any Company Compensatory Awards shall, except as may
otherwise be required with respect to Company Compensatory Awards by Section
409A of the Code, be made by the Surviving Corporation at, or within five (5)
Business Days of, the Effective Time, without interest. All payments with
respect to Company Compensatory Awards pursuant to this _Section 3.7_ shall
be made through the Surviving Corporation's payroll and/or equity award
maintenance systems, subject to withholding if required under applicable Tax
Law.

  



  

(e)   _Company ESPP_. As soon as practicable following the date
hereof, the Company shall take all actions with respect to the Company ESPP,
including communicating with participants and prospective participants in the
Company ESPP, to maintain the Company ESPP in accordance with its terms and
applicable law and to provide that (i) after the date hereof there will be no
new offering periods, no participant may increase his or her contribution
levels, and no new participant will commence participation; and (ii) in all
events, the Company shall terminate the Company ESPP prior to the Effective
Time. Prior to the Effective Time, the Company shall take all actions
(including, if appropriate, amending the terms of the Company ESPP) that are
necessary to give effect to the transactions contemplated by this _Section
3.7(e)_.

  



  

Section 3.8.   _Appraisal Rights_.

  



  

(a)  Notwithstanding anything to the contrary contained in this
Agreement, any shares of Company Common Stock that constitute Appraisal
Shares shall not be converted into the right to receive the Merger
Consideration, and each holder of Appraisal Shares shall be entitled only to
receive such consideration as is determined to be due with respect to such
Appraisal Shares pursuant to Section 262 of the DGCL. From and after the
Effective Time, a holder of Appraisal Shares shall not have and shall not be
entitled to exercise any of the voting rights or other rights of a
stockholder of the Surviving Corporation. If any holder of Appraisal Shares
shall fail to perfect or shall otherwise waive, withdraw or lose such holder's
right to appraisal under Section 262 of the DGCL, then (i) the right of such
holder to be paid such consideration as is determined to be due pursuant to
Section 262 of the DGCL shall cease, and (ii) such Appraisal Shares shall be
deemed to have been converted as of the Effective Time into and have become
exchangeable only for the right to receive (upon the surrender of the Company
Stock Certificate(s) or Book Entry Shares previously representing such
Appraisal Shares) the Merger Consideration, without interest and reduced by
the amount of any withholding that is required under applicable Tax Law, in
accordance with _Section 3.5_.

  



  

(b)  The Company (i) shall give Parent written notice of any
demand by any stockholder of the Company for appraisal of such stockholder's
Company Common Stock pursuant to Section 262 of the DGCL, and (ii) shall give
Parent the opportunity to participate in all negotiations and proceedings
with respect to any such demand. The Company shall not make any payment
with respect to any demands for appraisal or settle or offer to settle any
such demands for appraisal without the consent of Parent.

  



  

   

27

 



    



  

(c)  For purposes of this Agreement, "Appraisal Shares" shall
refer to shares of Company Common Stock outstanding immediately prior to the
Effective Time that are held by a holder who is entitled to demand and
properly demands appraisal of such shares pursuant to, and who complies in
all respects with, Section 262 of the DGCL.

  



  

Section 3.9.   _Merger Without Meeting of Stockholders_. The Merger
shall be effected under Section 251(h) of the DGCL. The parties hereto agree
to take all necessary and appropriate action to cause the Merger to become
effective as soon as reasonably practicable following the consummation of the
Offer, without a meeting of the stockholders of the Company in accordance with
Section 251(h) of the DGCL.

  



  

Section 3.10.   _Further Action_. If, at any time after the Effective
Time, any further action is necessary to carry out the purposes of this
Agreement, the officers and directors of the Surviving Corporation and Parent
shall (in the name of Merger Sub, in the name of the Company or otherwise)
take such action.

  



  

Article 4 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY

  



  

Except (x) as disclosed in the Company Disclosure Schedule (it being
acknowledged and agreed that disclosure of any item in any Section or
subsection of the Company Disclosure Schedule shall be deemed disclosed with
respect to any other Section or subsection of the Company Disclosure Schedule
to the extent that the relevance of any disclosed event, item or occurrence in
the Company Disclosure Schedule to such other Section or subsection is
reasonably apparent as to matters and items that are the subject of the
corresponding representation or warranty in this Agreement), and (y) as set
forth in the Company SEC Documents to the extent it is reasonably apparent
that any such disclosure set forth in the Company SEC Documents would qualify
the representations and warranties contained herein, and excluding from the
Company SEC Documents any risk factor disclosures, disclosures about market
risk or other cautionary, predictive or forward-looking disclosures contained
therein (other than those disclosures which relate to specific historical
events or circumstances affecting the Company) (provided that this clause (y)
shall not apply to the representations and warranties set forth in
_Section 4.1_ (Due Organization and Good Standing; Subsidiaries), _Section
4.3_ (Capitalization), _Section 4.19_ (Authority; Binding Nature of the
Agreement), _Section 4.20_ (No Vote Required), _Section 4.21_ (Non-
Contravention; Consents), _Section 4.22_ (Section 203 of the DGCL) and
_Section 4.24_ (Brokers)), the Company represents and warrants to each of
Parent and Merger Sub as follows:

  



  

Section 4.1.   _Due Organization and Good Standing; Subsidiaries_.

  



  

(a)  The Company (i) is a corporation that is duly organized,
validly existing and in good standing under the Law of its jurisdiction of
incorporation, (ii) has corporate power and authority to own, lease and
operate its properties and assets and to conduct its business as presently
conducted and (iii) is duly qualified or licensed to do business as a foreign
corporation and is in good standing (with respect to jurisdictions that
recognize such concept) in each jurisdiction where the character of the
properties owned, leased or operated by it or the nature of its business makes
such qualification or licensing necessary, except, with respect to clause
(iii), where the failure to be so qualified or licensed would not reasonably
be expected to have a Company Material Adverse Effect.

  



  

   

28

 



    



  

(b)   _Section 4.1(b)_ of the Company Disclosure Schedule
identifies each of the Company's Subsidiaries and indicates its jurisdiction
of organization. Each such Subsidiary (i) is a corporation or other entity
that is duly organized, validly existing and in good standing (with respect
to jurisdictions that recognize such concept) under the Law of its
jurisdiction of incorporation or organization, as applicable, (ii) has
corporate (or, in the case of any Subsidiary that is not a
corporation, other) power and authority to own, lease and operate its
properties and assets and to conduct its business as presently conducted and
(iii) is duly qualified or licensed to do business as a foreign corporation or
company and is in good standing (with respect to jurisdictions that recognize
such concept) in each jurisdiction where the character of the properties
owned, leased or operated by it or the nature of its business makes such
qualification or licensing necessary, except, with respect to clause (iii),
where the failure to be so qualified or licensed would not reasonably be
expected to have a Company Material Adverse Effect. All of the outstanding
shares of capital stock or other equity interests of each Subsidiary of the
Company are owned by the Company or a wholly owned Subsidiary of the Company,
free and clear of any Encumbrances (other than transfer restrictions arising
under applicable Law).

  



  

(c)  None of the Acquired Companies owns any capital stock of,
or any equity interest of, or any equity interest of any nature in, any other
Entity, other than in the Acquired Companies or short-term investments.

  



  

Section 4.2.   _Organizational Documents_. The Company has made
available to Parent complete and correct copies of the
Organizational Documents of the Company and each Subsidiary of the Company,
and each as so made available is in full force and effect. The Company is not
in violation of any of the provisions of the Company Certificate of
Incorporation or the Company Bylaws, and none of its Subsidiaries is in
material violation of its Organizational Documents. Neither the Company nor
any of its Subsidiaries has filed for bankruptcy or filed for reorganization
under the U.S. federal bankruptcy Law or similar state or federal Law, become
insolvent or become subject to conservatorship or receivership.

  



  

Section 4.3.   _Capitalization_.

  



  

(a)  The authorized capital stock of the Company consists of:
(i) 117,500,000 shares of Company Common Stock and (ii) 2,000,000 shares of
preferred stock, par value $0.01 per share (the "Company Preferred Stock"). As
of the close of business on September 25, 2020 (the "Capitalization Date"),
(i) 34,502,648 shares of Company Common Stock were issued and outstanding,
(ii) 4,262,061 shares of Company Common Stock were subject to issuance
pursuant to Company Options, (iii) 987,485 shares of Company Common Stock
were subject to issuance pursuant to Company RSUs, (iv) 47,242 shares of
Company Common Stock were subject to issuance pursuant to Company PRSUs
assuming target-level performance achievement and 70,864 shares of Company
Common Stock are reserved for issuance under Company PRSUs assuming maximum-
level performance achievement, (v) 158,085 shares of Company Common Stock
were reserved and available for issuance under the Company ESPP, (vi) no
shares of Company Common Stock were held by the Company as treasury shares
and (vii) no shares of Company Preferred Stock were issued and outstanding.

  



  

   

29

 



    



  

(b)   _Section 4.3(b)_ of the Company Disclosure Schedule sets
forth, as of the close of business on the Capitalization Date, a list of (i)
all outstanding Company Options, including the grant date, the number of
shares of Company Common Stock subject to each such award, and the exercise
or purchase price per share, (ii) all outstanding Company RSUs, including the
grant date, and the number of shares of Company Common Stock subject to each
such award and (iii) all outstanding Company PRSUs, including the grant date,
and the number of shares of Company Common Stock subject to each such award in
the case of target level and maximum level performance achievement. Except as
set forth in Section 4.3(b) of the Company Disclosure Schedule, no Company
Compensatory Awards are subject to Section 409A of the Code.

  



  

(c)  Except as set forth in the Company's Certificate of
Incorporation, and other than the Convertible Notes, as of the Capitalization
Date, (i) none of the outstanding Company Common Stock is entitled or subject
to any preemptive right, right of repurchase, right of participation or any
similar right; (ii) none of the outstanding Company Common Stock is subject to
any right of first refusal in favor of any of the Acquired Companies; and
(iii) there is no contract to which any of the Acquired Companies is a party
relating to the voting or registration of, or restricting any Person from
purchasing, selling, pledging or otherwise disposing of (or from granting any
option or similar right with respect to), any Company Common Stock. None of
the Acquired Companies is under any obligation, nor is any of the Acquired
Companies bound by any contract pursuant to which it will become
obligated, to repurchase, redeem or otherwise acquire any outstanding Company
Common Stock or other securities. The maximum number of shares of Company
Common Stock into which the Convertible Notes could be converted is
11,694,848.

  



  

(d)  Except for the Convertible Notes, there are no bonds,
debentures, notes or other indebtedness of the Acquired Companies issued and
outstanding having the right to vote (or convertible or exercisable or
exchangeable for securities having the right to vote) on any matters on which
stockholders of the Company may vote.

  



  

(e)  Except as set forth in _Sections 4.3(a)_ and _(b)_ and
except for the Convertible Notes, there was no: (i) outstanding subscription,
option, call, warrant or other right (whether or not currently exercisable) to
acquire any shares of the capital stock, restricted stock unit, stock-based
performance unit, shares of phantom stock, stock appreciation right,
profit participation right or any other right that is linked to, or the value
of which is based on or derived from, the value of any shares of capital
stock of the Company; (ii) outstanding security, instrument, bond, debenture
or note that is or may become convertible into or exchangeable for any shares
of the capital stock or other securities of any of the Acquired Companies; or
(iii) stockholder rights plan (or similar plan commonly referred to as a
"poison pill") or Contract under which any Acquired Company is or may become
obligated to sell or otherwise issue any shares of its capital stock or any
other securities.

  



  

(f)  All of the outstanding shares of Company Common Stock have
been duly authorized and validly issued, and are fully paid and
nonassessable.

  



  

   

30

 



    



  

Section 4.4.   _SEC Filings; Financial Statements._

  



  

(a)  All reports, schedules, forms, statements and other
documents (including exhibits and all other information incorporated therein)
required to be filed by the Company with the SEC since January 1, 2018 (the
"Company SEC Documents") have been filed with the SEC on a timely basis. As
of the time it was filed with the SEC (or, if amended or superseded by a
filing prior to the date hereof, then on the date of such filing): (i) each
of the Company SEC Documents complied as to form in all material respects
with the applicable requirements of the Securities Act, the Exchange Act and
the Sarbanes-Oxley Act (as the case may be); and (ii) none of the Company SEC
Documents contained when filed (and, in the case of registration statements
and proxy statements, on the dates of effectiveness and the dates of mailing,
respectively) any untrue statement of a material fact or omitted, as the case
may be, to state a material fact required to be stated or incorporated by
reference therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading.

  



  

(b)  The financial statements (including any related notes)
contained or incorporated by reference in the Company SEC Documents: (i)
complied as to form in all material respects with the published rules and
regulations of the SEC applicable thereto; (ii) were prepared in accordance
with GAAP applied on a consistent basis throughout the periods covered (except
as may be indicated in the notes to such financial statements or, in the case
of unaudited statements, as permitted by Form 10-Q, Form 8-K or any
successor form under the Exchange Act, and except that unaudited financial
statements may not contain footnotes and are subject to normal and recurring
year-end adjustments); and (iii) fairly present, in all material respects, the
financial position of the Company as of the respective dates thereof and the
results of operations of the Company for the periods covered thereby. No
financial statements of any Person other than the Acquired Companies are
required by GAAP to be included in the consolidated financial statements
of the Company.

  



  

(c)  The Company has established and maintains disclosure
controls and procedures and a system of internal control over financial
reporting (as such terms are defined by Rule 13a-15 or 15d-15 under the
Exchange Act). Since January 1, 2018, the principal executive officer and the
principal financial officer of the Company have made all certifications
required by the Sarbanes-Oxley Act. The Company is in compliance in all
material respects with all current listing requirements of NASDAQ.

  



  

(d)  None of the Acquired Companies has effected, entered into
or created any securitization transaction or "off-balance sheet arrangement"
(as defined in Item 303(c) of Regulation S-K under the Exchange Act) where the
result, purpose or intended effect of such transaction or arrangement is to
avoid disclosure of any material transaction involving, or material
liabilities of, the Acquired Companies in its published financial statements
or other Company SEC Documents.

  



  

(e)  As of the date hereof, there are no outstanding or
unresolved comments in comment letters received from the SEC with respect to
the Company SEC Documents.

  



  

   

31

 



    



  

(f)   Except as permitted by the Exchange Act, including
Sections 13(k)(2) and (3), since January 1, 2018, none of the Acquired
Companies has made or permitted to remain outstanding any "extensions of
credit" (within the meaning of Section 402 of the Sarbanes-Oxley Act) or
prohibited loans to any executive officer (as defined in Rule 3b-7 under the
Exchange Act) or director of the Company.

  



  

(g)  As of the date hereof, the Acquired Companies do not have
any liabilities of any nature (whether accrued, absolute, contingent or
otherwise), except for: (i) liabilities disclosed in the financial statements
(including any related notes) contained in the Company SEC Documents; (ii)
liabilities incurred in the ordinary course of business since the date of the
Most Recent Balance Sheet; (iii) liabilities to perform under Contracts
entered into by the Acquired Companies in the ordinary course of
business; (iv) liabilities incurred in connection with the Transactions; and
(v) liabilities that have not had, and would not reasonably be expected to
have, individually or in the aggregate, a Company Material Adverse Effect.

  



  

Section 4.5.   _Absence of Certain Changes_. Since the date of the
Most Recent Balance Sheet through the date hereof, and except as specifically
contemplated by, or as disclosed in, this Agreement, the Acquired Companies
have conducted their businesses in all material respects in the ordinary
course consistent with past practice and, since and through such dates, there
has not been any Company Material Adverse Effect.

  



  

Section 4.6.   _Intellectual Property Rights_.

  



  

(a)   _Section 4.6(a)_ of the Company Disclosure Schedule lists
all Patents, Marks and Copyrights included in the Company Intellectual
Property that are issued by, registered or the subject of an application filed
with, as applicable, the U.S. Patent and Trademark Office, the U.S. Copyright
Office or in any similar office or agency anywhere in the world (such
registrations and applications, the "Company Registered IP"), including, with
respect to each such registration and application, (i) the jurisdiction of
application/registration, (ii) the application or registration number, (iii)
the date of filing or issuance for each such item, and (iv) if applicable,
the expiry dates for such registration and/or application. As of the date of
this Agreement, to the Knowledge of the Company, no Company Registered IP is
invalid or unenforceable, except for such exceptions as have not had or would
not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect.

  



  

(b)  The Company Intellectual Property is owned by the Acquired
Companies free and clear of any Encumbrance, other than Permitted
Encumbrances.

  



  

(c)   _Section 4.6(c)_ of the Company Disclosure Schedule
identifies, as of the date of this Agreement, (i) each Company Inbound
License and (ii) each Company Outbound License.

  



  

(d)  The operation of the business of the Acquired Companies as
currently conducted does not infringe or misappropriate any Intellectual
Property owned by another Person, except as has not had, and would not
reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect. As of the date of this Agreement, there is no Legal
Proceeding pending or, to the Knowledge of the Company, threatened in
writing, against any of the Acquired Companies relating to any
infringement or misappropriation of any Intellectual Property of another
Person by any of the Acquired Companies, except as would not reasonably be
expected to have, individually or in the aggregate, a Company Material Adverse
Effect.

  



  

   

32

 



    



  

(e)  None of the Acquired Companies is subject to any judgment,
order, writ, injunction or decree of any court or any Governmental Entity or
any arbitrator, nor has any of the Acquired Companies entered into or is a
party to any agreement made in settlement of any pending or threatened
litigation, which materially restricts or impairs the use of any material
Company Intellectual Property.

  



  

(f)  No other Person is infringing or misappropriating any
Company Intellectual Property or Intellectual Property exclusively licensed
to the Acquired Companies under any Company Inbound License, except as would
not, individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect.

  



  

(g)  The Acquired Companies have taken commercially reasonable
steps necessary to maintain the confidentiality of the material Trade Secret
Rights held by any of the Acquired Companies, or purported to be held by any
of the Acquired Companies, as a trade secret, except as would not,
individually or in the aggregate, reasonably be expected to have a Company
Material Adverse Effect.

  



  

(h)  Notwithstanding anything to the contrary in this Agreement,
the representations and warranties set forth in this  _Section 4.6_ shall
constitute the only representations and warranties by the Company with respect
to Intellectual Property matters.

  



  

(i)  To the Knowledge of the Company, no funding, facilities
or personnel of any Governmental Entity or any university, college, research
institute or other educational institution has been used to create any
material Company Intellectual Property or Intellectual Property exclusively
licensed to the Acquired Companies under any Company Inbound License, except
for any such funding or use of facilities or personnel that has not resulted
in such Governmental Entity or institution obtaining ownership or other
rights to such Intellectual Property.

  



  

Section 4.7.   _Title to Assets; Real Property_.

  



  

(a)  Except as has not had, and would not reasonably be expected
to have, individually or in the aggregate, a Company Material Adverse Effect,
the Acquired Companies have good title to, or in the case of assets purported
to be leased by the Acquired Companies, valid leasehold interests in, each of
the tangible assets reflected as owned or leased by the Acquired Companies
on the Most Recent Balance Sheet (except for tangible assets sold or disposed
of since the date of the Most Recent Balance Sheet and except for tangible
assets being leased to the Acquired Companies with respect to which the lease
has expired since such date), free of any liens or Encumbrances (other than
Permitted Encumbrances).

  



  

(b)  None of the Acquired Companies owns any real property.

  



  

   

33

 



    



  

(c)   _Section 4.7(c)_ of the Company Disclosure Schedule sets
forth the address of each Leased Real Property and the applicable Acquired
Company which holds a leasehold interest in such Leased Real Property. The
Company has made available to Parent a correct and complete copy of each
lease or sublease with respect to each Leased Real Property and, as of the
date hereof, each such lease or sublease for a Leased Real Property is valid
and binding on the Acquired Companies, as the case may be, and, to the
Knowledge of the Company, each other party thereto, as applicable, and in full
force and effect, except as may be limited by bankruptcy, insolvency,
moratorium and other similar applicable Law affecting creditors' rights
generally and by general principles of equity. As of the date hereof, no
Acquired Company has, and to the Knowledge of the Company, none of the other
parties thereto have, violated any provision of, or committed or failed to
perform any act, and no event or condition exists, which with or without
notice, lapse of time or both would constitute a default under the provisions
of any such lease or sublease, except in each case for those violations and
defaults which, individually or in the aggregate, would not reasonably be
expected to result in a Company Material Adverse Effect and, as of the date
hereof, no Acquired Company has received written notice of any of
the foregoing.

  



  

Section 4.8.   _Contracts_.

  



  

(a)  As of the date hereof, none of the Acquired Companies is a
party to or is bound by any Contract:

  



  

(i)  that is a "material contract" (as such term is defined in
Item 601(b)(10) of Regulation S-K of the Exchange Act);

  



  

(ii)  pursuant to which any Acquired Company made or received
payments of more than an aggregate of $1,000,000 during the fiscal year ended
December 31, 2019 or is committed to make or entitled to receive payments of
more than an aggregate of $1,000,000 during the fiscal year ending December
31, 2020;

  



  

(iii)  evidencing a commitment by an Acquired Company to make a
future capital expenditure in excess of $1,000,000 that is not terminable by
such Acquired Company upon notice of thirty (30) days or less without material
penalty or liability;

  



  

(iv)  containing a covenant limiting the ability of any Acquired
Company to compete or engage in any line of business or to compete with any
Person in any geographic area that is not terminable by such Acquired Company
upon notice of thirty (30) days or less without material penalty or
liability;

  



  

(v)  relating to or evidencing indebtedness for borrowed money
or any guarantee of indebtedness for borrowed money by any Acquired Company
in excess of $1,000,000 (excluding loans to wholly-owned Subsidiaries in the
ordinary course of business consistent with past practice);

  



  

(vi)  that is a joint venture, partnership, strategic alliance,
research and development project or similar arrangement that is material to
the business of the Acquired Companies taken as a whole;

  



  

   

34

 



    



   



  

(vii)   that (A) is with any sole-source suppliers of material
products or services, or (B) obligates the Company with respect to any "most
favored nation" clauses, any exclusive dealing or minimum purchase or sale,
"take or pay" obligations, requirement to purchase substantially all of the
output or production of a particular supplier, or (C) prohibits the Company
or its Subsidiaries from acquiring products or services from any Person and,
in each case of clause (B) and (C) is material to the Company;

  



  

(viii)  that is a Company Inbound License or Company Outbound License;

  



  

(ix)  that is the type of Contract that would be required to be
disclosed under Item 404 of Regulation S-K of the Exchange Act; or

  



  

(x)  with any present or former officer, director or employee of
any Acquired Company (other than employment related agreements or
indemnification, confidentiality, assignment of invention, equity awards or
similar types of agreements entered into in the ordinary course of business
in connection with their engagement).

  



  

(b)  Each Contract of the type described above in this _Section
4.8_ , whether or not set forth in _Section 4.8_  of the Company Disclosure
Schedule, is referred to herein as a "Material Contract". Except Material
Contracts that have expired or terminated by their terms, as of the date
hereof, all of the Material Contracts are valid and binding on the Acquired
Companies, as the case may be, and, to the Knowledge of the Company, each
other party thereto, as applicable, and in full force and effect, except as
may be limited by bankruptcy, insolvency, moratorium and other similar
applicable Law affecting creditors' rights generally and by general
principles of equity. As of the date hereof, no Acquired Company has, and to
the Knowledge of the Company, none of the other parties thereto have,
violated any provision of, or committed or failed to perform any act, and no
event or condition exists, which with or without notice, lapse of time or
both would constitute a default under the provisions of any Material
Contract, except in each case for those violations and defaults which have not
had, and would not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect and, as of the date hereof, no
Acquired Company has received written notice of any of the foregoing. The
Company has made available to Parent complete and correct copies of all
Material Contracts in effect as of the date hereof.

  



  

Section 4.9.   _Compliance_ (a). The Company and its Subsidiaries are
and, since January 1, 2018, have been in compliance with all Laws applicable
to the Acquired Companies, and, since January 1, 2018, have not received any
written notice alleging any violation with respect to any applicable Laws,
except in each case as has not had, and could not reasonably be expected to
have, individually or in the aggregate, a Company Material Adverse Effect.

  



  

Section 4.10.   _Certain Business Practices_.

  



  

(a) Each of the Acquired Companies is and since January 1, 2018
has been in compliance with the Foreign Corrupt Practices Act of
1977 (including its provisions concerning maintaining accurate books and
records and adequate internal controls), as amended, the U.K. Bribery Act and
any other U.S. or foreign Law concerning corrupt payments applicable to any
Acquired Company. Since January 1, 2018 through the date of this Agreement,
none of the Acquired Companies has, to the Knowledge of the Company,
been investigated by any Governmental Entity with respect to, and none of the
Acquired Companies has been given written notice by a Governmental Entity of,
any violation by any of the Acquired Companies of the Foreign Corrupt
Practices Act of 1977, as amended, the U.K. Bribery Act, or any other U.S. or
foreign Law concerning corrupt payments. None of the Acquired Companies nor,
to the Knowledge of the Company, any Company Associate authorized to act, and
acting, on behalf of an Acquired Company has unlawfully paid or given,
offered or promised to pay or give, or authorized or ratified the payment or
giving, directly or indirectly, of any monies or anything of value to any
national, provincial, municipal or other government official or employee or
any political party or candidate for political office or Governmental Entity
for the direct or indirect purpose of influencing any act or decision of such
Person or of the Governmental Entity to obtain or retain business, or
direct business to any Person or to secure any other improper benefit or
advantage. For purposes of this provision, an "official or employee" includes
any known official or employee of any directly or indirectly government-owned
or controlled entity, and any known officer or employee of a public
international organization, as well as any Person known to be acting in an
official capacity for or on behalf of any such government or department,
agency, or instrumentality, or for or on behalf of any such public
international organization.

  



  

   

35

 



    



  

(b)  Since January 1, 2018, none of the Acquired Companies, and,
to the Knowledge of the Company, no director, officer, employee, consultant,
or agent thereof (in each case acting for or on behalf of any Acquired
Company) (i) is or has been a Sanctioned Person, (ii) has unlawfully
transacted business with or for the benefit of any Sanctioned Person or
otherwise violated Sanctions; nor (iii) has been given notice by a
Governmental Entity of any violation by any of the Acquired Companies of
applicable Sanctions.

  



  

Section 4.11.   _Legal Proceedings; Orders_.

  



  

(a)  As of the date hereof, there is no Legal Proceeding pending
or being overtly threatened in writing against the Acquired Companies that
could reasonably be expected to have a Company Material Adverse Effect. The
Company has made available to the Parent copies of all material pleadings and
other documents relating to all material Legal Proceedings pending against the
Acquired Companies as of the date hereof, except those in respect of which
the Company is entitled to attorney-client privilege.

  



  

(b)  As of the date hereof, there is no material Order
applicable to the Acquired Companies under which any of them is subject to
material ongoing obligations.

  



  

(c)  As of the date hereof, to the Knowledge of the Company,
there is no pending, or overtly threatened, investigation by any Governmental
Entity with respect to the Acquired Companies that could reasonably be
expected to have a Company Material Adverse Effect.

  



  

Section 4.12.   _Tax Matters_.

  



  

(a) The Acquired Companies have filed with the appropriate
Governmental Entities all material Tax Returns that are required to be filed
by them, and all such Tax Returns are true, correct and complete in all
material respects. All Taxes due and owing by the Acquired Companies as shown
to be due on such Tax Returns have been timely paid. None of the Acquired
Companies currently is the beneficiary of any extension of time within which
to file any material Tax Return other than customary extensions for which no
approval is required. There are no Encumbrances on any of the assets of the
Acquired Companies that arose in connection with any failure (or alleged
failure) to pay any Tax, other than Permitted Encumbrances.

  



  

   

36

 



    



  

(b)  The most recent financial statements contained in the
Company SEC Documents reflect an adequate reserve in accordance with GAAP for
all material amounts of Taxes payable by the Acquired Companies for taxable
periods and portions thereof accrued through the date of such financial
statements and since the date of such financial statements, neither no
Acquired Company has incurred any Tax liabilities other than Taxes relating
to ordinary course operations conducted by the Acquired Companies.

  



  

(c)  The Acquired Companies have timely withheld and paid to the
appropriate Governmental Entity all material Taxes required to have been
withheld and paid in connection with amounts paid or owing to any employee,
independent contractor, creditor, stockholder or other Third Party.

  



  

(d)  There is no dispute concerning any material Tax liability
of the Acquired Companies raised by any Governmental Entity in writing to the
Acquired Companies that is pending or remains unpaid and none of the Acquired
Companies has received written notice of any threatened audits, or
investigations relating to any material Taxes.

  



  

(e)  No claim has been made in writing or, to the Company's
Knowledge, otherwise, by a Governmental Entity in a jurisdiction where any of
the Acquired Companies does not file Tax Returns of a certain type that any
Acquired Company is or may be subject to taxation of such type or required to
file Tax Returns of such type in that jurisdiction.

  



  

(f)  None of the Acquired Companies has waived any statute of
limitations in respect of Taxes or agreed to, or requested, any extension of
time with respect to a Tax assessment or deficiency, in each case that is in
effect as of the date hereof.

  



  

(g)  There are no agreements relating to the allocating or
sharing of Taxes, including Tax indemnity agreements, to which the Acquired
Companies are a party other than customary agreements and contracts, the
principal purpose of which is not related to Taxes.

  



  

(h)  No Acquired Company has participated in any "listed
transaction" within the meaning of Treasury Regulations Section
1.6011-4(b)(2) (or any similar provision of state, local or foreign Law).

  



  

(i) None of the Acquired Companies (i) has been a member of
an affiliated group of corporations within the meaning of Section 1504 of the
Code or within the meaning of any similar provision of Law to which the
Acquired Companies may be subject, other than the affiliated group of which
the Company is the common parent or (ii) has any liability for the Taxes of
any Person (other than any Acquired Company) under Treasury Regulations
Section 1.1502-6, Section 1.1502-78 (or any similar provision of Law) as
a transferee or successor, or by contract or otherwise.

  



  

   

37

 



    



  

(j)  None of the Acquired Companies has been a "controlled
corporation" or a "distributing corporation" in any distribution that was
intended to be governed by Section 355 of the Code (or any similar provision
of state, local or non-U.S. law) that occurred during the two (2)-year period
ending on the date hereof or which otherwise constitutes part of a "plan" or
"series of related transactions" within the meaning of Section 355(e) of the
Code in conjunction with the Merger.

  



  

(k)  None of the Acquired Companies is bound with respect to any
current or any future taxable period by any closing agreement (within the
meaning of Section 7121 of the Code), private letter ruling, technical advice
or other ruling or written agreement with a Governmental Entity with respect
to Taxes, in each case, that could reasonably be expected to affect the
liability for Taxes of any of the Acquired Companies following the Closing.

  



  

(l)  Notwithstanding anything to the contrary in this
Agreement, the representations and warranties set forth in this  _Section
4.12_ and _Section 4.13_ (to the extent it relates to Taxes) shall constitute
the only representations and warranties by the Company with respect to Tax
matters in this Agreement.

  



  

Section 4.13.   _Employee Benefit Plans_.

  



  

(a)   _Section 4.13(a)_ of the Company Disclosure Schedule sets
forth a true and complete list of each Company Benefit Plan (other than any
employment agreement or offer letter that is terminable "at will" (or
following a notice period imposed by applicable Law) without any contractual
obligation on the part of any Acquired Company to make any severance,
termination, change in control, or similar payment). With respect to each
material Company Benefit Plan, the Company has made available to Parent, to
the extent applicable, true, correct and complete copies of (1) all documents
embodying such Company Benefit Plan, including (without limitation) all
amendments thereto and all related trust documents, insurance contracts or
other funding vehicles, (2) written descriptions of any Company Benefit Plans
that are not set forth in a written document, (3) the most recent summary
plan description for each applicable Company Benefit Plan, together with the
summary or summaries of material modifications thereto, (4) the most recent
determination or opinion letter issued by the IRS with respect to any Company
Benefit Plan and related trust intended to be qualified under Section 401(a)
of the Code and any pending request for such a determination letter, (5) the
two most recent annual reports (Form 5500 or 990 series and all schedules and
financial statements attached thereto) and (6) each trust agreement and group
annuity or insurance Contract and other funding or payment documents.

  



  

(b)  None of the Acquired Companies nor any of their respective
ERISA Affiliates contributes to or has in the past six (6) years maintained,
sponsored, contributed to, or had any obligation to maintain, sponsor or
contribute to, or had any liability or obligation in respect of, any "defined
benefit plan" (as defined in Section 3(35) of ERISA), or any
Multiemployer Plan, or any plan subject to Section 412 of the Code or Section
302 or Title IV of ERISA.

  



     

   

38

 



    



  

(c)   Each Company Benefit Plan intended to be qualified under
Section 401(a) of the Code has (i) received or is permitted to rely upon a
favorable determination, advisory and/or opinion letter from the IRS, and, to
the Knowledge of the Company, no event has occurred since the date of such
determination or opinion that would reasonably be expected to adversely affect
such determination or (ii) has pending or has time remaining in which to
file, an application for such determination from the IRS.

  



  

(d)  (i) Each Company Benefit Plan (A) has been maintained in
material compliance with its terms and with the requirements prescribed by
applicable Laws, including ERISA and the Code, (B) has been administered,
funded, and to the extent applicable, the assets of such Company Benefit Plan
have been invested, in all material respects, in accordance with its terms and
all applicable Laws, including ERISA and the Code, (ii) no material
litigation has commenced with respect to any Company Benefit Plan (other
than routine claims for benefits) and no such litigation is threatened in
writing; and (iii) there are no material governmental audits or
investigations pending or threatened in writing in connection with any Company
Benefit Plan. All contributions required to be made under each Company
Benefit Plan, as of the date of this Agreement, have been timely made and all
obligations in respect of each Company Benefit Plan have been properly
accrued and reflected in the Most Recent Balance Sheet.

  



  

(e)  Except as set forth in _Section 4.13(e)_ of the Company
Disclosure Schedules, or as provided in _Section 3.7_ , neither the execution
and delivery of this Agreement nor the consummation of the Transactions will
(either alone or together with any other event) (i) result in, or cause the
accelerated vesting, funding or delivery of, or increase the amount or value
of, any payment or benefit to any employee, officer, director or other
service provider of any Acquired Company, (ii) result in any
"parachute payment" (as defined in Section 280G(b)(2) of the Code) or (iii)
result in a requirement to pay any tax "gross-up" or similar "make-whole"
payments to any employee, director or consultant of any Acquired Company
(including those payable pursuant to Section 409A or 4999 of the Code), or
(iv) entitle any current or former employee or officer of any Acquired
Company to any severance pay, material unemployment compensation or any other
material payment.

  



  

(f)  No Company Benefit Plan provides for post-retirement or
post-termination health, life insurance or other welfare benefits except as
required under Part 6 of Subtitle B of Title I of ERISA or Section 4980B of
the Code or similar state Law. No Company Benefit Plan is maintained
primarily for the benefit of employees based outside of the United States, and
none of the Acquired Companies nor any of their respective ERISA Affiliates
has at any time sponsored or contributed to, or had any obligation to
sponsor or contribute to, or had any Liability or obligation in respect of,
any such non-U.S. plan.

  



  

(g)  Each Company Benefit Plan that is a "non-qualified deferred
compensation plan" (as such term is defined in Section 409A(d)(1) of the
Code) has been operated and maintained in material compliance with the
requirements of Section 409A of the Code and applicable guidance issued
thereunder.

  



  

(h)  Notwithstanding anything to the contrary in this Agreement,
the representations and warranties set forth in this  _Section 4.13_ shall
constitute the only representations and warranties by the Company with respect
to ERISA matters.

  



  

   

39

 



    



  

Section 4.14.   _Labor Matters_.

  



  

(a)  The Acquired Companies are in material compliance in all
respects with all applicable Laws and Orders respecting labor, employment,
fair employment practices (including equal employment opportunity laws), terms
and conditions of employment, workers' compensation, occupational safety and
health, affirmative action, employee privacy, plant closings,
immigration, classification and wages and hours, except as would not be
material. Neither the Company nor any of its Subsidiaries is delinquent in
any payments to their respective employees for any wages, salaries,
commissions, bonuses or other direct compensation for any services performed
for the Company or any of its Subsidiaries in any material respect.

  



  

(b)  As of the date hereof, the employees of the Acquired
Companies are not represented by a labor union or works council and there is
not, to the Knowledge of the Company, any attempt to organize any employees of
the Acquired Companies for the purpose of forming or joining a labor union or
works council. No strike, slowdown, picketing, work stoppage or other material
labor dispute by the employees of the Acquired Companies is ongoing or is
being threatened in writing.

  



  

(c)  As of the date hereof, no material Legal Proceeding by any
Company employee for unpaid wages, bonuses, commissions, unpaid overtime,
child labor or record keeping violations is pending or, to the Knowledge of
the Company, is threatened under the Fair Labor Standards Act, the Davis-
Bacon Act of 1931, the Walsh-Healey Act of 1936 or the McNamara-O'Hara Service
Contract Act of 1965, or any other Law. As of the date hereof, no
discrimination, illegal harassment and/or retaliation Legal Proceeding by any
Company employee is pending or, to the Knowledge of the Company, is threatened
against the Acquired Companies or any employee, officer or director of the
Company under the 1964 Civil Rights Acts, the Equal Pay Act of 1963, the Age
Discrimination in Employment Act, the Americans with Disabilities Act, the
Family and Medical Leave Act, the Fair Labor Standards Act, or any other
federal labor or employment Law or comparable state fair employment practices
act. To the Knowledge of the Company, no material wrongful discharge,
retaliation, libel, slander or other Legal Proceeding by any Company employee
that arises out of the employment relationship between the Acquired Companies
and their respective employees is pending or, to the Knowledge of the Company,
is threatened against the Acquired Companies under any applicable Law.

  



  

(d)  Within the past two (2) years, none of the Acquired
Companies has implemented or incurred any liability or obligation with
respect to any plant closing or layoff of employees that (in either case)
violated the WARN Act.

  



  

(e)  Notwithstanding anything to the contrary in this Agreement,
the representations and warranties set forth in this  _Section 4.14_ shall
constitute the only representations and warranties of the Company with respect
to employment and labor matters.

  



  

   

40

 



    



  

Section 4.15.   _Company Products_.

  



     

(a)   The Company is and has been in compliance with all
applicable laws administered or issued by FDA or any similar governmental
entity, whether in the U.S. or abroad, including the FDCA, its implementing
regulations, and all other Laws regarding developing, testing, manufacturing,
marketing, distributing or promoting Company Products, or complaint handling
or adverse event reporting, except as would not, individually or in the
aggregate, reasonably be expected to have a Company Material Adverse Effect.

  



  

(b)  For all marketed Company Products, the Acquired Companies
possess all permits, licenses, registrations, certificates, authorizations,
orders and approvals from the appropriate federal or state regulatory
authorities necessary to conduct its business as now conducted, including all
such permits, licenses, registrations, certificates, authorizations, orders
and approvals required by FDA or any other federal or state agencies or
bodies engaged in the regulation of drugs, pharmaceuticals, or biohazardous
materials, except as would not, individually or in the aggregate, reasonably
be expected to have a Company Material Adverse Effect. Except as set forth in
_Section 4.15(b)_ of the Company Disclosure Schedule, the Company has not
received any written notice of proceedings relating to the suspension,
modification, revocation or cancellation of any such permit, license,
registration, certificate, authorization, order or approval. Neither any
Acquired Company nor, to the Knowledge of the Company, any officer, employee
or agent of the Company, has been convicted of any crime or engaged in any
conduct that has previously caused or would reasonably be expected to
result in (A) disqualification or debarment by the FDA under 21 U.S.C.
Sections 335(a) or (b), or any by any other Governmental Entity under any
similar Law, (B) debarment, suspension, or exclusion under any federal
healthcare programs or by the General Services Administration, or (C)
exclusion under 42 U.S.C. Section 1320a-7 or any similar Law. Neither any
Acquired Company nor any of its officers, employees or, to the Knowledge of
the Company, contractors or agents is the subject of any pending or, to the
Knowledge of the Company, threatened investigation by FDA pursuant to its
"Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities"
policy as stated at 56 Fed. Reg. 46191 (September 10, 1991) (the "FDA
Application Integrity Policy") and any amendments thereto, or by any other
similar governmental entity pursuant to any similar policy. Neither the
Company nor any of its officers, employees or, to the Knowledge of the
Company, its contractors or agents has committed any act, made any statement
or failed to make any statement that would reasonably be expected to provide a
basis for FDA to invoke the FDA Application Integrity Policy or for any
similar governmental entity to invoke a similar policy. Neither the Company
nor any of its officers, employees or to the Knowledge of the Company, any of
its contractors or agents has made any materially false statements on, or
material omissions from, any notifications, applications, approvals, reports
and other submissions to FDA or any similar governmental entity.

  



  

(c) For all Company Products that are currently being marketed,
the Company and its Subsidiaries are in compliance with all Laws related to
governmental payment and procurement programs, including programs under
Medicare, Medicaid, TRICARE, and CHAMPVA, except as would not, individually
or in the aggregate, reasonably be expected to have a Company Material Adverse
Effect, and have not received any written notice of any alleged non-
compliance therewith. Except as set forth in _Section 4.15(c)_  of the
Company Disclosure Schedule, none of the Acquired Companies is engaged in or
the subject of termination proceedings as to any federal healthcare programs,
nor has it received written notice that its current participation in any
governmental payment and procurement program is subject to any contest,
termination or suspension.

  



  

   

41

 



    



  

Section 4.16.   _Environmental Matters_ (a). Except for such matters that
individually and in the aggregate have not had and would not reasonably be
expected to have a Company Material Adverse Effect: (i) each of the
Acquired Companies is, and for the past three (3) years has been, in
compliance with all applicable Environmental Laws and possesses and is in
compliance with all Environmental Permits; (ii) there are no Environmental
Claims pending or, to the Knowledge of the Company, threatened in writing
against the Acquired Companies; and (iii) to the Knowledge of the Company,
none of the Acquired Companies has released any Hazardous Materials at, on,
under or from any property currently or formerly owned or leased by the
Acquired Companies in an amount or manner which would reasonably be expected
to result in material liability to any Acquired Company under
Environmental Law. Notwithstanding anything to the contrary in this
Agreement, the representations and warranties set forth in this
_Section 4.16_ shall constitute the only representations and warranties of
the Company with respect to environmental matters.

  



  

Section 4.17.   _Insurance_. From January 1, 2018 through the date
hereof, none of the Acquired Companies has received any
communication notifying the Company of any (a) premature cancellation or
invalidation of any material insurance policy held by any Acquired
Company (except with respect to policies that have been replaced with similar
policies), (b) written denial of any material claim under any material
insurance policy held by the Acquired Companies or (c) material increase in
the amount of the premiums payable with respect to any material insurance
policy held by the Company that has not already gone into effect. As of the
date hereof, there is no pending material claim by any Acquired Company
against any insurance carrier under any insurance policy held by any
Acquired Company.

  



  

Section 4.18.   _Privacy and Data Security_. Each of the Acquired
Companies has complied with all applicable Privacy Laws relating to privacy
of Personal Information regarding data subjects (including clinical trial
participants, patients, patient family members, caregivers or advocates,
physicians and other health care professionals, clinical trial investigators,
researchers and pharmacists) that interact with any of the Acquired Companies
in connection with the operation of the Acquired Companies' business,
except for such non-compliance as has not had, and would not reasonably be
expected to have, individually or in the aggregate, a Company Material
Adverse Effect. The Acquired Companies have complied with each of their
respective written and published policies and procedures concerning the
privacy and security of Personal Information (the "Privacy Policies"), except
for such non-compliance as has not had, and would not reasonably be expected
to have, individually or in the aggregate, a Company Material Adverse Effect.
To the Knowledge of the Company, as of the date hereof, no claims have been
asserted or threatened against the Acquired Companies by any Person alleging
a violation of Privacy Laws and/or Privacy Policies.

  



  

Section 4.19. _Authority; Binding Nature of Agreement_. The Company has
the requisite corporate power and authority to enter into and to perform
its obligations under this Agreement. The Company Board has (a) approved,
adopted and declared advisable this Agreement and the Transactions, including
the Offer and the Merger, (b) determined that the Transactions, including the
Offer and the Merger, are in the best interests of the Company and its
stockholders, (c) agreed that this Agreement will be effected under Section
251(h) of the DGCL, and (d) resolved to recommend that the stockholders of the
Company accept the Offer and tender their shares of Company Common Stock to
Merger Sub pursuant to the Offer (such Company Board Recommendation not having
been rescinded, modified or altered in any way, as of the date hereof).
Assuming the Transactions are consummated in accordance with Section 251(h)
of the DGCL, and assuming the accuracy of Parent's and Merger Sub's
representations and warranties set forth in _Section 5.5_ , the execution and
delivery of this Agreement by the Company and the consummation by the Company
of the Merger have been duly authorized by all necessary corporate action on
the part of the Company, and no other corporate proceedings on the part of
the Company are necessary to authorize the execution, delivery and performance
by the Company of this Agreement. This Agreement has been duly executed and
delivered on behalf of the Company and, assuming the due authorization,
execution and delivery of this Agreement on behalf of Parent and Merger Sub,
constitutes the valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms, subject to (i) laws
of general application relating to bankruptcy, insolvency and the relief of
debtors and (ii) rules of law governing specific performance, injunctive
relief and other equitable remedies.

  



  

   

42

 



    



  

Section 4.20.   _No Vote Required_. Assuming the Transactions are
consummated in accordance with Section 251(h) of the DGCL and assuming the
accuracy of Parent and Merger Sub's representations and warranties set forth
in _Section 5.5_ , no stockholder votes or consents are needed to authorize
this Agreement or to consummate the Transactions.

  



  

Section 4.21.   _Non-Contravention; Consents_. Except, in the case of the
following clauses (b) and (c), as would not have, individually or in the
aggregate, a Company Material Adverse Effect, the execution and delivery of
this Agreement by the Company, the acquisition of Company Common Stock by
Merger Sub pursuant to the Offer and the consummation by the Company of the
Merger will not: (a) cause a violation of any of the provisions of the
Organizational Documents of any Acquired Company; (b) cause a violation by
the Company of any Law applicable to the business of any Acquired Company; or
(c) require any consent, cause a default, or give rise to a right of
termination, cancelation or acceleration of any obligation or loss of a
material benefit of any Acquired Company, under any Material Contract. Except
as may be required by the Exchange Act, the DGCL, the listing requirements of
NASDAQ, the HSR Act or other applicable Antitrust Laws, none of the Acquired
Companies is required to make any filing with or to obtain any consent from
any Governmental Entity at or prior to the Acceptance Time in connection with
the execution and delivery of this Agreement by the Company or the
consummation by the Company of the Merger, except where the failure to make
any such filing or obtain any such consent would not have, individually or in
the aggregate, a Company Material Adverse Effect.

  



  

Section 4.22.   _Section 203 of the DGCL_. Assuming the accuracy of
Parent and Merger Sub's representations and warranties set forth in _Section
5.5_ , the Company Board has taken or will take all action necessary to render
Section 203 of the DGCL inapplicable to the Offer and the Merger.

  



  

Section 4.23. _Opinion of Financial Advisor_. The Company Board has
received the opinion of Goldman Sachs and Co. LLC to the effect that, as of the
date of such opinion and based on and subject to the factors, assumptions,
qualifications and limitations set forth in such opinion, the Offer Price to
be paid to the holders of Company Common Stock (other than Parent, Merger Sub
and their respective Affiliates) pursuant to this Agreement is fair, from a
financial point of view, to such holders. A copy of such written opinion
shall be provided to Parent solely for informational purposes after receipt
thereof by the Company.

  



  

   

43

 



    



  

Section 4.24.   _Brokers_. No broker, finder or investment banker (other
than Goldman Sachs and Co. LLC) is entitled to any brokerage, finder's or other
similar fee or commission in connection with the Offer or the Merger based
upon arrangements made by or on behalf of any Acquired Company.

  



  

Section 4.25.   _Schedule 14D-9_. The Schedule 14D-9 will comply as to
form in all material respects with the requirements of the Exchange Act. On
the date filed with the SEC and on the date first published, sent or given to
the Company's stockholders, the Schedule 14D-9 will not contain any untrue
statement of a material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading, except
that no representation is made by the Company with respect to any information
supplied by Parent or Merger Sub for inclusion in the Schedule 14D-9.

  



  

Article 5 
 REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

  



  

Parent and Merger Sub hereby jointly and severally represent and warrant to
the Company, and the Debt Financing Borrower represents and warrants
solely with respect to Sections _5.1_ , _5.2_ , _5.3_ , _5.4_ , _5.6_ ,
_6.14_ and _6.15_ , as follows that:

  



  

Section 5.1.   _Due Organization and Good Standing_. Each of Parent,
Merger Sub and the Debt Financing Borrower is duly organized, validly
existing and in good standing (with respect to jurisdictions that recognize
such concept) under the Law of the jurisdiction of its organization, has full
corporate or other power and authority to own, lease and operate its
properties and assets and to conduct its business as presently conducted and
is duly qualified or licensed to do business as a foreign corporation or
company and is in good standing (with respect to jurisdictions that recognize
such concept) in each jurisdiction where the character of the properties
owned, leased or operated by it or the nature of its business makes such
qualification or licensing necessary, except in each case as would not
reasonably be expected to have, individually or in the aggregate, a Parent
Material Adverse Effect.

  



  

Section 5.2.   _Legal Proceedings; Orders_.

  



  

(a)  There is no Legal Proceeding pending (or, to the knowledge
of Parent, being overtly threatened) against Parent or Merger Sub that would
adversely affect Parent's or Merger Sub's ability to perform any of its
obligations under this Agreement or consummate any of the Transactions.

  



  

(b)  There is no Order to which Parent or Merger Sub is subject
that would adversely affect Parent's or Merger Sub's ability to perform any
of its obligations under this Agreement or consummate any of the Transactions.
There is no Order against the Debt Financing Borrower or its subsidiaries
that would prevent or materially delay the consummation of the Debt Financing
or the ability of the Debt Financing Borrower to fully perform its respective
covenants and obligations pursuant to the Commitment Letters and this
Agreement.

  



     

   

44

 



    



  

(c)   No investigation by any Governmental Entity with respect
to Parent, Merger Sub or any other Affiliate of Parent is pending or, to the
knowledge of Parent, is being overtly threatened, other than any investigation
that would not materially and adversely affect Parent's or Merger Sub's
ability to consummate any of the Transactions.

  



  

Section 5.3.   _Authority; Binding Nature of Agreement_.

  



  

(a)  Parent and the Debt Financing Borrower have the requisite
corporate power and authority to enter into and to perform its obligations
under this Agreement. The board of directors of Parent has (i) determined that
the Transactions, including the Offer and the Merger, are in the best
interests of Parent, and (ii) authorized and approved the execution, delivery
and performance of this Agreement by Parent. The execution and delivery of
this Agreement by Parent and the Debt Financing Borrower and performance of
their obligations hereunder and the consummation by Parent and the Debt
Financing Borrower of the Transactions have been duly authorized by all
necessary corporate action on the part of Parent and the Debt Financing
Borrower, and no other proceeding, approval, permit, consent, declaration,
registration or authorization by or in respect of, or filing with, any
Governmental Entity on the part of Parent or the Debt Financing Borrower are
necessary, required or advisable, directly or indirectly, to authorize the
execution, delivery and performance of this Agreement. This Agreement has
been duly executed and delivered on behalf of Parent and the Debt Financing
Borrower and, assuming the due authorization, execution and delivery of this
Agreement on behalf of the Company, constitutes the valid and binding
obligation of Parent and the Debt Financing Borrower, enforceable against
Parent and the Debt Financing Borrower in accordance with its terms, subject
to (A) laws of general application relating to bankruptcy, insolvency and the
relief of debtors, and (B) rules of law governing specific performance,
injunctive relief and other equitable remedies.

  



  

(b) Merger Sub is a newly formed, wholly-owned Subsidiary of
Parent and has the requisite corporate power and authority to enter into and
to perform its obligations under this Agreement. The board of directors of
Merger Sub has (i) determined that the Transactions, including the Offer and
the Merger, are fair to, and in the best interests of, Merger Sub and its
stockholder, (ii) declared this Agreement and the Transactions, including the
Offer and the Merger, advisable, and (iii) authorized and approved the
execution, delivery and performance of this Agreement by Merger Sub. The
execution and delivery of this Agreement by Merger Sub and the performance of
its obligations hereunder and the consummation by Merger Sub of
the Transactions have been duly authorized by all necessary corporate action
on the part of Merger Sub, and no other proceeding, approval, permit,
consent, declaration, registration or authorization by or in respect of, or
filing with, any Governmental Entity on the part of Merger Sub are necessary,
required or advisable, directly or indirectly, to authorize the
execution, delivery and performance of this Agreement, other than, with
respect to the Merger, the filing and recordation of the appropriate merger
documents as required by the DGCL. Parent, as the sole stockholder of Merger
Sub, will vote to adopt this Agreement immediately after the execution and
delivery of this Agreement. This Agreement has been duly executed and
delivered by Merger Sub and, assuming the due authorization, execution and
delivery of this Agreement on behalf of the Company, constitutes the valid
and binding obligation of Merger Sub, enforceable against Merger Sub in
accordance with its terms, subject to (A) laws of general application
relating to bankruptcy, insolvency and the relief of debtors, and (B) rules of
law governing specific performance, injunctive relief and other equitable
remedies.

  



  

   

45

 



    



  

Section 5.4.   _Non-Contravention; Consents_. Except for violations
and defaults that would not adversely affect Parent's, Merger Sub's or the
Debt Financing Borrower's ability to perform any of its obligations under this
Agreement or consummate any of the Transactions, the execution and delivery
of this Agreement by Parent, Merger Sub and the Debt Financing Borrower,
and the consummation of the Transactions, will not: (i) cause a violation of
any of the provisions of the Organizational Documents of Parent, Merger Sub
or the Debt Financing Borrower; (ii) cause a violation by Parent, Merger Sub
or the Debt Financing Borrower of any Law applicable to Parent, Merger Sub or
the Debt Financing Borrower; or (iii) cause a default on the part of Parent,
Merger Sub or the Debt Financing Borrower under any Contract. Except as may
be required by the Exchange Act, the DGCL, the HSR Act or other applicable
Antitrust Laws, none of Parent, Merger Sub, nor the Debt Financing Borrower
nor any of Parent's other Affiliates, is required to make any filing with or
to obtain any consent from any Person at or prior to the Acceptance Time or
the Effective Time in connection with the execution and delivery of this
Agreement by Parent, Merger Sub or the Debt Financing Borrower or
the consummation by Parent, Merger Sub or the Debt Financing Borrower of any
of the Transactions, except where the failure to make any such filing or
obtain any such consent would not adversely affect or materially delay
Parent's, Merger Sub's or the Debt Financing Borrower's ability to perform
any of its obligations under this Agreement or consummate any of the
Transactions. No vote of Parent's equityholders is necessary to adopt this
Agreement or to approve any of the Transactions.

  



  

Section 5.5.   _Not an Interested Stockholder_. Neither Parent nor
any of its "affiliates" or "associates" is, or has been within the three (3)
years preceding the date hereof, an "interested stockholder" (in each case
as such terms are defined in Section 203 of the DGCL) of the Company. Neither
Parent nor any of Parent's Subsidiaries directly or indirectly owns, and at
all times within the last three (3) years, neither Parent nor any of Parent's
Subsidiaries has directly or indirectly owned, beneficially or otherwise, any
Company Common Stock or any securities, contracts or obligations
convertible into or exchangeable for Company Common Stock.

  



  

   

46

 



    



  

Section 5.6.   _Financing_.

  



  

(a) Parent has provided the Company with true and correct
copies of the Equity Commitment Letter and Debt Commitment Letter, any
side letters related to the Commitment Letters and any fee letter related to
the Debt Commitment Letter (the "Debt Financing Fee Letter"); _provided_ ,
that in the case of the Debt Financing Fee Letter, fee amounts
and commercially sensitive economic terms and "market flex" provisions, none
of which (x) impose or permit the imposition of any different or additional
conditions, or expand or modify or permit the expansion or modification of any
of the existing conditions, to the consummation of the Debt Financing or (y)
would or would reasonably be expected to reduce the aggregate amount of the
Debt Financing available to Parent, Merger Sub or the Debt Financing Borrower
at the Offer Closing or the Closing below the amount necessary to fund the
Required Amount (after taking into account the Equity Financing and
any available cash of Parent, the Company and their respective Subsidiaries)
or affect the availability of the full amount of the Debt Financing at the
Offer Closing and the Closing necessary to fund the Required Amount (after
taking into account the Equity Financing), may have been redacted to the
extent required by the Debt Commitment Letter. Assuming (i) the
satisfaction or waiver of the conditions expressly set forth herein to
Parent's and Merger Sub's obligations to consummate the Offer and the Merger
and (ii) that the Financing is funded or invested at the Offer Closing and the
Closing in accordance with the Debt Commitment Letter and the Equity
Commitment Letter, as applicable, Parent will have, and will cause Merger
Sub to have, at the Offer Closing and the Closing (as applicable), the funds
necessary (both before and after giving effect to any exercise of "market
flex") to (x) consummate the Offer, the Merger and the other Transactions,
including payment in cash of the aggregate Offer Price at the Offer Closing
and the aggregate Merger Consideration at the Closing, (y) make the payments
pursuant to _Section 3.7_ and (z) pay all related fees, discounts and expenses
(collectively, the "Required Amount"). The only conditions precedent related
to the obligations of the Guarantors to fund the full amount of the Equity
Financing and the Debt Financing Sources to fund the full amount of the Debt
Financing are those expressly set forth in the Equity Commitment Letter and
the Debt Commitment Letter, respectively. The Commitment Letters are (x)
legal, valid and binding obligations of the Debt Financing Borrower and, to
the Knowledge of Parent, each of the other parties thereto, (y) enforceable
in accordance with their respective terms against the Debt Financing Borrower
and, to the Knowledge of Parent, each of the other parties thereto, in each
case except as such enforceability (i) may be limited by bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and other similar
Laws affecting or relating to the enforcement of creditors' rights generally
and (ii) is subject to general principles of equity, and (z) as of the
date of this Agreement, in full force and effect (except that such
enforceability (i) may be limited by bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and other similar Laws of general
application affecting or relating to the enforcement of creditors' rights
generally and (ii) is subject to general principles of equity). As of the date
hereof, the commitments and agreements contemplated by each Commitment Letter
have not been withdrawn, terminated, repudiated, rescinded, supplemented or
otherwise amended or modified in any respect, no terms thereunder have been
waived, and no such withdrawal, termination, repudiation, rescission,
supplement, amendment, modification or waiver is contemplated (other than to
add lenders, lead arrangers, bookrunners, syndication agents or other similar
entities who had not executed the Debt Commitment Letter as of the date
hereof). As of the date hereof, neither Parent, the Debt Financing Borrower
nor, to the Knowledge of Parent, any Debt Financing Source named therein, is
in breach of any of the terms or conditions set forth in the Debt Commitment
Letter or the Debt Financing Fee Letter, and no event has occurred that, with
or without notice, lapse of time or both, would or would reasonably be
expected to constitute a default or breach under the Debt Commitment Letter on
the part of Parent, the Debt Financing Borrower or, to the Knowledge of
Parent, any Debt Financing Source named therein. The Commitment Letters and
the Debt Financing Fee Letter constitute the entire and complete agreement
among the parties thereto with respect to the transactions contemplated
thereby and the financing for the Transactions, and, except as expressly
set forth in each Commitment Letter, (i) there are no conditions precedent to
the obligation of the Financing Sources to fund the Financing in an amount
necessary to fund the Required Amount, and (ii) there are no side letters or
contracts to which Parent, the Debt Financing Borrower or Merger Sub is a
party relating to the Transactions that would permit the Financing Sources to
reduce the total amount of the Financing below the amount necessary to fund
the Required Amount or impose any different or additional conditions, or
expand or modify any of the existing conditions, to the availability of all or
any portion of the Financing necessary to fund the Required Amount. Parent
and the Debt Financing Borrower have fully paid any and all commitment fees
or other fees required to be paid in connection with the Financing on or prior
to the date hereof. As of the date hereof, assuming the satisfaction or
waiver of the conditions to Parent's and Merger Sub's obligations to
consummate the Offer and the Merger, Parent does not have any reason to
believe that any of the conditions to the Financing will not be satisfied or
that the full amount of the Financing necessary to fund the Required Amount
(after taking into account available cash of Parent, the Company and their
respective Subsidiaries) will not be made available to Parent at the Offer
Closing and the Closing (as applicable) in order to consummate the
Transactions.

  



  

   

47

 



    



  

(b)  Without limiting _Section 9.10_ , in no event shall the
receipt or availability of any funds or financing by or to Parent, Merger Sub
or any of their respective Affiliates or any other financing transaction be a
condition to any of the obligations of Parent or Merger Sub hereunder.

  



  

Section 5.7.   _Offer Documents_. The Offer Documents will comply as
to form in all material respects with the requirements of the Exchange Act.
On the date filed with the SEC, on the date first published, sent or given to
the Company's stockholders and at all other times at or prior to the
Acceptance Time, the Offer Documents will not contain any untrue statement of
a material fact or omit to state any material fact required to be stated
therein or necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading, except that no
representation is made by Parent or Merger Sub with respect to any
information supplied in writing by the Company specifically for inclusion in
the Offer Documents.

  



  

Section 5.8.   _Information in Schedule 14D-9_. None of the
information supplied or to be supplied by or on behalf of Parent for
inclusion in the Schedule 14D-9 will, at the time the Schedule 14D-9 is filed
with the SEC, at the time the Schedule 14D-9 is mailed to the stockholders of
the Company, or at any other time at or prior to the Acceptance Time, contain
any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they are made,
not misleading.

  



  

Section 5.9.   _Brokers_. No broker, finder or investment banker is
entitled to any brokerage, finder's or other fee or commission in connection
with this Agreement, the Merger or the other Transactions based upon
arrangements made by or on behalf of Parent or Merger Sub for which the
Acquired Companies could be liable.

  



  

Section 5.10.   _Merger Sub_. As of the date hereof, the authorized
capital stock of Merger Sub consists of 1,000 shares of common stock, par
value $0.01 per share, all of which shares are validly issued and outstanding.
All of the issued and outstanding capital stock of Merger Sub is, and at the
Effective Time will be, owned by Parent. Merger Sub was formed solely for the
purpose of engaging in the Transactions, and, prior to the Effective Time,
Merger Sub will have engaged in no business and have no liabilities or
obligations other than in connection with the Transactions. There are no
actions pending or, to the knowledge of Parent, threatened against Parent or
any of its Subsidiaries, including Merger Sub, that would reasonably be
expected to have, individually or in the aggregate, a Parent Material Adverse
Effect.

  



  

Section 5.11.   _Stockholder, Labor and Employee Matters_. As of the date
hereof, neither Parent nor Merger Sub has, directly or indirectly: (a)
entered into any employment agreement, or made or entered into any formal or
informal arrangements or other understandings (whether or not binding), with
any of the Company's stockholders, directors, officers or employees (in their
capacity as such), or any other Contract with such Persons relating to this
Agreement, the Merger or any of the other Transactions; (b)
offered employment to any of the Company's stockholders, directors, officers
or employees; (c) had discussions with any of the Company's stockholders,
directors, officers or employees regarding the future terms of their
employment after the Closing; or (d) sold, or offered to sell, any direct or
indirect equity interest in the Company, Parent or any of its Affiliates to
any of the Company's stockholders, directors, officers or employees.

  



  

   

48

 



    



  

Section 5.12.   _Competing Businesses_. None of Parent or any of its
Affiliates owns any interest in any Person that (a) derives a portion of its
revenues from products or (b) is developing products, technologies,
intellectual property or other know-how in the same product markets in which
the Acquired Companies operate (including the development of products,
medicines, therapies, devices, and scientific technologies to treat, remedy,
modify, correct, or otherwise address the health of patients in the areas of
hematology and maternal and women's health), that would reasonably be expected
to have an adverse effect on the ability of Parent to consummate the
Transactions in a timely manner in accordance with the terms hereof.

  



  

Section 5.13.   _Limited Guarantee; Solvency_. Concurrently with the
execution of this Agreement, Parent has delivered to the Company the duly
executed limited guarantee of the Guarantors, dated as of the date of this
Agreement, in favor of the Company in respect of Parent's obligation to pay
the Parent Termination Fee and the other obligations specified therein, up to
the aggregate amount set forth therein (the "Limited Guarantee"). The Limited
Guarantee is (a) a legal, valid and binding obligation of the Guarantors, (b)
enforceable against the Guarantors in accordance with its terms, except as
such enforcement may be subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and other similar laws of general
applicability relating to or affecting creditors' rights, and by general
equitable principles, and (c) in full force and effect. No event has occurred
which, with or without notice, lapse of time or both, would or would
reasonably be expected to constitute a default or breach on the part of the
Guarantors under the Limited Guarantee. Neither Parent nor Merger Sub is
entering into this Agreement with the intent to hinder, delay or defraud
either their present or future creditors. Assuming satisfaction or waiver of
the conditions to Parent's and Merger Sub's obligations to consummate the
Offer and the Merger, the accuracy in all material respects of the
representations and warranties of the Company set forth in _Article 4_ , then
the Debt Financing Borrower and its Subsidiaries, on a consolidated basis,
will be Solvent as of the Offer Closing and the Closing and immediately after
giving effect to all of the Transactions, including the payment of the
Required Amount.

  



  

Article 6 
 COVENANTS

  



  

Section 6.1. _Interim Operations of the Company_. The Company agrees
that, during the period from the date hereof through the earlier of
the Acceptance Time or the date of termination of this Agreement, except (i)
to the extent Parent shall otherwise consent in writing (which consent shall
not be unreasonably withheld, conditioned or delayed), (ii) as set forth in
the Company Disclosure Schedule, (iii) as contemplated or permitted by this
Agreement, (iv) as may be necessary or appropriate to carry out the
Transactions, (v) as may on the advice of outside counsel be required to
facilitate compliance with any Law or Contract, or (vi) as required by the
rules or regulations of NASDAQ, (x) the Company shall, and shall cause its
Subsidiaries to, use commercially reasonable efforts to conduct its business
in the ordinary course; _provided_ that the parties agree that the Company
and its Subsidiaries may continue any changes in their respective business
practices adopted prior to the date hereof to address and adapt to the
coronavirus (COVID-19) pandemic and the Company may take such further actions
as it deems reasonably advisable or necessary to (A) protect the health and
safety of the Company's or Company Subsidiary's employees, suppliers,
customers and other individuals having business dealings with the Company or
any Subsidiary of the Company or (B) respond to third-party supply or service
disruptions caused by the coronavirus (COVID-19) pandemic, and (y) the
Company shall not, nor shall it permit any of its Subsidiaries to, do any of
the following:

  



  

   

49

 



    



  

(a)  amend the Company Certificate of Incorporation, the Company
Bylaws or the Organizational Documents of any of the Company's Subsidiaries
(whether by merger, consolidation or otherwise);

  



  

(b)  (i) declare, set aside or pay any dividends on, or make any
other distributions (whether in cash, stock, property or otherwise) in
respect of, or enter into any agreement with respect to the voting of, any
capital stock of any Acquired Company, other than (x) dividends and
distributions by a direct or indirect wholly owned Subsidiary of the Company
to its parent, consistent with past practice, and (y) distributions resulting
from the vesting or exercise of Company Compensatory Awards that are
outstanding on the date hereof, (ii) split, combine or reclassify any capital
stock of the Acquired Companies, or (iii) purchase, redeem or otherwise
acquire any Company securities, except for (x) acquisitions of shares of
Company Common Stock by the Company in satisfaction of the applicable
exercise price and/or withholding taxes with respect to any Company
Compensatory Awards that are outstanding on the date hereof or granted in a
manner not in violation of this Agreement, and (y) the acquisition of
Convertible Notes deemed to occur upon conversion thereof in accordance with
their terms;

  



  

(c)   (i) issue, deliver, sell, grant, pledge, transfer, subject
to any Encumbrance (other than transfer restrictions arising under applicable
Law) or dispose of any Company securities, other than (w) the issuance of
shares of Company Common Stock upon the exercise or settlement of Company
Compensatory Awards outstanding as of the date hereof or granted not in
violation of this Agreement, in accordance with the terms of the applicable
Company Compensatory Award, (x) the issuance of Company securities required
to be made pursuant to the terms of the Company ESPP, or (y) the delivery of
shares of Company Common Stock upon conversion of Convertible Notes in
accordance with their terms, or (ii) amend any term of any security of the
Acquired Companies (in each case, whether by merger, consolidation or
otherwise);

  



  

(d)  adopt a plan or agreement of, or resolutions providing for
or authorizing, complete or partial liquidation, dissolution, merger,
consolidation, restructuring, recapitalization or other reorganization, each
with respect to the Acquired Companies;

  



  

(e) except to the extent required pursuant to the terms of any
Company Benefit Plan as in effect on the date of this Agreement that is not
then out of compliance with applicable Law, (A) adopt, establish, enter into,
terminate, amend or modify any material Company Benefit Plan, (B) increase
the base compensation payable or to become payable to the Company's employees
at the Vice President level or above, (C) grant or amend any award under any
Company Benefit Plan (including any equity or equity-based compensation), or
remove or modify existing restrictions in any Company Benefit Plan or awards
made thereunder, (D) enter into any employment, change in control, severance,
separation, retention or similar agreement with the Company's employees or
service providers (other than ordinary course offer letters and related
confidentiality, assignment of invention agreements and similar agreements
ancillary to employment not prohibited by clause (F) below), or enter into
any consulting agreement other than in the ordinary course of business that is
not terminable on less than thirty (30) days' notice without penalty, (E)
take any action to accelerate the time of payment or vesting of any
rights, compensation, benefits or funding obligations under any Company
Benefit Plan or otherwise, (F) hire any employee at the Vice President level
or above or terminate the employment of any such employee, other than for
cause (as determined by the Company in its reasonable discretion consistent
with past practice) or due to such employee's death or disability or (G)
make any material determination under any Company Benefit Plan that is
inconsistent with the Company's ordinary course of business or past practice;

  



  

   

50

 



    



  

(f)  acquire any business, assets or capital stock of any
Person or division thereof, whether in whole or in part (and whether by
purchase of stock, purchase of assets, merger, consolidation, or otherwise),
other than one or more acquisitions of assets or rights in the ordinary
course of business consistent with past practice that, individually, involve a
purchase price of not more than $100,000;

  



  

(g)  enter into any joint venture or strategic alliance, or
similar long-term business combination, arrangement or agreement;

  



  

(h)  enter into any long-term license, supply or distribution
agreement, in each case with an expected annual cost or revenue to the
Company in excess of $250,000 and which cannot be terminated on less than
thirty (30) days' notice without penalty;

  



  

(i)  sell, lease, license, pledge, transfer, subject to any
Encumbrance or otherwise dispose of any Intellectual Property assets,
material assets or material properties except (i) pursuant to existing
Contracts or commitments specified in the Company Disclosure Letter, (ii)
non-exclusive licenses of Intellectual Property assets to its customers,
contractors, partners or suppliers in the ordinary course of business
consistent with past practice, (iii) sales of inventory or used equipment in
the ordinary course of business consistent with past practice, or (iv)
Permitted Encumbrances;

  



  

(j)  change any of the accounting methods used by the Company
materially affecting its assets, liabilities or business, except for such
changes that are required by GAAP or Regulation S-X promulgated under the
Exchange Act or as otherwise specifically disclosed in the Company SEC
Documents;

  



  

(k) (x) incur or assume any long-term or short-term
indebtedness for borrowed money, except in respect of indebtedness owing by
any wholly-owned Subsidiary of the Company to the Company or another wholly-
owned Subsidiary of the Company in the ordinary course of business consistent
with past practice, or (y) assume, guarantee, endorse or otherwise become
liable or responsible (whether directly, contingently or otherwise) for
indebtedness of borrowed money of any other Person (other than
another Acquired Company in the ordinary course of business consistent with
past practice);

  



  

   

51

 



    



  

(l)  enter into, modify in any material respect or voluntarily
terminate any Material Contract or any Contract that would have constituted a
Material Contract if in effect on the date of this Agreement (provided that
the Company shall be permitted to renew any Contract so long as such renewal
is on substantially the same terms as currently in place);

  



  

(m)  take any action (other than consummation of the Merger) that
would reasonably be expected to result in an adjustment to the Conversion
Rate (as defined in and pursuant to the Indenture) for the Convertible Notes;
or

  



  

(n)  make inconsistent with past practice, rescind or change any
material Tax election, settle or compromise any claim relating to a material
amount of Taxes, waive or extend the statute of limitations in respect of a
material amount of Taxes, enter into any closing agreement within the meaning
of Section 7121 of the Code (or any analogous provision of state, local or
foreign Law) with respect to a material amount of Taxes, amend any Tax Return
relating to a material amount of Taxes or make any material change in any of
the methods, principles or practices used by it for Tax accounting except as
required by Law, surrender any right to claim a material Tax refund
(including any such refund to the extent it is used to offset or otherwise
reduce Tax liability) or enter into any Tax sharing agreements or similar
arrangements, including Tax indemnity arrangements (other than customary
agreements and contracts, the principal purpose of which is not related to
Taxes); or

  



  

(o)  authorize, commit or agree to take any of the foregoing
actions.

  



  

Notwithstanding the foregoing, nothing contained in this Agreement shall give
to Parent or Merger Sub, directly or indirectly, rights to control or direct
the operations of the Acquired Companies prior to the Effective Time. In
addition, notwithstanding the foregoing, nothing in this _Section 6.1 _ shall
restrict the Acquired Companies from, or require the consent of Parent prior
to, engaging in any transaction or entering into any agreement exclusively
among the Acquired Companies in the ordinary course of business consistent
with past practice. If reasonably requested by Parent, the Company will upon
or shortly before the Acceptance Time use its commercially reasonable
efforts to convert its marketable securities into cash in a manner and timing
reasonably acceptable to the Company.

  



  

Section 6.2.   _No Solicitation_.

  



  

(a)  The Company shall not, and shall cause its Subsidiaries and
its and their respective directors, officers and employees not to, and shall
not authorize or instruct its Company Representatives to, and shall use its
reasonable best efforts to cause its Company Representatives not to:

  



  

(i) solicit, initiate, or knowingly facilitate or encourage
the submission or announcement of any Acquisition Proposal or
Acquisition Inquiry (including by approving any transaction, or approving any
Person becoming an "interested stockholder," for purposes of Section 203 of
the DGCL);

  



  

   

52

 



    



  

(ii)  furnish any non-public information regarding the Company to
any Person, or afford to any Person access to the business, properties,
assets, books, records or other non-public information, or to any personnel,
of the Company or any of its Subsidiaries, for the purpose of facilitating or
encouraging, or in response to, an Acquisition Proposal or Acquisition
Inquiry;

  



  

(iii)  engage or participate in or continue any discussions or
negotiations with any Person with respect to any Acquisition Proposal or
Acquisition Inquiry (it being understood that the foregoing shall not prohibit
the Company or the Company Representatives from making such Person aware of
the restrictions of this _Section 6.2_ in response to the receipt of an
Acquisition Proposal or Acquisition Inquiry or clarifying the terms of any
such Acquisition Proposal or Acquisition Inquiry);

  



  

(iv)  terminate, waive, amend or modify any provision of, or grant
permission under, any confidentiality agreement to which the Company or any
of its Subsidiaries is a party and that contains a "standstill" provision;

  



  

(v)  enter into any Alternative Acquisition Agreement or any
Contract requiring the Company to abandon, terminate or fail to consummate
the Transactions; or

  



  

(vi)  resolve or agree to take any of the foregoing actions.

  



  

(b)  Notwithstanding the foregoing clause (a) or anything else
to the contrary contained in this Agreement, in response to a _bona fide_
written Acquisition Proposal that did not result from a material breach of
this _Section 6.2_ , if the Company Board determines in good faith, after
consultation with the Company's outside legal counsel and financial
advisor, that (i) such Acquisition Proposal either constitutes a Superior
Proposal or would reasonably be expected to lead to a Superior Proposal and
(ii) the failure to take the actions set forth in clauses (x), (y) and/or (z)
below with respect to such Acquisition Proposal would be inconsistent with
the Company Board's fiduciary obligations to the Company's stockholders, then
(x) the Company and its representatives may engage in discussions or
negotiations with the Third Party that has made such Acquisition Proposal
(and such Third Party's representatives), (y) if such Third Party executes or
has executed an Acceptable Confidentiality Agreement, the Company may provide
such Person (and such Person's representatives) with information concerning
the Company and its Subsidiaries and/or (z) the Company may decline to
enforce, or may waive, any standstill or similar provision in effect on
September 10, 2020. Prior to or concurrent with providing any material non-
public information to any such Third Party, the Company shall make such
material non-public information available to Parent (to the extent such
material non-public information has not been previously made available by the
Company to Parent or Parent's representatives).

  



  

(c) The Company shall, and shall direct and use reasonable
efforts to cause all Company Representatives to, immediately cease and cause
to be terminated any existing solicitation of, or discussions or negotiations
with, any Third Party relating to any Acquisition Proposal or Acquisition
Inquiry, and shall immediately terminate "data room" access to all such
Third Parties and their advisors.

  



  

   

53

 



    



  

(d)  If the Company receives an Acquisition Proposal or an
Acquisition Inquiry, then the Company shall promptly (and in no event later
than forty-eight (48) hours after receipt of such Acquisition Proposal or
Acquisition Inquiry), notify Parent in writing of its receipt of such
Acquisition Proposal or Acquisition Inquiry, which notification shall include
(i) the identity of the Third Party making such Acquisition Proposal or
Acquisition Inquiry (unless such disclosure is prohibited by the terms of
a confidentiality agreement with such Third Party in effect on September 10,
2020), and (ii) the material terms and conditions of such Acquisition
Proposal or Acquisition Inquiry (including copies of any material documents
relating thereto (or reasonable summaries thereof if providing copies thereof
is prohibited by the terms of a confidentiality agreement with such Third
Party in effect on September 10, 2020), and shall thereafter keep Parent
reasonably informed of any material change to the terms of any such
Acquisition Proposal or Acquisition Inquiry.

  



  

(e)  Nothing contained in this _Section 6.2_ or elsewhere in
this Agreement shall prohibit the Company, the Company Board (or any
committee thereof) or their representatives from: (i) taking and disclosing to
the stockholders of the Company a position contemplated by Rule 14e-2(a)
promulgated under the Exchange Act or making a statement contemplated by Item
1012(a) of Regulation M-A or Rule 14d-9(f) promulgated under the Exchange
Act, or from issuing a "stop, look and listen" statement pending disclosure
of its position thereunder (or any substantially similar communication);
_provided_ that any such disclosure does not contain an express Change in
Recommendation; (ii) disclosing to the Company's stockholders any factual
information regarding the business, financial condition or results of
operations of the Company or the fact that an Acquisition Proposal has been
made, the identity of the party making such Acquisition Proposal or the
material terms of such Acquisition Proposal (and no such disclosure shall,
taken by itself, be deemed to be a Change in Recommendation); or (iii)
communicating with any Person (or the representatives of such Person) that
makes any Acquisition Proposal or Acquisition Inquiry to the extent necessary
to direct such Person to the provisions of this _Section 6.2_ and/or to
clarify and understand the terms and conditions of an Acquisition Proposal
made by such Person; _provided, however_ , that the Company Board shall not
make any Change in Recommendation except in accordance with _Section 2.3(d)_.

  



  

Section 6.3.   _Filings; Other Action_.

  



  

(a) Each of the Company, Parent and Merger Sub shall: (i)
promptly (and, with respect to any filings under the HSR Act, in no
event later than the date that is five (5) Business Days after the date
hereof) use reasonable best efforts to make and effect all registrations,
filings and submissions required to be made or effected by it or otherwise
advisable pursuant to the HSR Act, any other applicable Antitrust Laws, the
Exchange Act and other applicable Law with respect to the Offer and the
Merger; (ii) use commercially reasonable efforts to obtain all other consents
and approvals required from Third Parties in connection with the
Transactions; and (iii) use reasonable best efforts to cause to be taken, on a
timely basis, all other actions necessary or appropriate for the purpose of
consummating and effectuating the Transactions; _provided, however_ , that in
no event shall the Company be required to pay, prior to the Effective Time,
any fee, penalty or other consideration to any Person for any consent or
approval required for the consummation of any of the Transactions. Without
limiting the generality of the foregoing, each of Parent and Merger Sub (A)
shall promptly use its best efforts to provide all information requested by
any Governmental Entity in connection with the Offer, the Merger or any of
the other Transactions and (B) shall use its reasonable best efforts to
promptly take, and to cause its Affiliates to take, all actions and steps
necessary to obtain and secure the expiration or termination of any
applicable waiting periods under the HSR Act or any other applicable
Antitrust Laws and obtain any clearance or approval required to be obtained
from the U.S. Federal Trade Commission, the U.S. Department of Justice, or
any other Governmental Entity in connection with the Transactions as soon as
possible, but in any event no later than ten (10) Business Days prior to the
End Date.

  



  

   

54

 



    



  



   



  

(b)  Without limiting the generality of anything contained in
_Section 6.3(a)_ , subject to applicable Law, each party hereto shall: (i)
give the other parties prompt written notice of the making or commencement of
any request, inquiry, investigation, action or Legal Proceeding by or before
any Governmental Entity with respect to the Offer or the Merger or any of the
other Transactions; (ii) keep the other parties informed as to the status of
any such request, inquiry, investigation, action or Legal Proceeding; and
(iii) promptly inform the other parties of any communication to or from the
U.S. Federal Trade Commission, the U.S. Department of Justice or any other
Governmental Entity regarding the Offer or the Merger. Each party hereto will
consult and cooperate with the other parties and will consider in good faith
the views of the other parties in connection with any analysis, appearance,
presentation, memorandum, brief, argument, opinion or proposal made or
submitted in connection with any such request, inquiry, investigation, action
or Legal Proceeding. In addition, except as may be prohibited by any
Governmental Entity or by any Law, in connection with any such request,
inquiry, investigation, action or Legal Proceeding, each party hereto will
permit authorized representatives of the other parties to be present at each
meeting or conference relating to such request, inquiry, investigation, action
or Legal Proceeding and to have access to and be consulted in connection with
any document, opinion or proposal made or submitted to any Governmental
Entity in connection with such request, inquiry, investigation, action or
Legal Proceeding.

  



  

(c)  Subject to the timing deadlines referenced above in
_Section 6.3(a)_ , in the event that any litigation or other administrative
or judicial action or Legal Proceeding is commenced challenging the Offer or
the Merger or any of the other Transactions and such litigation, action or
Legal Proceeding seeks, or would reasonably be expected to seek, to prevent
the consummation of the Offer or the Merger or the other Transactions, Parent
and Merger Sub shall take any and all reasonable actions to resolve any such
litigation, action or Legal Proceeding and each of the Company, Parent and
Merger Sub shall cooperate with each other and use its respective reasonable
best efforts to contest any such litigation, action or Legal Proceeding and to
have vacated, lifted, reversed or overturned any decree, judgment, injunction
or other order, whether temporary, preliminary or permanent, that is
in effect and that prohibits, prevents or restricts consummation of the Offer
or the Merger or the other Transactions.

  



  

(d) Neither Parent nor Merger Sub shall, nor shall they permit
their Subsidiaries or direct or indirect related parent companies to, acquire
or agree to acquire any rights, interests, assets, business, Person or
division thereof (through acquisition, license, joint venture, collaboration
or otherwise), if such acquisition would reasonably be expected to increase
the risk of not obtaining any applicable clearance, consent, approval or
waiver under Antitrust Laws with respect to the Offer or the Merger or the
other Transactions or otherwise not complying with the requirements of this
Section.

  



  

   

55

 



    



  

Section 6.4.   _Access_. Upon reasonable advance written notice, the
Company shall afford Parent's representatives reasonable access, during
normal business hours throughout the period prior to the Effective Time, to
the Acquired Companies' books and records and, during such period, the
Company shall, and shall instruct any Company Representatives to, furnish
promptly to Parent all readily available information concerning its business
as Parent may reasonably request; _provided, however_ , that the Acquired
Companies shall not be required to permit any inspection or other access, or
to disclose any information, that in the reasonable judgment of the Company
could: (a) result in the disclosure of any trade secrets of Third Parties; (b)
violate any obligation of the Acquired Companies with respect to
confidentiality, non-disclosure or privacy; (c) jeopardize protections
afforded to any of the Acquired Companies under the attorney-client privilege
or the attorney work product doctrine; (d) violate any Law; or (e) materially
interfere with the conduct of the Acquired Companies' business; and _provided
further_ that any such access shall be afforded and any such information
shall be furnished at Parent's expense. No investigation pursuant to this 
_Section 6.4_ shall affect any representation or warranty in this Agreement of
any party hereto or any condition to the obligations of the parties hereto.
Notwithstanding anything herein to the contrary, Parent and Merger Sub shall
not, and shall cause their respective representatives not to, contact any
partner, licensor, licensee, customer or supplier of the Company in connection
with the Offer, the Merger or any of the other Transactions without the
Company's prior written consent, and Parent and Merger Sub acknowledge and
agree that any such contact shall be arranged by and with a representative of
the Company participating. All information obtained by Parent and its
representatives pursuant to this _Section 6.4_ shall be treated as
confidential information of the Acquired Companies for purposes of the
Confidentiality Agreement.

  



  

Section 6.5.   _Interim Operations of Merger Sub_. During the period
from the date hereof through the earlier of the Effective Time or the date of
termination of this Agreement, Merger Sub shall not engage in any activities
of any nature except as provided in or contemplated by this Agreement.

  



  

Section 6.6. _Publicity_. The initial press release relating to this
Agreement shall be a joint press release issued by the Company and Parent,
and thereafter the Company and Parent shall consult with each other before
issuing any press release or otherwise making any public statements with
respect to this Agreement or any of the transactions contemplated by the
Transaction Documents and shall not issue any such press release or make any
such public statement without the prior consent of the other parties hereto,
which consent shall not be unreasonably withheld or delayed; _provided_ that
(i) a party hereto may, without the prior consent of the other parties
hereto, issue such press release or make such public statement as may be
required by Law or Order or the applicable rules of NASDAQ if it has used its
commercially reasonable efforts to consult with the other parties hereto and
to obtain such party's consent but has been unable to do so prior to the time
such press release or public statement is so required to be issued or made,
(ii) the Company will not be obligated to engage in such consultation with
respect to communications that are (A) principally directed to employees,
customers, partners or vendors so long as such communications are consistent
with previous releases, public disclosures or public statements made jointly
by the parties (or individually, if approved by the other party), or (B)
relating to an Acquisition Proposal, Superior Proposal, Change
in Recommendation or "stop-look-and-listen" communication or similar
communication of the type contemplated by Rule 14d-9(f) under the Exchange
Act.

  



  

   

56

 



    



  

Section 6.7.   _Other Employee Benefits_.

  



  

(a)  For a period of not less than twelve (12) months after the
Closing Date (or, if earlier, the date of termination of the relevant
employee), Parent shall, or shall cause the Surviving Corporation to, provide
to each employee of the Acquired Companies who is employed as of immediately
prior to the Effective Time (each, a "Continuing Employee") with (i) base
salary or base hourly wage rate (as applicable) no less favorable than those
provided to such Continuing Employee prior to the Effective Time, (ii) cash
target bonus and in the case of field-based employees only, cash target
incentive compensation opportunity (excluding retention, change in control
and equity-based compensation), if any, that are substantially comparable
in the aggregate to those provided to Continuing Employees immediately prior
to the Effective Time, (iii) retirement and welfare benefits (excluding any
severance benefits, post-employment health benefits, post-employment welfare
benefits and defined benefit pension and nonqualified deferred compensation
plans), that are substantially comparable in the aggregate to (A) those
provided to Continuing Employees immediately prior to the Effective Time or
(B) those provided to employees of Parent or its applicable Subsidiaries, as
determined by Parent in its sole discretion.

  



  

(b)  Parent shall, or shall cause the Surviving Corporation to,
unless prohibited by applicable Law, give, or use commercially reasonable
efforts to cause to be given, to Continuing Employees credit for purposes of
eligibility to participate (other than any defined benefit pension, post-
employment health benefits or post-employment welfare benefits plan), vesting
and, with respect to vacation, paid-time off and other leave benefits only,
determining level and accrual of benefits under employee benefit
plans, programs or policies maintained by Parent or the Surviving Corporation
and in which such employees participate after the Effective Time, for such
employees' service prior to the Closing with the Company or any of its
Subsidiaries, to the same extent recognized by the Company and its
Subsidiaries prior to the Effective Time. Such crediting of service shall not
operate to duplicate any benefit or the funding of any such benefit.

  



  

(c) From and after the Effective Time, with respect to each
benefit plan maintained by Parent or the Surviving Corporation that is
an "employee welfare benefit plan" as defined in Section 3(1) of ERISA (each,
a "Parent Welfare Plan") in which any Continuing Employee is or becomes
eligible to participate, Parent shall use reasonable best efforts to cause
each such Parent Welfare Plan to (i) waive all limitations as to pre-existing
conditions, waiting periods, required physical examinations and exclusions
with respect to participation and coverage requirements applicable under
such Parent Welfare Plan for such Continuing Employees and their eligible
dependents to the same extent that such pre-existing conditions, waiting
periods, required physical examinations and exclusions would not have applied
or would have been waived under the corresponding Company Benefit Plan in
which such Continuing Employee was a participant immediately prior to his
or her commencement of participation in such Parent Welfare Plan but, with
respect to long-term disability and life insurance benefits and coverage,
solely to the extent permitted under the terms and conditions of Parent's
applicable insurance contracts in effect as of the Effective Time; _provided,
however_ , that for purposes of clarity, to the extent such benefit coverage
includes eligibility conditions based on periods of employment, _Section
6.7(b)_ shall control; and (ii) provide each Continuing Employee and their
eligible dependents with credit for any co-payments and deductibles paid
in the calendar year that, and prior to the date that, such Continuing
Employee commences participation in such Parent Welfare Plan in satisfying
any applicable co-payment or deductible requirements under such Parent Welfare
Plan for the applicable calendar year, to the extent that such expenses were
recognized for such purposes under the comparable Company Benefit Plan.

  



  

   

57

 



    



  

(d)  Parent shall cause the Surviving Corporation to honor in
accordance with their terms all deferred compensation plans, agreements and
arrangements, severance and separation pay plans, agreements and arrangements,
and all written employment, severance, retention, incentive, change in
control and termination agreements (including any change in control provisions
therein) applicable to employees of the Acquired Companies and in effect on
the date of this Agreement (as listed in Section 6.7(d) of the
Company Disclosure Schedule, the "Assumed Employee Arrangements"); _provided_
, for the avoidance of doubt, that nothing in this _Section 6.7(d)_ shall be
deemed to prevent Parent or the Surviving Corporation from terminating or
severing any employees from and after the Closing in its sole discretion.
Parent hereby acknowledges that the consummation of the Offer constitutes a
"change of control" or a "change in control" (or a term of similar import) for
purposes of any Company Benefit Plan that contains a definition of "change of
control" or "change in control" (or a term of similar import), as applicable,
including under the Assumed Employee Arrangements. Outstanding cash bonuses
pursuant to the Company's annual bonus plan, the Assumed Employee
Arrangements or any incentive compensation plan for field-based
employees with respect to service during the 2020 calendar year, as in effect
immediately prior to the date hereof and listed in Section 6.7(d) of the
Company Disclosure Schedule (including the amounts payable pursuant to such
annual bonus plan and incentive compensation plan), shall be paid to Company
employees who participate in such plans to the extent provided in Section
6.7(d) of the Company Disclosure Schedule.

  



  

(e)  The Company shall terminate any and all Company Benefit
Plans intended to qualify under Section 401(k) of the Code (the "Company
401(k) Plans"), effective not later than the Business Day immediately
preceding the Acceptance Time. The Company or its applicable Subsidiary shall
provide Parent with evidence that such Company 401(k) Plans have been
terminated pursuant to resolutions of the Company Board (the form and
substance of which shall be subject to review and approval by Parent). The
Company shall take (or cause to be taken) such other actions in furtherance of
terminating such 401(k) Plans as Parent may reasonably require and Parent
shall take all necessary and legally permissible actions to direct its or one
of its Affiliate's defined contribution plan to accept the rollover by any
participant of the Company 401(k) Plan of any "eligible
rollover distribution" (within the meaning of Section 402(c)(4) of the Code)
from or outstanding loans under the Company 401(k) Plans.

  



  

(f) Upon Parent's reasonable request from time to time prior
to Closing, the Company shall, a reasonable period of time following receipt
of such request (but in no event more than five (5) Business Days following
such request), provide Parent with the then-most recent calculations and
reasonable back-up information relating to Sections 280G and 4999 of the
Code relating to the Merger, including any non-compete valuations.

  



  

   

58

 



    



  

(g)  Nothing in this _Section 6.7_ or elsewhere in this
Agreement is intended nor shall be construed to (i) be treated as an
amendment to any particular Company Benefit Plan, (ii) prevent Parent from
amending or terminating any benefit plans in accordance with their terms,
(iii) create a right in any employee to employment with Parent, the Surviving
Corporation or any Acquired Company, or (iv) create any third-party
beneficiary rights in any Person with respect to the compensation, terms and
conditions of employment and/or benefits that may be provided to any
Continuing Employee by Parent, the Surviving Corporation or any Acquired
Company or under any benefit plan which Parent, any Acquired Company or the
Surviving Corporation may maintain.

  



  

Section 6.8.   _Compensation Arrangements_. Prior to the Acceptance
Time, the compensation committee of the Company Board (the "Compensation
Committee") will cause each Company Benefit Plan and Company employment
agreement pursuant to which consideration is payable to any officer, director
or employee who is a holder of any security of the Company to be approved by
the Compensation Committee (comprised solely of "independent directors") in
accordance with the requirements of Rule 14d-10(d)(2) under the Exchange Act
and the instructions thereto as an "employment compensation, severance or
other employee benefit arrangement" within the meaning of Rule 14d-10(d)(2)
under the Exchange Act and satisfy the requirements of the non-exclusive safe
harbor set forth in Rule 14d-10(d) of the Exchange Act.

  



  

Section 6.9.   _Indemnification; Directors ' and Officers'
Insurance_.

  



  

(a) For six (6) years after the Acceptance Time, Parent shall,
or shall cause the Surviving Corporation to, maintain directors' and
officers' liability insurance, fiduciary liability insurance and employment
practices liability insurance in respect of any acts, errors or omissions
occurring on or before the Acceptance Time, including in respect of
the Transactions, covering each such person currently covered by the
Company's directors' and officers' liability insurance, fiduciary liability
insurance and employment liability insurance policies on terms with respect
to coverage and amount no less favorable than those of such policies in
effect on the date hereof; _provided, however_ , that in satisfying its
obligation under this _Section 6.9(a)_ , neither Parent nor the Surviving
Corporation shall be obligated to pay annual premiums in excess of 300% of
the amount the Company paid in its last full fiscal year prior to the date
hereof for such insurance (the "Current Premium") and if such premiums for
such insurance would at any time exceed 300% of the Current Premium, then
Parent shall, and shall cause the Surviving Corporation to, maintain policies
of insurance that, in Parent's and the Surviving Corporation's good faith
judgment, provide the maximum coverage available at an annual premium equal
to 300% of the Current Premium. The provisions of the immediately
preceding sentence shall be deemed to have been satisfied if prepaid "tail"
or "runoff" policies have been obtained by the Company prior to the
Acceptance Time, which policies provide such persons currently covered by such
policies with coverage for an aggregate period of six (6) years with respect
to claims arising from any acts, errors or omissions that occurred on or
before the Acceptance Time, including in respect of the Transactions;
_provided, however_ , that the amount paid for such prepaid policies does not
exceed 300% of the Current Premium. If such prepaid policies have
been obtained prior to the Acceptance Time, the Surviving Corporation shall
(and Parent shall cause the Surviving Corporation to) maintain such policies
in full force and effect for their full term, and continue to honor the
obligations thereunder.

  



  

   

59

 



    



  

(b)  From and after the Acceptance Time, the Surviving
Corporation shall: (i) indemnify and hold harmless each individual who at the
Acceptance Time is, or at any time prior to the Acceptance Time was, a
director or officer of the Company or of a Subsidiary of the Company (each an
"Indemnified Party") for any and all costs and expenses (including fees and
expenses of legal counsel, which shall be advanced as they are incurred;
_provided_ that, if required by applicable Law, the Indemnified Party shall
have made an undertaking to repay such expenses if it is ultimately determined
that such Indemnified Party was not entitled to indemnification under this
_Section 6.9(b)_ , such undertaking to be unsecured, interest-free and made
without reference to the Indemnified Party's ability to repay such advances
or ultimate entitlement to indemnification), judgments, fines, penalties or
liabilities (including amounts paid in settlement or compromise) imposed upon
or reasonably incurred by such Indemnified Party in connection with or
arising out of any demand, action, suit or other Legal Proceeding (whether
civil or criminal) in which such Indemnified Party may be involved or with
which he or she may be threatened (regardless of whether as a named party or
as a participant other than as a named party, including as a witness) (an
"Indemnified Party Proceeding") (A) by reason of such Indemnified Party's
being or having been such director or officer or an employee or agent of the
Company or any Subsidiary of the Company or otherwise in connection with any
action taken or not taken at the request of the Company or any Subsidiary of
the Company or (B) arising out of such Indemnified Party's service in
connection with any other corporation or organization for which he or she
serves or has served as a director, officer, employee, agent, trustee or
fiduciary at the request of the Company (including in any capacity with
respect to any employee benefit plan), in each of (A) or (B), whether or not
the Indemnified Party continues in such position at the time such Indemnified
Party Proceeding is brought or threatened and at, or at any time prior to,
the Acceptance Time (including any Indemnified Party Proceeding relating in
whole or in part to the Transactions or relating to the enforcement of this
provision or any other indemnification or advancement right of any Indemnified
Party), to the fullest extent permitted under applicable Law; and (ii)
fulfill and honor in all respects the obligations of the Company pursuant to:
(x) each indemnification agreement in effect as of the date hereof between the
Company and any Indemnified Party; and (y) any indemnification provision
(including advancement of expenses) and any exculpation provision set forth in
the Company Certificate of Incorporation or Company Bylaws as in effect on
the date hereof. Parent's and the Surviving Corporation's obligations under
the foregoing clauses (i) and (ii) shall continue in full force and effect for
a period of six (6) years from the Acceptance Time; _provided_ , _however_ ,
that all rights to indemnification, exculpation and advancement of expenses in
respect of any claim asserted or made within such period shall continue until
the final disposition of such claim. If Parent or the Surviving Corporation
fails to comply with its obligations in this _Section 6.9(b)_ and an
Indemnified Party commences a suit which results in a determination that
Parent or the Surviving Corporation failed to comply with such obligation,
Parent shall pay such Indemnified Party his or her costs and expenses
(including reasonable fees and expenses of legal counsel) in connection with
such suit, together with interest thereon at the "prime rate" as published in
_The Wall Street Journal_ , Eastern Edition, in effect on the date such
payment was required to be made through the date of payment (calculated daily
on the basis of a year of 365 days and the actual number of days elapsed,
without compounding).

  



  

   

60

 



    



  

(c)   If Parent, the Surviving Corporation or any of its
successors or assigns (i) consolidates with or merges into any other Person
and shall not be the continuing or surviving corporation or Entity of such
consolidation or merger or (ii) transfers or conveys all or substantially all
of its properties and assets to any Person, then, and in each such case proper
provision shall be made so that the successors and assigns of Parent or the
Surviving Corporation, as the case may be, shall assume the obligations set
forth in this _Section 6.9_.

  



  

(d)  The provisions of this _Section 6.9_ are (i) intended to be
for the benefit of, and shall be enforceable by, each Indemnified Party, his
or her heirs and his or her representatives and (ii) in addition to, and not
in substitution for, any other rights to indemnification or contribution that
any such individual may have under any certificate of incorporation or
bylaws, by contract or otherwise. The obligations of Parent and the Surviving
Corporation under this _Section 6.9_ shall not be terminated or modified in
such a manner as to adversely affect the rights of any Indemnified Party
unless (x) such termination or modification is required by applicable Law or
(y) the affected Indemnified Party shall have consented in writing to such
termination or modification (it being expressly agreed that the Indemnified
Parties shall be third-party beneficiaries of this _Section 6.9_ ).
Parent and the Surviving Corporation jointly and severally agree to pay or
advance, upon written request of an Indemnified Party, all costs, fees and
expenses, including attorneys' fees, that may be incurred by the Indemnified
Parties in enforcing their indemnity rights and other rights provided in this
_Section 6.9_.

  



  

Section 6.10.   _Section 16 Matters_. Prior to the Effective Time, the
Company shall, and shall be permitted to, take all such steps as may
reasonably be necessary to cause the Transactions, including any dispositions
of shares of Company Common Stock (including any Company Compensatory Awards)
by each Person who is or will be subject to the reporting requirements of
Section 16(a) of the Exchange Act with respect to the Company, to be exempt
under Rule 16b-3 under the Exchange Act.

  



  

Section 6.11.   _Transaction Litigation_. The Company shall as promptly
as reasonably practicable notify Parent in writing of, and shall give Parent
the opportunity to participate in the defense and settlement of, any
Transaction Litigation. The Company shall keep Parent reasonably apprised of
the proposed strategy and other significant decisions with respect to any
Transaction Litigation (to the extent that the attorney-client privilege is
not undermined or otherwise adversely affected), and Parent may offer
comments or suggestions with respect to such Transaction Litigation which the
Company shall consider in good faith. Without otherwise limiting the
Indemnified Parties' rights with regard to the right to counsel, following the
Effective Time, the Indemnified Parties shall be entitled to continue to
retain Goodwin Procter LLP or such other counsel selected by such
Indemnified Parties to defend any Transaction Litigation.

  



  

Section 6.12.   _Convertible Notes_.

  



  

(a) Parent and/or the Merger Sub will be permitted, at their
option, to commence and conduct, in accordance with the terms of
the Indenture, one or more offers to purchase and (if it so elects) to
conduct a consent solicitation (a "Debt Offer") with respect to the
outstanding Convertible Notes. If the Parent and/or Merger Sub elect to
conduct a Debt Offer, Parent shall provide the Company with drafts of the
necessary offer to purchase, letter of transmittal or other related documents
in connection with the Debt Offer (collectively, the "Debt Offer Documents")
a reasonable period of time in advance of commencing the applicable Debt
Offer to allow the Company and its counsel to review and comment on the
related Debt Offer Documents. Parent will reasonably consult with the Company
regarding the timing and commencement of any Debt Offer and any relevant
tender or consent deadlines. The closing (or, if applicable,
effectiveness) of any Debt Offer shall be expressly conditioned on the
satisfaction of the conditions to the Closing or the acceptance for purchase
of the Convertible Notes by Parent or Merger Sub, and the Company shall
reasonably cooperate with Parent and Merger Sub to cause any such Debt Offer
to close on the Closing Date. For the avoidance of doubt; the consummation of
a Debt Offer shall not be a condition to Closing. If the Parent and/or Merger
Sub elect to conduct a Debt Offer, (i) the Debt Offer shall be conducted in
compliance with the Indenture and applicable Law, including all SEC rules and
regulations, and (ii) the Company shall, and shall cause its Subsidiaries and
their respective Company Representatives to use their reasonable best efforts
to, provide all cooperation reasonably requested by Parent in connection with
any Debt Offer, at the sole expense of Parent.

  



  

   

61

 



    



  

(b)  Subject to the receipt of any requisite consents, the
Company shall execute a supplemental indenture to the Indenture in accordance
with the Indenture, amending the terms and provisions of the Indenture as
described in the Debt Offer Documents as reasonably requested by Parent or
Merger Sub, which supplemental indenture shall become operative no earlier
than the Closing Date or the acceptance for purchase of the Convertible Notes
by Parent or Merger Sub, and shall use commercially reasonable efforts to
cause the Trustee to enter into such supplemental indenture prior to or
substantially simultaneously with the Closing as determined by Parent;
_provided_ , _however_ , that in no event shall the Company or any of its
officers, directors or other Company Representatives have any obligation to
authorize, adopt or execute any amendments or other agreement that is not
permitted under applicable Law or would become operative prior to the Closing
Date or the time of acceptance for purchase of the Convertible Notes by
Parent or Merger Sub. The Company shall use its, and shall cause its Company
Representatives to use their, commercially reasonable efforts to, provide all
cooperation reasonably requested by Parent in connection with the execution of
the supplemental indentures referred to in the immediately preceding
sentence, at the sole expense of Parent. If requested by Parent, the Company
shall use its commercially reasonable efforts to cause its legal counsel to
provide all customary legal opinions required in connection with the
transactions contemplated by this _Section 6.12(b)_ to the extent such legal
opinion is required to be delivered prior to the Closing Date.
Notwithstanding the foregoing, in no event shall the Company or its legal
counsel be required to give an opinion with respect to a Debt Offer that in
the opinion of the Company, its legal counsel or the Trustee does not comply
with applicable Laws or the Indenture, or an opinion with respect to
financing by Parent or Merger Sub.

  



  

(c) Prior to the Effective Time, the Company shall take all
actions required by the Indenture to be performed by the Company as a result
of the execution and delivery of this Agreement and the consummation of the
Transactions, including the giving of any notices that may be required in
connection with the Convertible Notes and the delivery to the Trustee of any
certificates, opinions, documents or instruments required to be delivered to
the Trustee, in each case, in connection with the Transactions or otherwise
required pursuant to the terms of the Indenture as reasonably determined by
Parent. Following the Effective Time, if any Convertible Notes remain
outstanding, Parent shall cause the Surviving Corporation to (at Parent's
sole expense) take all actions required by the Indenture to be performed by
the Company as a result of the execution and delivery of this Agreement and
the consummation of the Merger and the other transactions contemplated by this
Agreement, including the giving of any notices that may be required in
connection with the Convertible Notes, the delivery to the Trustee of
any certificates, opinions, documents or instruments required to be delivered
to the Trustee in connection with such transactions or otherwise required
pursuant to the terms of the Indenture.

  



  

   

62

 



    



  

(d)  Parent agrees to hold harmless and reimburse the Company,
its Subsidiaries and their respective Company Representatives from and for
all costs, expenses and liabilities such Persons may incur for actions taken
at the direction or request of Parent or its representatives in connection
with any Debt Offer, except to the extent incurred as a result of the bad
faith, gross negligence or willful misconduct of, or material breach of this
Agreement by, the Company, its Subsidiaries and their respective Company
Representatives, and such Company Representatives shall be express third
party beneficiaries of this sentence, and Parent's obligation in this
sentence shall survive any termination or expiration of this Agreement.

  



  

Section 6.13.   _Delisting of Company Common Stock_. The Surviving
Corporation shall cause the Company Common Stock to be de-listed from NASDAQ
and de-registered under the Exchange Act as promptly as practicable following
the Effective Time.

  



  

   

63

 



    



  

Section 6.14. _Financing_ (a). Parent, Merger Sub and the Debt Financing
Borrower shall use reasonable best efforts to take, or cause to be taken,
all actions and do, or cause to be done, all things necessary, proper or
advisable to consummate and obtain the Financing on the terms and subject
only to the conditions set forth in the Commitment Letters, including using
reasonable best efforts to (i) maintain in full force and effect the
Commitment Letters, (ii) satisfy on a timely basis and in any event no later
than the Closing Date all conditions applicable to Parent, Merger Sub and the
Debt Financing Borrower under the Debt Commitment Letter, (iii) comply at all
times with its obligations under the Commitment Letters to the extent
constituting a condition to the availability of funds thereunder, (iv)
negotiate and enter into definitive agreements with respect to the Debt
Financing on the terms and subject only to the conditions set forth in the
Debt Commitment Letter (or on other terms that, with respect to
conditionality, are no less favorable to Parent, Merger or the Debt Financing
Borrower than the terms contained in the Debt Commitment Letter), (v) enforce
its rights under the Commitment Letters and (vi) consummate the Debt Financing
at or prior to the Closing Date. Upon the reasonable written request of the
Company (or its counsel), Parent shall promptly (and in any event within two
(2) Business Days following such written request) inform the Company and its
counsel in reasonable detail of the current status of the Debt Financing and
the status of Parent's efforts to obtain the Debt Financing. Without limiting
the foregoing, Parent shall promptly (and in any event within one (1) Business
Day following becoming aware thereof) notify the Company in writing if at any
time prior to the Closing Date Parent becomes aware of (A) any breach
or default (or any event or circumstance that, with or without notice, lapse
of time or both, would or would reasonably be expected to give rise to any
breach or default) by any party to the Debt Commitment Letter of which Parent
becomes aware that would, or would reasonably be expected to, result in Debt
Financing in the amount necessary to fund the Required Amount (after taking
into account the Equity Financing) not being available at Closing, (B) the
receipt, on or prior to the Closing Date, of any written notice or other
written communication from any Debt Financing Source with respect to any
actual breach, default, termination or repudiation by any party to the Debt
Commitment Letter that would, or would reasonably be expected to, result in
Debt Financing in the amount necessary to fund the Required Amount (after
taking into account the Equity Financing) not being available at Closing or
(C) if for any reason Parent believes in good faith that Parent or the
Debt Financing Borrower will not be able to obtain on or prior to the Closing
Date all or any portion of the Debt Financing in the amount necessary to fund
the Required Amount (after taking into account the Equity Financing and any
available cash of Parent, the Company and their respective Subsidiaries).
Upon the reasonable written request of the Company, Parent shall promptly
(and in any event within two (2) Business Days following such written request)
provide any information reasonably requested by the Company relating to any
circumstance referred to in clauses (A), (B) or (C) of the immediately
preceding sentence. Parent, Merger Sub and the Debt Financing Borrower shall
not, without the prior written consent of the Company, agree to or permit any
termination of or amendment, restatement, amendment and restatement,
supplement or modification to be made to the Commitment Letters (other than
to add lenders, lead arrangers, bookrunners, syndication agents or other
similar entities who had not executed the Debt Commitment Letter as of the
date hereof)- if such termination, amendment, restatement, amendment and
restatement, supplement, modification or waiver would (A) reduce the aggregate
amount of the Financing such that the aggregate amount of the Financing would
be below the amount required to pay the Required Amount (after taking
into account available cash of Parent, the Company and their respective
Subsidiaries), (B) impose new or additional conditions precedent to the
availability of the Financing or otherwise expand, amend or modify any of the
conditions precedent to the Financing in a manner that would reasonably be
expected to materially delay or prevent the funding of the Financing
(or satisfaction of the conditions to the Financing) at the Offer Closing and
at the Closing or (C) adversely impact the ability of Parent, Merger Sub and
the Debt Financing Borrower to enforce its rights against other parties to the
Commitment Letters. Parent shall promptly (and in any event within two (2)
Business Days following receipt) deliver to the Company copies of
any amendment, restatement, amendment and restatement, replacement,
supplement or other modification to, or waiver of any provision under, the
Debt Commitment Letter or the Debt Financing Fee Letter. In the event that the
Debt Financing necessary to fund the Required Amount (after taking into
account the Equity Financing and any available cash of Parent, the Company
and their respective Subsidiaries) will not be available to Parent and the
Debt Financing Borrower in accordance with the terms of the Debt Commitment
Letter, Parent shall promptly (and in any event within one (1) Business Day
following the occurrence thereof) notify the Company in writing and, prior to
the termination of this Agreement in accordance with _Article 8_  hereto, use
its reasonable best efforts to take, or cause to be taken, all actions and do,
or cause to be done, all things necessary, proper or advisable to arrange,
obtain and consummate as promptly as practicable following the occurrence of
any such financing failure event, alternative debt financing (the
"Alternative Financing"), including from alternative sources in an amount
sufficient to fund the Required Amount (after taking into account the Equity
Financing and any available cash of Parent, the Company and their respective
Subsidiaries) as promptly as possible following the occurrence of such event,
which Alternate Financing will not include terms and conditions that are less
favorable to Parent or the Debt Financing Borrower than those contained in
the Debt Commitment Letter and Debt Financing Fee Letter (determined after
giving effect to all amendments and other modifications permitted pursuant to
the "market flex" provisions of the Debt Financing Fee Letter as if such
amendments and other modifications had been implemented to the maximum extent
permitted thereunder). It is understood and agreed that (i) if Parent is
required to proceed with any Alternative Financing, Parent shall be subject
to the same obligations with respect to such Alternative Financing as set
forth in this Agreement with respect to the Debt Financing and (ii) such
Alternative Financing shall not, without the prior written consent of
the Company, (A) be less than the aggregate amount of the Debt Financing
necessary to fund the Required Amount (after taking into account the Equity
Financing and any available cash of Parent, the Company and their respective
Subsidiaries) (determined after giving effect to all amendments and other
modifications permitted pursuant to the "market flex" provisions of the Debt
Financing Fee Letter as if such amendments and other modifications had been
implemented to the maximum extent permitted thereunder), (B) impose new or
additional conditions to the consummation of the Debt Financing other than
those expressly set forth in the Debt Commitment Letter delivered on the date
hereof or otherwise expand any of the conditions to the consummation of the
Debt Financing set forth therein or (C) otherwise expand, amend or modify any
provision applicable under the Debt Commitment Letter in a manner that would
not be permitted pursuant to Section 6.14(a). In the event that Alternative
Financing is obtained, Parent shall promptly provide the Company with a copy
of the new financing commitment that provides for such Alternative Financing
(the "Alternative Financing Commitment Letter"). If applicable, any reference
in this Agreement to "Debt Financing" shall include "Alternative Financing",
any reference to "Debt Commitment Letter" shall include the "Alternative
Financing Commitment Letter" and any references to "Debt Financing Documents"
shall include the definitive documentation relating to any such Alternative
Financing.

  



  

   

64

 



    



  

(b)  Notwithstanding anything to the contrary contained in this
Agreement, nothing in this Section 6.14 will require, and in no event will
the reasonable best efforts of Parent, the Debt Financing Borrower or Merger
Sub be deemed or construed to require, Parent, the Debt Financing Borrower or
Merger Sub to (i) seek the Equity Financing from any source other than a
counterparty to, or in any amount in excess of that contemplated by, the
Equity Commitment Letter or (ii) pay any fees materially in excess of what it
was obligated to pay under the original Debt Commitment Letter (determined
after giving effect to all amendments and other modifications permitted
pursuant to the "market flex" provisions of the Debt Financing Fee Letter as
if such amendments and other modifications had been implemented to the
maximum extent permitted thereunder).

  



  

Section 6.15.   _Financing Assistance_ (a).

  



  

(a) During the period from the date hereof through the earlier of the
Closing Date or the date of termination of this Agreement, the Company shall
use reasonable best efforts to provide, and shall cause its Subsidiaries and
use reasonable best efforts to cause their respective Company Representatives
to provide, in each case at Parent's sole expense, such cooperation as may be
reasonably requested in writing (which, for purposes of this Section 6.15 may
be through email) by Parent in connection with the arrangement of the Debt
Financing, including using reasonable best efforts to: (i) furnish pertinent
and customary information regarding the Company and its Subsidiaries as may
be reasonably requested by Parent in connection with the Debt Financing and
customarily required for completion of similar financings; (ii) upon
reasonable notice and at reasonable times and locations, participate in a
reasonable number of conference calls and presentations with
prospective lenders (which may be telephonic meetings) and otherwise
cooperate with the marketing efforts for any of the Debt Financing; (iii)
provide Parent and the Debt Financing Sources with all documentation and other
information with respect to the Company and its Subsidiaries as shall have
been reasonably requested in writing by Parent that is required in connection
with the Debt Financing by U.S. regulatory authorities under applicable
"know-your-customer" and anti-money laundering rules and regulations,
including the Patriot Act, and the requirements of 31 C.F.R. 1010.230; and
(iv) execute and deliver any guarantee, pledge and security documents, other
definitive financing documents, or other certificates or documents as may be
reasonably requested by Parent and otherwise reasonably facilitate the
pledging of collateral and the granting of security interests in respect of
the Debt Financing (including intellectual property), which guarantee,
pledge, security documents, definitive financing documents or other
certificates or documents shall only be effective at Closing. Notwithstanding
anything to the contrary in this Section 6.15(a), nothing will require the
Company to provide (or be deemed to require the Company to prepare) any (1)
pro forma financial statements; (2) information regarding any post-Closing or
pro forma cost savings, synergies, capitalization, ownership or other post-
Closing pro forma adjustments; (3) description of all or any portion of the
Financing, including any "description of notes"; (4) risk factors relating to
all or any component of the Financing; (5) other information required by
Rules 3-10 or 3-16 of Regulation S-X under the Securities Act, any
Compensation Discussion and Analysis or other information required by Item 402
of Regulation S-K under the Securities Act or any other information
customarily excluded from an offering memorandum for private placements of
non-convertible high-yield debt securities under Rule 144A promulgated under
the Securities Act; or (6) any financial or other information not readily
available or prepared in the ordinary course of business of the Company at the
time requested by Parent (the foregoing clauses (1) through (6) is referred
herein as "Excluded Information").

  



  

   

65

 



    



  

(b) Notwithstanding anything in Section 6.15(a) to the
contrary, (i) such requested cooperation shall not unreasonably disrupt or
interfere (in the judgment of the Company) with the business or the
operations of the Company or its Subsidiaries, (ii) nothing in this Section
6.15 shall require cooperation to the extent that it would (A) subject any of
the Company's or its Subsidiaries' respective directors, managers, officers
or employees to any actual or potential personal liability with respect to
matters related to the Debt Financing, (B) conflict with, or violate, the
Company's and/or any of its Subsidiaries' organization documents, material
contractual obligations or any applicable Law, (C) cause any Offer Condition
or condition to the Closing set forth in Article VII to not be satisfied or
(D) cause any breach of this Agreement, (iii) neither the Company nor any of
its Subsidiaries shall be required to pay any commitment or other similar fee
or incur or assume any liability or other obligation in connection with the
financings contemplated by the Commitment Letters or the Financing prior to
the Effective Time or be required to take any action that would subject it to
actual or potential liability, to bear any cost or expense or to make any
other payment or agree to provide any indemnity in connection with
the Commitment Letters, the Financing or any information utilized in
connection therewith, in each case, that would not be reimbursed or
indemnified by Parent or Merger Sub, (iv) none of the Company, its
Subsidiaries or their respective directors, officers or employees shall be
required to execute, deliver or enter into, or perform any agreement,
certificate, document or instrument with respect to the Financing that is not
contingent upon the Closing and the directors and managers of the Company and
its Subsidiaries shall not be required to adopt resolutions approving the
agreements, documents and instruments pursuant to which the Financing is
obtained unless Parent and Merger Sub shall have determined that such
directors and managers are to remain as directors and managers of such Person
on and after the Closing and such resolutions are contingent upon the
occurrence of, or only effective as of, the Closing, (v) disclosure of any
confidential information to the Debt Financing Sources shall be made subject
to the acknowledgment and acceptance by such Debt Financing Source that
such information is being disseminated on a confidential basis in accordance
with the customary market standards for dissemination of such type of
information and (vi) Parent, Merger Sub and the Debt Financing Borrower agree
to use their commercially reasonable efforts to maintain attorney-client
privilege. The Company hereby consents to the use of its and its Subsidiary's
logos in connection with the debt financing contemplated by the Debt
Commitment Letter; provided that such logos are used solely in a manner that
is not intended to, nor reasonably likely to, harm or disparage the Company's
or the Company's Subsidiaries' reputation or goodwill or any of their
respective products, services, offerings or intellectual property rights.

  



  

   

66

 



    



  

(c)  Parent agrees to indemnify, hold harmless and reimburse the
Company, its Subsidiaries and their respective Company Representatives prior
to the Closing or the termination of this Agreement (and thereafter, promptly
upon demand and in each case directly to the applicable Company
Representative) from and for all costs, expenses, fees, losses, damages,
claims, judgments, fines, penalties, interest, awards and liabilities such
Persons may incur in connection with the Debt Financing and the
performance of their respective obligations under this Section 6.15 and the
provision of any information utilized in connection therewith (other than
information provided by the Company or its Subsidiaries) (including reasonable
and documented costs and expenses of counsel and advisors), except to the
extent incurred as a result of the gross negligence or willful misconduct of
the Company, its Subsidiaries and their respective Company Representatives,
and such Subsidiaries and Company Representatives shall be express third party
beneficiaries of this sentence, and Parent's obligation in this sentence
shall survive any termination or expiration of this Agreement.

  



  

Article 7 
 CONDITIONS TO EACH PARTY'S OBLIGATION TO EFFECT THE MERGER

  



  

The obligation of each party to effect the Merger shall be subject to the
satisfaction or waiver of the following conditions prior to the Effective
Time:

  



  

Section 7.1.   _Consummation of the Offer_. Merger Sub (or Parent on
Merger Sub's behalf) shall have accepted for payment the Company Common Stock
validly tendered pursuant to the Offer and not withdrawn.

  



  

Section 7.2.   _No Restraints_. No temporary restraining order,
preliminary or permanent injunction or other Order preventing the
consummation of the Merger shall have been issued by any Governmental Entity
of competent jurisdiction and remain in effect, and there shall not be any
Law enacted or deemed applicable to the Merger that makes consummation of the
Merger illegal.

  



  

   

67

 



    



  

Article 8 
 TERMINATION

  



  

Section 8.1.   _Termination_. This Agreement may be terminated and
the Offer and the Merger may be abandoned:

   



  

(a)   by mutual written consent of the Company and Parent at any
time prior to the Acceptance Time;

  



  

(b)  by Parent or the Company upon prior written notice to the
other, if the Acceptance Time has not occurred by 11:59 p.m., Eastern Time,
on January 28, 2021 (the "End Date"); _provided_ that the right to terminate
this Agreement pursuant to this _Section 8.1(b)_ shall not be available to
any party (or any Affiliate of such party) whose breach of
any representation, warranty, covenant or agreement set forth in this
Agreement has been the proximate cause of, or resulted in, the failure of the
Acceptance Time to have occurred on or before the End Date;

  



  

(c)  by Parent or the Company upon prior written notice to the
other at any time prior to the Acceptance Time if there shall be any Law
(other than an Order, which is addressed below) enacted after the date hereof
and remaining in effect that makes the acceptance for payment of, or the
payment for, Company Common Stock tendered pursuant to the Offer or the Merger
illegal or that prohibits the consummation of the Offer or the Merger, or any
court of competent jurisdiction or other Governmental Entity shall have
issued a final and non-appealable Order or shall have taken any other action,
having the effect of permanently restraining, enjoining or otherwise
prohibiting the acceptance for payment of, or payment for, Company Common
Stock tendered pursuant to the Offer or the Merger or prohibiting the
consummation of the Offer or the Merger, and such Order shall have become
final and non-appealable;  _provided, however,_ that the right to terminate
this Agreement pursuant to this _Section 8.1(c)_ shall not be available to
any party (or any Affiliate of such party) whose breach of any representation,
warranty, covenant or agreement set forth in this Agreement has been the
proximate cause of, or resulted in, the issuance, promulgation, enforcement or
entry of any such Order;

  



  

(d)  by Parent or the Company upon prior written notice to the
other if the Offer (as it may have been extended pursuant to _Section 2.1(e)_
) expires as a result of the non-satisfaction of one or more Offer Conditions,
or is terminated or withdrawn prior to the Acceptance Time (to the extent
permitted under the terms of this Agreement), without Merger Sub having
accepted for payment any Company Common Stock tendered pursuant to the Offer;
_provided, however_ , that a party shall not be permitted to terminate this
Agreement pursuant to this _Section 8.1(d)_ if the non-satisfaction of any
Offer Condition or the termination or withdrawal of the Offer results from
the failure of such party (or any Affiliate of such party) to perform any
covenant required to be performed by such party (or any Affiliate of such
party) at or prior to the Acceptance Time;

  



  

(e)  by Parent upon prior written notice to the Company at any
time prior to the Acceptance Time if the Company Board shall have effected a
Change in Recommendation ( _provided_ that, any written notice, including
pursuant to _Section 2.3(d)_ , of the Company's intention to make a Change in
Recommendation in advance of making a Change in Recommendation shall not
result in Parent having any termination rights pursuant to this _Section
8.1(e)_ unless such written notice otherwise constitutes a Change in
Recommendation); _provided, however_ , that Parent shall not be permitted to
terminate this Agreement pursuant to this _Section 8.1(e)_ unless the notice
of termination pursuant to this _Section 8.1(e)_ is delivered by Parent
to the Company within five (5) Business Days following the occurrence of the
event giving rise to Parent's right to terminate this Agreement pursuant to
this _Section 8.1(e)_ ;

  



  

   

68

 



    



  

(f)   by the Company prior to the Acceptance Time upon prior
written notice to Parent in connection with the Company Board making a Change
in Recommendation in response to a Superior Proposal in order to enter into an
Alternative Acquisition Agreement, if the Company and the Company Board shall
have complied in all material respects with the notice, negotiation and other
requirements set forth in _Section 2.3(d)_ with respect to such Superior
Proposal;

  



  

(g)  by Parent upon prior written notice to the Company at any
time prior to the Acceptance Time, if a breach of any representation or
warranty in _Article 4_ or failure to perform any covenant or obligation
contained in this Agreement on the part of the Company shall have occurred
that would cause a failure of any of the conditions set forth in clauses
"2(c)," "2(d)" and "2(e)" of _Annex I_ to exist; _provided, however_ ,
notwithstanding anything to the contrary, the covenant set forth in Section
6.15 shall be deemed satisfied unless (x) the Debt Financing has not been
obtained primarily as a result of the Company's material breach of its
obligations under Section 6.15, (y) Parent provided to the Company written
notice of such breach within two (2) Business Days of first becoming aware of
such breach and (z) the Company failed to cure such breach within four (4)
Business Days after such notice is received by the Company; provided,
_further_ , _however_ , that, for purposes of this _Section 8.1(g)_ , if such
a breach is curable by the Company within twenty (20) Business Days of
the date Parent gives the Company notice of such breach and the Company is
continuing to use commercially reasonable efforts to cure such breach, then
Parent may not terminate this Agreement under this _Section 8.1(g)_ on account
of such breach unless such breach shall remain uncured upon the expiration of
such twenty (20) Business Day period; _provided further_ , _however_ , that
Parent shall not be entitled to terminate this Agreement pursuant to this
_Section 8.1(g)_ if Parent, Merger Sub or the Debt Financing Borrower is in
breach of its obligations under this Agreement such that the Company would be
entitled to terminate this Agreement pursuant to _Section 8.1(h)_ ;

  



  

(h)  by the Company upon prior written notice to Parent at any
time prior to the Acceptance Time, if a breach in any material respect of any
representation or warranty or failure to perform in any material respect any
covenant or obligation contained in this Agreement on the part of Parent,
Merger Sub or the Debt Financing Borrower shall have occurred, in each case if
such breach or failure prevents or would reasonably be expected to prevent
Parent, Merger Sub or the Debt Financing Borrower from consummating the
Offer, the Merger or any other Transactions; _provided_ , _however_ , that,
for purposes of this _Section 8.1(h)_ , if such a breach is curable by Parent
within twenty (20) Business Days of the date the Company gives Parent written
notice of such breach and Parent is continuing to use its commercially
reasonable efforts to cure such breach, then the Company may not terminate
this Agreement under this _Section 8.1(h)_ on account of such breach unless
such breach shall remain uncured upon the expiration of such twenty (20)
Business Day period; _provided further_ , _however_ , that the Company shall
not be entitled to terminate this Agreement pursuant to this _Section 8.1(h)_
if the Company is in breach of its obligations under this Agreement such that
Parent would be entitled to terminate this Agreement pursuant to _Section
8.1(g)_ ;

  



  

(i) by the Company upon prior written notice to Parent if
Merger Sub fails to commence the Offer in accordance with _Section 2.1_ on or
prior to the tenth (10th) Business Day following the date hereof; _provided_ ,
_however_ , that the right to terminate this Agreement pursuant to this
_Section 8.1(i)_ shall not be available to the Company if the Company is in
breach of any representation, warranty, covenant or agreement set forth in
this Agreement that has been the proximate cause of, or resulted in, Merger
Sub's failure to commence the Offer in accordance with the terms of
this Agreement; or

  



  

   

69

 



    



  

(j)  by the Company, if each of the following conditions is
satisfied: (i) on the Expiration Date (disregarding any extension pursuant to
_Section 2.1(f)_ , but, for the avoidance of doubt, after giving effect to all
other extensions thereof), all of the Offer Conditions have been satisfied or
waived (other than those conditions that by their nature are to be satisfied
at the Acceptance Time, but which conditions would be capable of being
satisfied if the Expiration Date were the date of the Company's delivery of
the Company's Notice), (ii) Merger Sub shall have failed to consummate (as
defined in Section 251(h) of the DGCL) the Offer within two (2) Business Days
following the Expiration Date, (iii) the Company has delivered written notice
(the "Company's Notice") to Parent of the Company's intention to terminate
this Agreement pursuant to this _Section 8.1(j)_  if Merger Sub fails to
consummate (as defined in Section 251(h) of the DGCL) the Offer by one minute
after 11:59 p.m. Eastern Time on the fourth (4th) Business Day following the
date of the Company's delivery of the Company's Notice (or such
shorter period of time as remains prior to one minute after 11:59 p.m.
Eastern Time on the End Date; the shorter of such periods, the
"Failure Notice Period"), (iv) Merger Sub fails to consummate (as defined in
Section 251(h) of the DGCL) the Offer prior to the expiration of the Failure
Notice Period and (v) at all times during the Failure Notice Period, the
Company stood ready, willing and able to consummate the Transactions.

  



  

Section 8.2.   _Effect of Termination_. In the event of the
termination of this Agreement as provided in _Section 8.1_ , this Agreement
shall be of no further force or effect without liability of any party (or any
representative of such party) to each other party hereto; _provided,
however,_ that: (a) this _Section 8.2_ , _Article 1_ and the applicable
definitions elsewhere in this Agreement, the last sentence of _Section
6.4(a)_ , _Section 6.12(d)_ , _Section 6.15(c)_ , _Section 8.3_ and _Article
9_ shall survive the termination of this Agreement and shall remain in full
force and effect; and (b) subject in all respects to the limitations set
forth in this _Section 8.2_ , _Section 8.3_ , _Section 9.12_ and
_Section 9.15_ , the termination of this Agreement shall not relieve any
party from any liabilities or damages (which the parties acknowledge and
agree shall not be limited to reimbursement of expenses or out-of-pocket
costs, and may include to the extent proven the benefit of the bargain lost
by such party or such party's equity holders (taking into consideration all
relevant matters) determined to be damages of such party arising out of its
Willful and Material Breach of any provision of this Agreement or any other
agreement delivered in connection herewith or any fraud, subject only, with
respect to any such liabilities of the Company, to _Section 8.3(b)_ and, with
respect to any such liabilities of Parent and Merger Sub, to _Section 8.3(c)_.

  



  

Section 8.3.   _Expenses; Termination Fees_.

  



  

(a) Except as set forth in this _Section 8.3_ , all fees and
expenses incurred in connection with this Agreement and the Offer, the Merger
and the other Transactions shall be paid by the party incurring such expenses,
whether or not the Offer and Merger are consummated. For the avoidance of
doubt, (i) Parent shall pay all filing fees payable for filings required or
otherwise made pursuant to the HSR Act or any other applicable Antitrust
Laws, and (ii) the Company shall not be required to pay any fees or other
payments to any Governmental Entity in connection with any filings under the
HSR Act or such other filings as may be required under applicable Antitrust
Laws in connection with the Merger or the other Transactions.

  



  

   

70

 



    



  

(b)  If: (i) (A) this Agreement is validly terminated by Parent
or the Company pursuant to _Section 8.1(b)_ or _Section 8.1(d)_ , (B)
following the date hereof and prior to the time of the termination of this
Agreement, an Acquisition Proposal shall have been publicly announced (and
such Acquisition Proposal shall not have been withdrawn prior to the time of
the termination of this Agreement) and (C) the Company consummates an
Acquisition Proposal (with all references to 20% in the definition of
Acquisition Proposal being treated as 50% for purposes of this clause (i))
within nine (9) months after such termination or the Company enters into a
definitive agreement within nine (9) months after such termination to effect
an Acquisition Proposal, which Acquisition Proposal is subsequently
consummated; (ii) this Agreement is terminated by Parent pursuant to _Section
8.1(e)_ ; or (iii) this Agreement is terminated by the Company pursuant to
_Section 8.1(f)_ , then in the case of each of clauses (i) through (iii), the
Company shall pay or cause to be paid to Parent, in cash at the time specified
in the next sentence, a termination fee in the amount of $16.25 million (the
"Termination Fee"). Any Termination Fee shall be paid: (x) in the case
of clause (i) of the preceding sentence of this _Section 8.3(b)_ , within two
(2) Business Days after the consummation of the transactions contemplated by
such Acquisition Proposal, (y) in the case of clause (ii) of the preceding
sentence of this _Section 8.2(b)_ , within two (2) Business Days following
termination of this Agreement and (z) in the case of clause (iii) of the
preceding sentence of this _Section 8.3(b)_ , substantially concurrently with
a termination of this Agreement under _Section 8.1(f)_ (or no later than on
the next Business Day if such termination occurs on a day that is not a
Business Day). Any Termination Fee due under this _Section 8.3(b)_ shall be
paid by wire transfer of immediately available funds to an account designated
in writing by Parent. For the avoidance of doubt, the Termination Fee shall be
payable only once and not in duplication even though the Termination Fee may
be payable under one or more provisions hereof. In the event that
Parent shall receive full payment of the Termination Fee, the receipt of the
Termination Fee shall be deemed to be liquidated damages for any and all
losses or damages suffered or incurred by Parent, Merger Sub, any of their
respective Affiliates or any other Person in connection with this Agreement
(and the termination hereof), the Offer and the Merger (and the abandonment
thereof) or any matter forming the basis for such termination, and none of
Parent, Merger Sub, any of their respective Affiliates or any other
Person shall be entitled to bring or maintain any claim, action or proceeding
against the Company or any of its Affiliates for damages or any equitable
relief arising out of or in connection with this Agreement, any of the
Transactions or any matters forming the basis for such termination.

  



  

(c) If this Agreement is validly terminated by the Company (i)
pursuant to _Section 8.1(h)_ or _Section 8.1(i)_ , and the material breach or
failure to perform by Parent or Merger Sub or the failure to commence the
Offer within the time period specified in Section 2.1(a), as the case may be,
is the primary reason for the failure of the Offer Closing or Closing to
be consummated, or pursuant to _Section 8.1(j)_ , or (ii) if Parent shall
terminate this Agreement pursuant to _Section 8.1(b)_ and at such time the
Company could have terminated this Agreement pursuant to _Section 8.1(h)_ ,
_Section 8.1(i)_ or _Section 8.1(j)_ , then, if the Company so elects, Parent
shall pay or cause to be paid to the Company a termination fee of $30.0
million (the "Parent Termination Fee"). Any Parent Termination Fee shall be
paid, within two (2) Business Days of the date of the Company's termination
of the Agreement, by wire transfer of immediately available funds to an
account designated in writing by the Company. For the avoidance of doubt, the
Parent Termination Fee shall be payable only once and not in duplication even
though the Parent Termination Fee may be payable under one or more provisions
hereof. Notwithstanding anything in this Agreement to the contrary, in the
event that this Agreement is terminated by the Company because of a Debt
Failure, or if the Company elects to receive the Parent Termination Fee under
other circumstances where the Parent Termination Fee is payable pursuant to
this _Section 8.3(c)_ , the Parent Termination Fee (including, without
duplication, the Company's right to enforce the Limited Guarantee with respect
thereto, in accordance with the terms thereof, and receive the Parent
Termination Fee from the Guarantors to the extent payable thereunder), shall
be the sole and exclusive remedy of the Company and its Subsidiaries against
the Parent Related Parties or the Debt Financing Sources Related Parties for
all liabilities, losses, damages, claims, costs, expenses, interest,
awards, judgments and penalties suffered as a result of the failure of the
Transactions to be consummated or for a breach or failure to perform
hereunder or otherwise, and upon payment of such amount, none of the Parent
Related Parties or the Debt Financing Sources Related Parties shall have any
further liability relating to or arising out of this Agreement or the
Transactions, except that Parent and Merger Sub (or their Affiliates) will
remain obligated with respect to, and the Company may be entitled to remedies
with respect to, the Confidentiality Agreement, _Section 6.12(d)_ , _Section
6.15(c)_ , _Section 8.2_ , _Section 8.3(a)_ and _Section 8.3(d)_.
Notwithstanding anything to the contrary in this Agreement or any other
Transaction Document, in any case where the Parent Termination Fee is or would
be payable because of a Debt Failure or where the Company otherwise elects to
receive the Parent Termination Fee, the maximum aggregate liability, whether
in equity or at Law, in Contract, in tort or otherwise, together with any
payment of the Parent Termination Fee and any other payment in connection
with this Agreement or otherwise, of the Parent Related Parties collectively
(including monetary damages for breach, whether willful, intentional,
unintentional or otherwise) (i) under this Agreement or any other Transaction
Document, (ii) in connection with the failure of the Offer, Merger or the
other Transactions to be consummated, or (iii) in respect of any
representation or warranty made or alleged to have been made in connection
with this Agreement or any other Transaction Documents, will not exceed under
any circumstances an amount equal to (x) the Parent Termination Fee , plus (y)
the amounts, if any, due and owing under _Section 6.12(d)_ , _Section
6.15(c)_ and _Section 8.3(d)_ , plus (z) the reimbursement of any other
expenses explicitly required pursuant to this Agreement (collectively, the
"Maximum Liability Amount"), and in no event will the Company, its Affiliates
or any of the Company Representatives seek, directly or indirectly, to
recover against the Parent Related Parties, or compel payment by the Parent
Related Parties of, any damages or other payments whatsoever (including
multiple, consequential, indirect, special, statutory, exemplary or punitive
damages) in excess of the Maximum Liability Amount set forth in this _Section
8.3(c)_. For the avoidance of doubt, nothing in this _Section 8.3(c)_ limits
the Company's right to pursue specific performance as provided in (but
subject to the limitations of) _Section 9.12_.

  



  

   

71

 



    



  

(d) The Company, Parent and Merger Sub acknowledge and agree
that the agreements contained in this _Section 8.3_ are an integral part of
the Transactions, and that, without these agreements, the Company, Parent and
Merger Sub would not enter into this Agreement. In the event that the Company
shall fail to pay the Termination Fee when due, Parent shall be entitled to
receive interest on such unpaid Termination Fee, commencing on the date that
the Termination Fee became due, at a rate equal to the "prime rate" as
published in _The Wall Street Journal_ , Eastern Edition, in effect on the
date such payment was required to be made through the date of payment
(calculated daily on the basis of a year of 365 days and the actual number of
days elapsed, without compounding) and any reasonable and documented out of
pocket costs and expenses (including reasonable attorneys' fees and expenses)
incurred by Parent and its Affiliates in connection with enforcing its
rights under this _Section 8.3(d)_. In the event that Parent shall fail to
pay or cause to be paid the Parent Termination Fee when due, the Company
shall be entitled to receive interest on such unpaid Parent Termination Fee,
commencing on the date that the Parent Termination Fee became due, at a rate
equal to the "prime rate" as published in _The Wall Street Journal_ , Eastern
Edition, in effect on the date such payment was required to be made through
the date of payment (calculated daily on the basis of a year of 365 days and
the actual number of days elapsed, without compounding) and any reasonable
and documented out of pocket costs and expenses (including reasonable
attorneys' fees and expenses) incurred by the Company in connection with
enforcing its rights under this _Section 8.3(d)._

  



  

Article 9 
 MISCELLANEOUS PROVISIONS

  



  

Section 9.1.   _Amendment_. Any provision of this Agreement may be
amended, modified, supplemented or waived prior to the Effective Time if, but
only if, such amendment, modification, supplement or waiver is in writing and
is signed, in the case of an amendment, modification or supplement by each
party to this Agreement (or their respective boards of directors, if required)
or, in the case of a waiver, by each party against whom the waiver is to be
effective (or its board of directors, if required); _provided, however_
, that following the Acceptance Time, this Agreement may not be amended,
modified or supplemented.

  



  

Section 9.2.   _Waiver_ (a). No failure on the part of any party to
exercise any power, right, privilege or remedy under this Agreement, and no
delay on the part of any party in exercising any power, right, privilege or
remedy under this Agreement, shall operate as a waiver of such power, right,
privilege or remedy; and no single or partial exercise of any such power,
right, privilege or remedy shall preclude any other or further exercise
thereof or of any other power, right, privilege or remedy. No party shall be
deemed to have waived any claim arising out of this Agreement, or any power,
right, privilege or remedy under this Agreement, unless the waiver of such
claim, power, right, privilege or remedy is expressly set forth in a written
instrument duly executed and delivered on behalf of such party; and any such
waiver shall not be applicable or have any effect except in the specific
instance in which it is given.

  



  

Section 9.3.   _No Survival of Representations and Warranties_. None
of the representations and warranties of the Company contained in this
Agreement, or contained in any certificate, schedule or document delivered
pursuant to this Agreement or in connection with any of the Transactions,
shall survive the Acceptance Time. This _Section 9.3_ shall not limit any
covenant or agreement of the parties which by its terms contemplates
performance after the Acceptance Time.

  



  

   

72

 



    



  

Section 9.4. _Entire Agreement_. This Agreement, the other
agreements referred to herein and the Confidentiality Agreement constitute
the entire agreement and supersede all prior agreements and understandings,
both written and oral, among or between any of the parties with respect to
the subject matter hereof and thereof. Without limiting the generality of the
foregoing: (a) Parent and Merger Sub acknowledge and agree that the Company
has not made and is not making any representations or warranties whatsoever
regarding the subject matter of this Agreement, express or implied, except as
provided in _Article 4_  (including the Company Disclosure Schedule), that
they are not relying and have not relied on any representations or warranties
whatsoever regarding the subject matter of this Agreement, express or implied,
except as provided in _Article 4_ (including the Company Disclosure
Schedule), and that no employee, agent, advisor or other representative of
the Company has made or is making any representations or warranties
whatsoever regarding the subject matter of this Agreement; (b) without
limiting the foregoing, Parent and Merger Sub acknowledge and agree that
neither the Company nor any of its representatives has made any
representation or warranty, whether express or implied, as to the accuracy or
completeness of any information regarding the Company or its Affiliates
furnished or made available to Parent or Merger Sub and its representatives
except as expressly set forth in this Agreement, and neither the Company nor
any other Person shall be subject to any liability to Parent or Merger Sub or
any other Person resulting from the Company's making available to Parent or
Merger Sub or Parent's or Merger Sub's use of such information, or any
information, documents or material made available to Parent or Merger Sub in
any due diligence materials provided to Parent or Merger Sub, including
in the "data room," management presentations (formal or informal) or in any
other form in connection with the Transactions; (c) without limiting the
foregoing, Parent and Merger Sub acknowledge and agree that the Company has
not made and is not making any representations or warranties whatsoever
regarding any forecasts, projections, estimates or budgets discussed with,
delivered to or made available to Parent, or otherwise regarding the future
revenues, future expenses, future results of operations (or any component
thereof), future cash flows or future financial condition (or any component
thereof) of the Company or the future business and operations of the Company;
and (d) the Company acknowledges and agrees that Parent and Merger Sub have
not made and are not making any representations or warranties whatsoever
regarding the subject matter of this Agreement, express or implied, except as
provided in _Article 5_ , that it is not relying and has not relied on
any representations or warranties whatsoever regarding the subject matter of
this Agreement, express or implied, except as provided in _Article 5_ , and
that no representative of Parent or Merger Sub has made or is making any
representations or warranties whatsoever regarding the subject matter of this
Agreement.

  



  

Section 9.5.   _Applicable Law; Jurisdiction_. This agreement is made
under, and shall be construed and enforced in accordance with, the laws of
the State of Delaware applicable to agreements made and to be performed solely
therein, including its statute of limitations, without giving effect to
principles of conflicts of law. Each of the parties hereto (a) consents to and
submits to the exclusive personal jurisdiction of the Court of Chancery of
the State of Delaware, New Castle County, or, if that court does not have
jurisdiction, a federal court sitting in Wilmington, Delaware (the "Delaware
Courts") in any action or proceeding arising out of or relating to this
Agreement or any of the Transactions, (b) agrees that all claims in respect
of such action or proceeding shall be heard and determined in any such court,
(c) shall not attempt to deny or defeat such personal jurisdiction by motion
or other request for leave from any such court and (d) shall not bring any
action or proceeding arising out of or relating to this Agreement or any of
the Transactions in any other court. Each of the parties hereto waives any
defense of inconvenient forum to the maintenance of any action or proceeding
so brought and waives any bond, surety or other security that might be
required of any other Person with respect thereto.

  



  

   

73

 



    



   



  

Section 9.6.   _Assignability; Parties in Interest_. This Agreement
shall be binding upon, and shall be enforceable by and inure to the benefit
of, the parties hereto and their respective successors and assigns. This
Agreement shall not be assignable by any party without the express written
consent of the other parties hereto, and any attempt to make any such
assignment without such consent shall be null and void _provided_ that Parent
may assign all or any portion of its rights to any of its Debt
Financing Sources pursuant to the terms of the Debt Financing for purposes of
creating a security interest therein or otherwise assigning as collateral
security in respect of the Debt Financing. Except for the provisions of
_Article 2_ (which, from and after the Acceptance Time, shall be for the
benefit of Persons that are holders of Company Common Stock who have tendered
pursuant to the Offer (and not validly withdrawn) Company Common Stock),
_Article 3_ (which, from and after the Effective Time, shall be for the
benefit of Persons who are holders of the Company Common Stock and Company
Compensatory Awards immediately prior to the Effective Time) and _Section
6.9_ (which, from and after the Acceptance Time, shall be for the benefit of
the Indemnified Parties), nothing in this Agreement, express or implied, is
intended to or shall confer upon any Person, other than the parties hereto,
any right, benefit or remedy of any nature; _provided, however,_ that the
Company shall be entitled and have the right to pursue and recover damages in
accordance with the terms of this Agreement in the name of and on behalf of
its stockholders in the event of any breach by Parent or Merger Sub of this
Agreement or in the event of fraud, which right is hereby acknowledged and
agreed to by Parent and Merger Sub.

  



  

Section 9.7.   _Notices_. Any notices or other communications
required or permitted under, or otherwise given in connection with, this
Agreement shall be in writing and shall be deemed to have been duly given (a)
on the date delivered or sent if delivered in person or sent by facsimile
transmission or email ( _provided_ confirmation of facsimile transmission or
email is obtained), (b) on the fifth (5th) Business Day after dispatch by
registered or certified mail or (c) on the next Business Day if transmitted
by nationally recognized overnight courier, in each case as follows:

  



  

if to Parent, Merger Sub or the Surviving Corporation, to:

  



  

Covis Group S.a r.l.

  

2, avenue Charles de Gaulle

  

L-1653 Luxembourg, Grand Duchy of Luxembourg

  

Attention: Michael Porter, CEO

  

Email: [*]

  



  

with a copy (which shall not constitute notice) to:

  



  

Paul, Weiss, Rifkind, Wharton and Garrison LLP

  

1285 Avenue of the Americas

  

New York, NY 10019

  

Attention: David K. Lakhdhir

  

Facsimile: +1 (212) 492-0030

  

Email: dlakhdhir@paulweiss.com

  



  

if to the Company (prior to the Merger), to:

  



  

AMAG Pharmaceuticals, Inc.

  

1100 Winter Street

  

Waltham, MA 02451

  

Attention: Scott Myers

  

Facsimile: +1 (617) 649-1654

  

Email: [*]

  



     

   

75

 



    



  

with a copy (which shall not constitute notice) to:

  



  

Goodwin Procter LLP

  

100 Northern Avenue

  

Boston, MA 02210

  

Attention: Stuart M. Cable

  

Jacqueline Mercier

  

Lillian Kim

  

Facsimile: +1 (617) 649-1409

  

Email: scable@goodwinlaw.com; JMercier@goodwinlaw.com;

  

LKim@goodwinlaw.com

  



  

Section 9.8.   _Severability_. Any term or provision of this
Agreement that is invalid or unenforceable in any situation in any
jurisdiction shall not affect the validity or enforceability of the remaining
terms and provisions hereof or the validity or enforceability of the
offending term or provision in any other situation or in any other
jurisdiction. If the final judgment of a court of competent jurisdiction
declares that any term or provision hereof is invalid or unenforceable, the
parties hereto agree that the court making such determination shall have the
power to limit the term or provision, to delete specific words or phrases or
to replace any invalid or unenforceable term or provision with a term or
provision that is valid and enforceable and that comes closest to expressing
the intention of the invalid or unenforceable term or provision, and this
Agreement shall be enforceable as so modified. In the event such court does
not exercise the power granted to it in the prior sentence, the parties hereto
agree to replace such invalid or unenforceable term or provision with a valid
and enforceable term or provision that will achieve, to the extent possible,
the economic, business and other purposes of such invalid or unenforceable
term.

  



  

Section 9.9.   _Counterparts_. This Agreement may be executed and
delivered (including by facsimile or other form of electronic transmission)
in one or more counterparts, and by the different parties hereto in separate
counterparts, each of which when executed shall be deemed to be an original
but all of which taken together shall constitute one and the same agreement.

  



  

Section 9.10.   _Obligation of Parent_. Parent shall cause Merger Sub to
comply in all respects with each of the representations, warranties,
covenants, obligations, agreements and undertakings made or required to be
performed by Merger Sub in accordance with the terms of this Agreement, the
Offer, the Merger, and the other Transactions. As a material inducement to the
Company's willingness to enter into this Agreement and perform its
obligations hereunder, Parent hereby unconditionally guarantees full
performance and payment by Merger Sub of each of the covenants, obligations
and undertakings required to be performed by Merger Sub under this Agreement
and the Transactions, subject to all terms, conditions and limitations
contained in this Agreement, and hereby represents, acknowledges and agrees
that any such breach of any such representation and warranty or default in the
performance of any such covenant, obligation, agreement or undertaking of
Merger Sub shall also be deemed to be a breach or default of Parent, and
the Company shall have the right, exercisable in its sole discretion, to
pursue any and all available remedies it may have arising out of any such
breach or nonperformance directly against either or both of Parent and Merger
Sub in the first instance. As applicable, references in this _Section 9.10_
to "Merger Sub" shall also include the Surviving Corporation following the
Effective Time.

  



  

Section 9.11.   _Disclosure_. Nothing contained in this Agreement shall
be deemed to limit the ability of the Company or the Company Board to make
any disclosure if the Company Board (or a committee thereof) determines in
good faith (after consultation with counsel) that failure to do so would
create a material risk of either (a) a breach by the Company Board of its
fiduciary duties to the holders of Company Common Stock or (b) a violation of
any Law.

  



  

   

76

 



    



  

Section 9.12.   _Specific Performance_.

  



  

(a)  The parties agree that irreparable damage would occur and
that the parties would not have any adequate remedy at law in the event that
any of the provisions of this Agreement were not performed in accordance with
their specific terms or were otherwise breached, except as expressly provided
in the following sentence. It is accordingly agreed that, subject to
_Section 9.12(b)_ , the parties shall be entitled to an injunction or
injunctions to prevent breaches or threatened breaches of this Agreement and
to enforce specifically the terms and provisions of this Agreement (including
specific performance or other equitable relief to cause Parent to perform any
obligations required of it to enforce its rights under the Equity Commitment
Letter) in the Delaware Courts and, in any action for specific performance,
each party waives the defense of adequacy of a remedy at law and waives
any requirement for the securing or posting of any bond in connection with
such remedy, this being in addition to any other remedy to which they are
entitled at law or in equity (subject to the limitations set forth in this
Agreement). The parties hereto further agree that (i) by seeking the remedies
provided for in this _Section 9.12(a)_ , a party shall not in any respect
waive its right to seek any other form of relief that may be available to a
party under this Agreement (including monetary damages) for breach of any of
the provisions of this Agreement or (except as provided in _Section 8.3(c)_ )
in the event that this Agreement has been terminated or in the event that the
remedies provided for in this _Section 9.12(a)_ are not available or otherwise
are not granted, and (ii) nothing set forth in this _Section 9.12_ shall
require any party hereto to institute any proceeding for (or limit any
party's right to institute any proceeding for) specific performance under this
_Section 9.12_ prior or as a condition to exercising any termination right
under _Article 8_ (and pursuing damages after such termination), nor shall
the commencement of any Legal Proceeding pursuant to this _Section 9.12_ or
anything set forth in this _Section 9.12_  restrict or limit any party's
right to terminate this Agreement in accordance with the terms of _Article 8_
or pursue any other remedies under this Agreement that may be available at
any time.

  



  

(b) Notwithstanding _Section 9.12(a)_ , it is explicitly agreed
that the right of the Company or any Affiliate or stockholder thereof to
enforce or seek an injunction, specific performance or other equitable
remedies in connection with enforcing the Parent's, Merger Sub's obligation
(i) to cause the Equity Financing to be funded (whether under this Agreement
or the Equity Commitment Letter) or (ii) to fund the Offer Price or the
Merger Consideration or (iii) to cause the Acceptance Time to occur and
to effect the Offer Closing and the Closing (but, for the avoidance of doubt,
not the right of the Company to seek an injunction, specific performance or
other equitable remedies for any other reason) will be subject to the
following conditions: (A) all of the Offer Conditions have been satisfied or
waived (other than those Offer Conditions that by their nature are to be
satisfied at the Acceptance Time, but subject to the fulfillment or waiver of
such Offer Conditions at the Acceptance Time), including any deemed
satisfaction or waiver of the Offer Conditions pursuant to _Section 2.1(f)_ ),
(B) the Debt Financing shall have been funded in accordance with the terms of
the Debt Commitment Letter or the Debt Financing Sources shall have
irrevocably confirmed in writing that the Debt Financing will be funded in
accordance with the terms thereof at the Offer Closing and at the Closing if
the Equity Financing is funded at the Offer Closing and at the Closing;
_provided_ , that Parent and Merger Sub shall not be required to draw down
the Equity Financing or consummate the Offer or the Merger, as applicable, if
the Debt Financing is not in fact funded at the Offer Closing or the Closing
(other than as a result of a material breach by any of the Covis Parties of
any of their representations, warranties or covenants set forth in
_Section 5.6_ or _Section 6.14_ ), as applicable, (C) the Company shall have
irrevocably confirmed in writing to Parent that if specific performance is
granted and the Financing is funded, then it would take such actions required
of it by this Agreement to cause the consummation of the Offer and the
Closing to occur and (D) Parent or Merger Sub shall have failed to
consummate the applicable Transactions within two (2) Business Days after
delivery of the Company's irrevocable written confirmation. Notwithstanding
anything in this Agreement to the contrary, for the avoidance of doubt, while
the Company may, subject in all respects to _Section 8.2_ , _Section 8.3(c)_
, _Section 9.12(b)_ and _Section 9.15_  (including, in each case, the
limitations set forth therein and herein), pursue both a grant of specific
performance in accordance with (but subject to the limitations of) this
_Section 9.12_ and the payment of the Parent Termination Fee, if, as and when
available pursuant to _Section 8.3(c)_ , under no circumstances shall the
Company, directly or indirectly, be permitted or entitled to receive (1) both
a grant of specific performance under this _Section 9.12(b)_ that results in
the Closing, on the one hand, and the payment of the Parent Termination Fee
and any amounts as and when due, pursuant to _Section 8.3(d)_ , on the other
hand, or (2) both payment of any monetary damages whatsoever from Parent
or Merger Sub pursuant to an Order or settlement arising in connection with
any Legal Proceeding initiated by the Company for matters related to this
Agreement, on the one hand, and payment of any of the Parent Termination Fee
and any amounts as and when due, pursuant to _Section 8.3(d)_ , on the other
hand.

  



  

   

77

 



    



  

Section 9.13.   _Waiver of Jury Trial_. EACH OF THE PARTIES HERETO HEREBY
IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING
ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY.

  



  

Section 9.14.   _Debt Financing Sources_.

  



  

(a) Notwithstanding anything in this Agreement to the contrary,
the Company on behalf of itself, its Subsidiaries and its Affiliates hereby:
(i) agrees that any action, whether in law or in equity, whether in contract
or in tort or otherwise, involving any Debt Financing Sources Related Party,
arising out of or relating to, this Agreement, the Debt Financing or any of
the agreements entered into in connection with the Debt Financing (including
the Debt Commitment Letter) or any of the transactions contemplated hereby or
thereby or the performance of any services thereunder (a "Debt Financing
Action") shall be subject to the exclusive jurisdiction of any federal or
state court in the Borough of Manhattan, New York, New York, so long as such
forum is and remains available, and any appellate court thereof and hereby
irrevocably submits itself and its property with respect to any such Debt
Financing Action to the exclusive jurisdiction of such court, and such Debt
Financing Action (except to the extent relating to the interpretation of any
provisions in this Agreement (including any provision in any documentation
related to the Debt Financing (including the Debt Commitment Letter) that
expressly specifies that the interpretation of such provisions shall be
governed by and construed in accordance with the law of the State of
Delaware)) shall be governed by the laws of the State of New York (without
giving effect to any conflicts of law principles that would result in the
application of the laws of another jurisdiction), (ii) agrees not to bring or
support, or permit any of its Affiliates to bring or support, any Debt
Financing Action of any kind or description, whether in law or in equity,
whether in contract or in tort or otherwise, against any Debt Financing
Sources Related Party in any way arising out of or relating to, this
Agreement, the Debt Financing (including the Debt Commitment Letter) or any of
the transactions contemplated hereby or thereby or the performance of any
services thereunder in any forum other than any federal or state court in the
Borough of Manhattan, New York, New York, (iii) agrees that service of
process in any Debt Financing Action shall be effective if notice is given in
accordance with the procedures set forth in _Section 9.7_ , (iv) irrevocably
waives, to the fullest extent that it may effectively do so, the defense of
an inconvenient forum to the maintenance of any Debt Financing Action in
any such court with respect to any Debt Financing Action involving any Debt
Financing Sources Related Party, (v) knowingly, intentionally and voluntarily
waives to the fullest extent permitted by applicable Law, trial by jury in any
Debt Financing Action involving any Debt Financing Sources Related Party, as
the case may be, in any way arising out of or relating to, this Agreement,
the Debt Financing (including the Debt Commitment Letter) or any of the
transactions contemplated hereby or thereby or the performance of any
services thereunder and (vi) agrees that the Debt Financing Sources Related
Parties are express third party beneficiaries of, and may enforce, any of the
provisions in this Agreement reflecting the agreements in this _Section 9.14_
, and such provisions and the definitions of "Debt Financing Sources" and
"Debt Financing Sources Related Parties" shall not be amended, modified or
waived in any way that is adverse to the Debt Financing Sources Related
Parties without the prior written consent of the Debt Financing Sources party
to the Debt Commitment Letter.

  



  

   

78

 



    



  

(b)  The Debt Financing Sources Related Parties will not have
any liability to the Company, or its Subsidiaries, or any of their respective
controlled Affiliates relating to or arising out of this Agreement, the Debt
Financing, the Debt Commitment Letter or any of the transactions contemplated
hereby or thereby or the performance of any services thereunder, whether in
law or in equity, whether in contract or in tort or otherwise (other than,
after giving effect to the Closing, the Company in respect of the agreements
contemplated by the Debt Financing and/or the Debt Commitment Letter to which
it is a party). Prior to the Closing, the Company shall not be entitled to
directly enforce any rights under the Debt Commitment Letter, which rights
shall only be permitted to be enforced by Parent (or its applicable
Affiliate).

  



  

Section 9.15. _Non-Recourse_. Each party agrees, on behalf of itself and
its Related Parties, that all Legal Proceedings (whether in Contract or in
tort, in Law or in equity or otherwise, or granted by statute or otherwise,
whether by or through attempted piercing of the corporate, limited
partnership or limited liability company veil or any other theory or doctrine,
including alter ego or otherwise) that may be based upon, in respect of,
arise under, out or by reason of, be connected with, or relate in any manner
to: (a) this Agreement, any of the other Transaction Documents or any of the
transactions contemplated hereunder or thereunder (including the Financing);
(b) the negotiation, execution or performance this Agreement or any of the
other Transaction Documents (including any representation or warranty made in
connection with, or as an inducement to, this Agreement or any of the other
Transaction Documents); (c) any breach or violation of this Agreement or any
of the other Transaction Documents and (d) any failure of any of the
transactions contemplated hereunder or thereunder (including the Financing)
to be consummated, in each case, may be made only against (and are those
solely of) the Persons that are, in the case of this Agreement, expressly
identified as parties to this Agreement, and in the case of the other
Transaction Documents, Persons expressly identified as parties to such
Transaction Documents and in accordance with, and subject to the terms and
conditions of, this Agreement or such Transaction Documents, as applicable.
Notwithstanding anything in this Agreement or any of the other Transaction
Documents to the contrary, each party agrees, on behalf of itself and its
Related Parties, that no recourse under this Agreement or any of the other
Transaction Documents or in connection with any of the transactions
contemplated hereunder (including the Financing) or under any other
Transaction Document will be sought or had against any other Person,
including any Related Party and any Debt Financing Sources Related Party, and
no other Person, including any Related Party and any Debt Financing Sources
Related Party, will have any liabilities (whether in Contract or in tort, in
Law or in equity or otherwise, or granted by statute or otherwise, whether by
or through attempted piercing of the corporate, limited partnership or
limited liability company veil or any other theory or doctrine, including
alter ego or otherwise), for any claims, causes of action or liabilities
arising under, out of, in connection with or related in any manner to the
items in the immediately preceding clauses (a) through (d), it being expressly
agreed and acknowledged that no personal Liability or losses whatsoever will
attach to, be imposed on or otherwise be incurred by any of the
aforementioned, as such, arising under, out of, in connection with or related
in any manner to the items in the immediately preceding clauses (a) through
(d), in each case, except for claims that the Company, Parent or Merger Sub,
as applicable, may assert (subject, with respect to the following clauses
(ii) and (iii), in all respects to the limitations set forth in _Section 8.2_
, _Section 8.3(c)_ , _Section 8.3(d)_ , _Section 9.12_ and this _Section
9.15_ ) (i) against any Person that is party to, and solely pursuant to the
terms and conditions of, the Confidentiality Agreement, (ii) against each
Guarantor (and their legal successors and assigns of their obligations
hereunder) under, and pursuant to the terms and conditions of the
Limited Guarantee, (iii) against each Guarantor for specific performance of
its obligation to fund its committed portions of the Equity Financing in
accordance with, and pursuant to the terms and conditions of, the Equity
Commitment Letter, or (iv) against the Company, Parent, Merger Sub and the
Debt Financing Borrower solely in accordance with, and pursuant to the
terms and conditions of, this Agreement. Notwithstanding anything to the
contrary in this Agreement or any of the other Transaction Documents, no
Parent Related Party or Debt Financing Sources Related Party will be
responsible or liable for any multiple, consequential, indirect, special,
statutory, exemplary or punitive damages that may be alleged as a result of
this Agreement or any of the other Transaction Documents or any of the
transactions contemplated hereunder or thereunder (including the Financing),
or the termination or abandonment of any of the foregoing. This Section 9.15
is subject to, and does not alter the scope or application of, Section 9.12.

  



  

   

79

 



    



  

Section 9.16.   _Construction_.

  



  

(a)  For purposes of this Agreement, whenever the context
requires: the singular number shall include the plural, and vice versa; the
masculine gender shall include the feminine and neuter genders; the feminine
gender shall include the masculine and neuter genders; and the neuter gender
shall include masculine and feminine genders.

  



  

(b)  The parties hereto agree that any rule of construction to
the effect that ambiguities are to be resolved against the drafting party
shall not be applied in the construction or interpretation of this Agreement.

  



  

(c) As used in this Agreement, the words "include" and
"including," and variations thereof, shall not be deemed to be terms of
limitation, but rather shall be deemed to be followed by the words "without
limitation." The word "or" is not exclusive. The words "hereof," "herein,"
"hereby," "herewith" and words of similar import shall unless otherwise
stated, be construed to refer to this Agreement as a whole and not to any
particular provision of this Agreement.

  



  

   

80

 



    



  

(d)  Except as otherwise indicated, all references in this
Agreement to "Sections," "Exhibits," "Annexes" and "Schedules" are intended
to refer to Sections of this Agreement and Exhibits, Annexes and Schedules to
this Agreement.

  



  

(e)  All references in this Agreement to "$" are intended to
refer to U.S. dollars.

  



  

[ _Remainder of page intentionally left blank_ ]

  



  

   

81

 



    



  

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as
of the date first above written.

  



       | Covis Group S.a r.l. 
---|--- 
     | a Luxembourg corporation 
     | 
     | By:  | /s/ Michael Porter 
     | Name: Michael Porter 
     | Title: Class A Manager 
     | 
     | By:  | /s/ Xavier Rouviere 
     | Name: Xavier Rouviere 
     | Title: Class B Manager 
     | 
     | Covis Mergerco Inc. 
     | a Delaware corporation 
     | 
     | By:  | /s/ Michael Porter 
     | Name: Michael Porter 
     | Title: President 
     | 
     | Covis  Finco S. r.l., solely with  respect to Sections 5.1, 5.2,
5.3, 5.4, 5.6, 6.14 and 6.15, a Luxembourg corporation 
     | 
     | By:  | /s/ Michael Porter 
     | Name: Michael Porter 
     | Title: Class A Manager 
     | 
     | By:  | /s/ Xavier Rouviere 
     | Name: Xavier Rouviere 
     | Title: Class B Manager 
     | 
     | AMAG Pharmaceuticals 
     | a Delaware corporation 
     | 
     | By:  | /s/ Scott Myers 
     | Name: Scott D. Myers 
     | Title: President and Chief Executive Officer 
    



  

SIGNATURE PAGE TO AGREEMENT AND PLAN OF MERGER

  



     

   



 



    



  

Annex I 
  
 Conditions of the Offer

  



  

Capitalized terms used in this _Annex I_ and not otherwise defined herein
will have the meanings assigned to them in the Agreement and Plan of Merger
to which it is attached (the " _Agreement_ ").

  



  

(1) Notwithstanding any other terms or provisions of the Offer or the
Agreement, Merger Sub shall not be obligated to irrevocably accept for
payment, or, subject to the rules and regulations of the SEC, including Rule
14e-1(c) under the Exchange Act (relating to Merger Sub's obligation to
purchase or return the tendered Company Common Stock promptly after
termination or withdrawal of the Offer), purchase any Company Common Stock
validly tendered (and not validly withdrawn prior to the Expiration Date)
pursuant to the Offer (and not theretofore accepted for payment or paid for),
unless:

  



  

(i) there shall have been validly tendered and not validly withdrawn prior to
the Expiration Date that number of shares of Company Common Stock that,
considered together with all other shares of Company Common Stock (if any)
beneficially owned by Parent and its Affiliates (excluding any shares of
Company Common Stock tendered pursuant to guaranteed delivery procedures that
have not yet been "received" (as such term is defined in Section 251(h)(6)(f)
of the DGCL)), represent one more than 50% of the sum of (x) the total
number of shares of Company Common Stock outstanding at the time of the
expiration of the Offer, _plus_ (y) the aggregate number of shares of Company
Common Stock then issuable to holders of Company Options from which the
Company has received notices of exercise prior to the expiration of the Offer
(and as to which such shares have not yet been issued to such exercising
holders of Company Options), it being understood that Company Compensatory
Awards cancelled in accordance with _Section 3.7_ shall not be included in
such calculation, _plus_ (z) the aggregate number of shares of Company Common
Stock issuable to holders of Convertible Notes from which the Company has
received valid notices of conversion to shares of Company Common Stock in
accordance with the Convertible Notes prior to the expiration of the Offer
(and as to which shares of Company Common Stock have not yet been issued to
such exercising holders of Convertible Notes) (such condition, the "Minimum
Condition") and

  



  

(ii) the waiting period (and any extension thereof) applicable to the
consummation of the Offer and the Merger under the HSR Act shall have expired
or been terminated.

  



  

(2) In addition and notwithstanding any other provisions of the Offer,
but subject to the terms and conditions set forth in the Agreement, Merger
Sub shall not be required to, and Parent shall not be required to cause Merger
Sub to, irrevocably accept for payment or, subject to any applicable rules
and regulations of the SEC, including Rule 14e-1(c) under the Exchange
Act (relating to Merger Sub's obligation to pay for or return tendered shares
of Company Common Stock promptly after termination or withdrawal of the
Offer), purchase any shares of Company Common Stock validly tendered (and not
validly withdrawn prior to the Expiration Date) pursuant to the Offer (and
not theretofore accepted for payment) if at any time on or after the date of
the commencement of the Offer and prior to the Expiration Date, any of the
following events shall occur and be continuing at the Expiration Date:

  



  

   

Annex I - 1

 



    



  

(a) the Agreement shall have been terminated in accordance with its
terms;

  



  

(b) any Governmental Entity of competent jurisdiction shall have
enacted, issued, promulgated, enforced or entered any Law that is in
effect and restrains, enjoins or otherwise prohibits consummation of the
Offer or the Merger;

  



  

(c) (i) the representations and warranties of the Company set forth in
the Agreement that are qualified by reference to Company Material Adverse
Effect shall not have been true and correct as of the date of the Agreement
and as of the Expiration Date as though made on and as of such date and time
(except to the extent that any such representation and warranty expressly
speaks as of an earlier date, in which case such representation and warranty
shall not have been true and correct as of such earlier date); (ii) the
representations and warranties of the Company set forth in the Agreement that
are not qualified by reference to Company Material Adverse Effect (other than
the representations and warranties set forth in _Section 4.3(a)_
(Capitalization), _Section 4.19_ (Authority; Binding Nature of Agreement),
_Section 4.23_ (Opinion of Financial Advisor) and _Section 4.24_ (Brokers))
shall not have been true and correct as of the date of the Agreement and as
of the Expiration Date as though made on and as of such date and time (except
to the extent that any such representation and warranty expressly speaks as of
an earlier date, in which case such representation and warranty shall not
have been true and correct as of such earlier date); _provided_ , _however_ ,
that the condition set forth in this clause (2)(c)(ii) shall be deemed to
have been satisfied even if any representations and warranties of the
Company are not so true and correct if the failure of such representations
and warranties of the Company to be so true and correct, individually or in
the aggregate, shall not have resulted in a Company Material Adverse Effect
that has not been cured prior to the Expiration Date; (iii) the
representations and warranties set forth in _Section 4.19_ (Authority; Binding
Nature of Agreement), _Section 4.23_ (Opinion of Financial Advisor) and
_Section 4.24_ (Brokers) shall not have been true and correct in all
material respects as of the date of the Agreement and as of the Expiration
Date as though made on and as of such date and time (except to the extent
that any such representation and warranty expressly speaks as of an earlier
date, in which case such representation and warranty shall not have been true
and correct as of such earlier date); or (iv) the representations and
warranties set forth in _Section 4.3(a)_ (Capitalization) shall not have been
true and correct in all respects as of the date of the Agreement and as of
the Expiration Date as though made on and as of such date and time (except to
the extent that any such representation and warranty expressly speaks as of
an earlier date, in which case such representation and warranty shall not have
been true and correct as of such earlier date), except for _de minimis_
inaccuracies;

  



  

(d) the Company shall not have performed or complied in all material
respects with the obligations or covenants required to be performed by it
under the Agreement and such failure to perform or comply shall not have been
cured prior to the Expiration Date;

  



  

(e) the Company shall not have delivered to Parent, dated as of the
Expiration Date, a certificate signed on behalf of the Company by a senior
executive officer of the Company to the effect that the conditions set forth
in the foregoing clauses (2)(c) and (2)(d) have been satisfied as of
immediately prior to the Expiration Date; or

  



     

   

Annex I - 2

 



    



  

(f) since the date of the Agreement, there shall have occurred and be
continuing any event, change, effect, occurrence, circumstance or
development that, individually or in the aggregate, has had or would
reasonably be expected to have, a Company Material Adverse Effect.

  



  

Except for the Minimum Condition and condition "2(a)" above, the foregoing
conditions are for the sole benefit of Parent and Merger Sub and may be
waived by Parent and Merger Sub, in whole or in part at any time and from time
to time, in the sole discretion of Parent and Merger Sub; _provided_ that the
Minimum Condition may be waived by Parent and Merger Sub only with the prior
written consent of the Company, which may be granted or withheld in the
Company's sole discretion; and _provided further_ that any such waiver by
Parent, Merger Sub and/or the Company shall be subject to the terms of this
Agreement and the applicable rules and regulations of the SEC. The failure by
Parent or Merger Sub at any time to exercise any of the foregoing rights shall
not be deemed a waiver of any such right and each such right shall be deemed
an ongoing right which may be asserted at any time and from time to time.

  



  

   

Annex I - 3

    



      '

